<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>Publication Bias Detective: Der Beweis, der nie Licht sah</title>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:ital,wght@0,400;0,600;0,700;1,400;1,600&amp;family=Source+Sans+Pro:wght@300;400;600;700&amp;display=swap" rel="stylesheet"/>
<script src="https://cdn.plot.ly/plotly-2.27.0.min.js"></script>
<script>
if (typeof Plotly === 'undefined') {
  document.addEventListener('DOMContentLoaded', function() {
    document.querySelectorAll('[id*="plot"], [id*="chart"], .plotly-graph-div, .js-plotly-plot').forEach(function(el) {
      el.innerHTML = '<div style="padding:2rem;text-align:center;background:#2a2a4a;border:1px dashed #D4AF37;border-radius:8px;color:#FAF8F5;margin:1rem 0;"><p style="font-size:1.1rem;margin-bottom:0.5rem;">Interactive chart unavailable offline</p><p style="font-size:0.85rem;opacity:0.7;">Connect to the internet to load interactive Plotly.js visualizations</p></div>';
    });
  });
}
</script>
<style>
    :root {
      --navy: #1E2761;
      --deep-navy: #141B3D;
      --gold: #D4AF37;
      --cream: #FAF8F5;
      --red: #dc2626;
      --green: #16a34a;
      --purple: #7c3aed;
      --amber: #f59e0b;
      --teal: #0d9488;
      --detective-blue: #1e3a5f;
      --evidence-red: #991b1b;
    }
    * { margin: 0; padding: 0; box-sizing: border-box; }
    html, body {
      height: 100%;
      font-family: 'Source Sans Pro', sans-serif;
      background: var(--deep-navy);
      color: var(--cream);
    }
    .course-container { display: flex; height: 100vh; overflow: hidden; }

    /* Sidebar */
    .sidebar {
      width: 320px;
      background: linear-gradient(180deg, var(--detective-blue) 0%, var(--deep-navy) 100%);
      border-right: 1px solid rgba(212,175,55,0.2);
      display: flex; flex-direction: column; flex-shrink: 0;
    }
    .sidebar-header {
      padding: 1.5rem;
      border-bottom: 1px solid rgba(212,175,55,0.2);
      background: rgba(0,0,0,0.2);
    }
    .sidebar-header h1 {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.3rem; font-weight: 700; color: var(--gold); margin-bottom: 0.25rem;
    }
    .sidebar-header p { font-size: 0.75rem; color: rgba(255,255,255,0.6); }
    .sidebar-badge {
      display: inline-block; padding: 0.25rem 0.5rem;
      background: linear-gradient(135deg, var(--evidence-red), #b91c1c);
      border-radius: 4px; font-size: 0.65rem; font-weight: 700;
      text-transform: uppercase; letter-spacing: 0.05em; margin-top: 0.5rem;
    }
    .module-list { flex: 1; overflow-y: auto; padding: 1rem 0; }
    .module-item {
      display: flex; align-items: center; gap: 0.75rem;
      padding: 0.65rem 1.25rem; cursor: pointer; transition: all 0.2s;
      border-left: 3px solid transparent;
    }
    .module-item:hover { background: rgba(212,175,55,0.1); }
    .module-item.active { background: rgba(212,175,55,0.15); border-left-color: var(--gold); }
    .module-item.completed .module-number { background: var(--green); color: white; }
    .module-number {
      width: 26px; height: 26px; border-radius: 50%;
      background: rgba(255,255,255,0.1); display: flex;
      align-items: center; justify-content: center;
      font-size: 0.75rem; font-weight: 600; flex-shrink: 0;
    }
    .module-info { flex: 1; min-width: 0; }
    .module-title { font-size: 0.85rem; font-weight: 600; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; }
    .module-subtitle { font-size: 0.7rem; color: rgba(255,255,255,0.5); }
    .sidebar-footer { padding: 1rem; border-top: 1px solid rgba(212,175,55,0.2); }
    .progress-bar-container { margin-top: 0.75rem; }
    .progress-label { font-size: 0.75rem; color: rgba(255,255,255,0.6); margin-bottom: 0.25rem; }
    .progress-bar { height: 6px; background: rgba(255,255,255,0.1); border-radius: 3px; overflow: hidden; }
    .progress-fill { height: 100%; background: linear-gradient(90deg, var(--evidence-red), var(--gold)); border-radius: 3px; transition: width 0.3s; }

    /* Main Content */
    .main-content { flex: 1; display: flex; flex-direction: column; overflow: hidden; }
    .top-bar {
      display: flex; justify-content: space-between; align-items: center;
      padding: 1rem 2rem; background: rgba(0,0,0,0.3);
      border-bottom: 1px solid rgba(212,175,55,0.15);
    }
    .module-indicator { font-size: 0.9rem; color: rgba(255,255,255,0.7); }
    .slide-counter { font-size: 0.8rem; color: var(--gold); margin-left: 1rem; }
    .top-bar-actions { display: flex; gap: 0.75rem; }
    .top-bar-btn {
      padding: 0.5rem 1rem; background: rgba(255,255,255,0.1);
      border: 1px solid rgba(255,255,255,0.2); border-radius: 6px;
      color: var(--cream); font-size: 0.85rem; cursor: pointer; transition: all 0.2s;
    }
    .top-bar-btn:hover { background: rgba(255,255,255,0.15); }
    .top-bar-btn:disabled { opacity: 0.5; cursor: not-allowed; }
    .slide-container { flex: 1; overflow-y: auto; padding: 2rem; }
    .slide { display: none; max-width: 1000px; margin: 0 auto; }
    .slide.active { display: block; }

    /* Storytelling Styles */
    .rhetoric-question {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.8rem; font-style: italic; color: var(--gold);
      text-align: center; padding: 3rem 2rem; line-height: 1.5;
      border-left: 4px solid var(--evidence-red);
      background: linear-gradient(135deg, rgba(153,27,27,0.1), transparent);
      margin: 1rem 0;
    }
    .case-file {
      background: linear-gradient(135deg, rgba(30,58,95,0.4), rgba(15,15,26,0.6));
      border: 1px solid rgba(212,175,55,0.3);
      border-radius: 12px; padding: 2rem; margin: 1.5rem 0;
    }
    .case-file-header {
      display: flex; align-items: center; gap: 1rem; margin-bottom: 1.5rem;
      padding-bottom: 1rem; border-bottom: 1px solid rgba(212,175,55,0.2);
    }
    .case-number {
      background: var(--evidence-red); color: white;
      padding: 0.5rem 1rem; border-radius: 4px;
      font-weight: 700; font-size: 0.8rem; text-transform: uppercase;
    }
    .case-title { font-size: 1.3rem; font-weight: 700; color: var(--gold); }
    .case-source { font-size: 0.8rem; color: rgba(255,255,255,0.5); margin-top: 0.25rem; }
    .evidence-timeline { margin: 1.5rem 0; }
    .timeline-event {
      display: flex; gap: 1rem; padding: 1rem 0;
      border-left: 2px solid rgba(212,175,55,0.3); margin-left: 1rem; padding-left: 1.5rem;
      position: relative;
    }
    .timeline-event::before {
      content: ''; position: absolute; left: -6px; top: 1.2rem;
      width: 10px; height: 10px; border-radius: 50%;
      background: var(--gold); border: 2px solid var(--deep-navy);
    }
    .timeline-event.buried::before { background: var(--evidence-red); }
    .timeline-event.revealed::before { background: var(--green); }
    .timeline-year {
      font-weight: 700; color: var(--gold); min-width: 80px;
      font-family: 'Cormorant Garamond', serif; font-size: 1.1rem;
    }
    .timeline-text { color: rgba(255,255,255,0.85); line-height: 1.6; }

    .evidence-box {
      background: rgba(153,27,27,0.15); border: 1px solid rgba(153,27,27,0.4);
      border-radius: 8px; padding: 1.5rem; margin: 1rem 0;
    }
    .evidence-box.found {
      background: rgba(22,163,74,0.15); border-color: rgba(22,163,74,0.4);
    }
    .evidence-header {
      display: flex; align-items: center; gap: 0.75rem;
      font-weight: 700; margin-bottom: 1rem; font-size: 1.1rem;
    }
    .evidence-icon { font-size: 1.5rem; }

    .statistic-card {
      background: linear-gradient(135deg, rgba(124,58,237,0.2), rgba(124,58,237,0.05));
      border: 1px solid rgba(124,58,237,0.3);
      border-radius: 12px; padding: 1.5rem; text-align: center; margin: 1rem 0;
    }
    .statistic-value {
      font-size: 3rem; font-weight: 700; color: var(--gold);
      font-family: 'Cormorant Garamond', serif;
    }
    .statistic-label { font-size: 0.9rem; color: rgba(255,255,255,0.7); margin-top: 0.5rem; }
    .statistic-context { font-size: 0.8rem; color: var(--evidence-red); margin-top: 0.5rem; font-weight: 600; }

    /* Tool Panel */
    .tool-panel {
      background: linear-gradient(135deg, rgba(13,148,136,0.1), rgba(13,148,136,0.02));
      border: 1px solid rgba(13,148,136,0.3);
      border-radius: 12px; padding: 1.5rem; margin: 1.5rem 0;
    }
    .tool-header {
      display: flex; align-items: center; gap: 0.75rem;
      margin-bottom: 1rem; padding-bottom: 0.75rem;
      border-bottom: 1px solid rgba(13,148,136,0.2);
    }
    .tool-icon { font-size: 1.5rem; }
    .tool-title { font-size: 1.1rem; font-weight: 700; color: var(--teal); }
    .tool-description { font-size: 0.85rem; color: rgba(255,255,255,0.6); margin-bottom: 1rem; }
    .tool-controls {
      display: flex; flex-wrap: wrap; gap: 1rem; margin-bottom: 1rem;
      padding: 1rem; background: rgba(0,0,0,0.2); border-radius: 8px;
    }
    .tool-control { display: flex; flex-direction: column; gap: 0.25rem; }
    .tool-control label { font-size: 0.8rem; color: rgba(255,255,255,0.6); }
    .tool-control input, .tool-control select {
      padding: 0.5rem; border-radius: 4px; border: 1px solid rgba(255,255,255,0.2);
      background: rgba(255,255,255,0.1); color: var(--cream); font-size: 0.9rem;
    }
    .plot-area {
      background: rgba(0,0,0,0.3); border-radius: 8px;
      min-height: 400px; margin: 1rem 0;
    }

    /* Decision Tree */
    .decision-tree {
      background: linear-gradient(135deg, rgba(245,158,11,0.1), rgba(245,158,11,0.02));
      border: 1px solid rgba(245,158,11,0.3);
      border-radius: 12px; padding: 1.5rem; margin: 1.5rem 0;
    }
    .decision-title {
      font-size: 1.2rem; font-weight: 700; color: var(--amber); margin-bottom: 0.5rem;
    }
    .decision-situation {
      font-size: 0.95rem; color: rgba(255,255,255,0.8);
      padding: 1rem; background: rgba(0,0,0,0.2); border-radius: 8px;
      margin-bottom: 1.5rem; line-height: 1.6;
    }
    .decision-node { margin: 1rem 0; }
    .decision-question {
      font-weight: 600; color: var(--cream); margin-bottom: 1rem;
      padding: 1rem; background: rgba(245,158,11,0.1); border-radius: 8px;
    }
    .decision-branches { display: flex; flex-direction: column; gap: 0.5rem; }
    .decision-branch {
      width: 100%; text-align: left; font-family: inherit; font-size: inherit;
      color: var(--cream); padding: 1rem; background: rgba(255,255,255,0.05);
      border: 1px solid rgba(255,255,255,0.1); border-radius: 8px;
      cursor: pointer; transition: all 0.2s;
    }
    .decision-branch:hover {
      background: rgba(255,255,255,0.1); border-color: var(--gold);
    }
    .decision-branch:focus {
      outline: 3px solid var(--gold); outline-offset: 2px;
    }
    .decision-outcome {
      padding: 1.5rem; border-radius: 8px; margin-top: 1rem;
    }
    .decision-outcome.good {
      background: rgba(22,163,74,0.15); border: 1px solid rgba(22,163,74,0.4);
    }
    .decision-outcome.bad {
      background: rgba(220,38,38,0.15); border: 1px solid rgba(220,38,38,0.4);
    }
    .decision-outcome.neutral {
      background: rgba(245,158,11,0.15); border: 1px solid rgba(245,158,11,0.4);
    }
    .outcome-title { font-weight: 700; font-size: 1.1rem; margin-bottom: 0.75rem; }
    .outcome-text { line-height: 1.6; margin-bottom: 0.75rem; }
    .outcome-case { font-size: 0.85rem; color: rgba(255,255,255,0.6); font-style: italic; }

    /* Method Box */
    .method-box {
      background: rgba(255,255,255,0.03); border: 1px solid rgba(255,255,255,0.1);
      border-radius: 8px; padding: 1.5rem; margin: 1rem 0;
    }
    .method-box h3 { color: var(--gold); margin-bottom: 0.75rem; }
    .method-box ul { padding-left: 1.5rem; }
    .method-box li { margin: 0.5rem 0; line-height: 1.5; }

    /* Quiz */
    .quiz-container { margin: 1.5rem 0; }
    .quiz-question {
      font-size: 1.1rem; font-weight: 600; margin-bottom: 1.5rem;
      padding: 1rem; background: rgba(124,58,237,0.1); border-radius: 8px;
    }
    .quiz-options { display: flex; flex-direction: column; gap: 0.75rem; }
    .quiz-option {
      padding: 1rem; background: rgba(255,255,255,0.05);
      border: 1px solid rgba(255,255,255,0.1); border-radius: 8px;
      cursor: pointer; transition: all 0.2s;
    }
    .quiz-option:hover { background: rgba(255,255,255,0.1); }
    .quiz-option.correct { background: rgba(22,163,74,0.2); border-color: var(--green); }
    .quiz-option.incorrect { background: rgba(220,38,38,0.2); border-color: var(--red); }
    .quiz-explanation {
      margin-top: 1rem; padding: 1rem; background: rgba(124,58,237,0.1);
      border-radius: 8px; display: none;
    }
    .quiz-explanation.visible { display: block; }

    /* Slide Title */
    .slide-title {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 2rem; color: var(--gold); margin-bottom: 1.5rem;
      border-bottom: 2px solid rgba(212,175,55,0.3); padding-bottom: 0.75rem;
    }

    /* Principle Display */
    .principle-display {
      text-align: center; padding: 3rem;
      background: linear-gradient(135deg, rgba(212,175,55,0.1), transparent);
      border-radius: 12px; margin: 1rem 0;
    }
    .principle-number {
      font-size: 4rem; font-weight: 700; color: var(--gold); opacity: 0.3;
      font-family: 'Cormorant Garamond', serif;
    }
    .principle-text {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.8rem; font-style: italic; color: var(--cream);
      max-width: 700px; margin: 0 auto; line-height: 1.5;
    }

    /* Cycle Return */
    .cycle-return {
      background: linear-gradient(135deg, rgba(212,175,55,0.1), transparent);
      border-left: 4px solid var(--gold);
      padding: 1.5rem; margin: 1.5rem 0; border-radius: 0 8px 8px 0;
    }
    .cycle-return .principle-recall {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.2rem; font-style: italic; color: var(--gold);
    }

    /* Clinical Guide */
    .clinical-guide {
      background: rgba(13,148,136,0.1); border: 1px solid rgba(13,148,136,0.3);
      border-radius: 12px; padding: 1.5rem; margin: 1.5rem 0;
    }
    .clinical-guide h3 { color: var(--teal); margin-bottom: 1rem; }
    .clinical-guide ul { padding-left: 1.5rem; }
    .clinical-guide li { margin: 0.75rem 0; line-height: 1.5; }

    /* Glossary Overlay */
    .glossary-overlay {
      position: fixed; top: 0; left: 0; right: 0; bottom: 0;
      background: rgba(0,0,0,0.9); z-index: 1000;
      display: none; justify-content: center; align-items: center;
    }
    .glossary-overlay.open { display: flex; }
    .glossary-panel {
      background: var(--navy); border: 1px solid rgba(212,175,55,0.3);
      border-radius: 12px; width: 90%; max-width: 600px; max-height: 80vh;
      overflow: hidden; display: flex; flex-direction: column;
    }
    .glossary-header {
      padding: 1rem 1.5rem; border-bottom: 1px solid rgba(212,175,55,0.2);
      display: flex; justify-content: space-between; align-items: center;
    }
    .glossary-close {
      background: none; border: none; color: var(--cream);
      font-size: 1.5rem; cursor: pointer;
    }
    .glossary-search {
      padding: 0.75rem 1rem; margin: 1rem;
      background: rgba(255,255,255,0.1); border: 1px solid rgba(255,255,255,0.2);
      border-radius: 8px; color: var(--cream); font-size: 1rem; width: calc(100% - 2rem);
    }
    .glossary-content { flex: 1; overflow-y: auto; padding: 1rem; }
    .glossary-term { padding: 1rem; border-bottom: 1px solid rgba(255,255,255,0.1); }

    /* Contrast Box - Two-path comparison style */
    .contrast-box {
      display: grid;
      grid-template-columns: 1fr 1fr;
      gap: 0;
      margin: 1.5rem 0;
      border-radius: 12px;
      overflow: hidden;
    }
    .contrast-side {
      padding: 1.5rem;
    }
    .contrast-side.dark {
      background: linear-gradient(135deg, rgba(153,27,27,0.3), rgba(153,27,27,0.1));
      border: 1px solid rgba(153,27,27,0.4);
    }
    .contrast-side.light {
      background: linear-gradient(135deg, rgba(22,163,74,0.3), rgba(22,163,74,0.1));
      border: 1px solid rgba(22,163,74,0.4);
    }
    .contrast-header {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.3rem;
      font-weight: 700;
      margin-bottom: 1rem;
      padding-bottom: 0.75rem;
      border-bottom: 1px solid rgba(255,255,255,0.2);
    }
    .contrast-side.dark .contrast-header { color: #fca5a5; }
    .contrast-side.light .contrast-header { color: #86efac; }
    .contrast-items { list-style: none; padding: 0; }
    .contrast-items li {
      padding: 0.5rem 0;
      padding-left: 1.5rem;
      position: relative;
      line-height: 1.5;
    }
    .contrast-side.dark .contrast-items li::before {
      content: '✗';
      position: absolute;
      left: 0;
      color: #ef4444;
    }
    .contrast-side.light .contrast-items li::before {
      content: '✓';
      position: absolute;
      left: 0;
      color: #22c55e;
    }
    .contrast-consequence {
      margin-top: 1rem;
      padding: 1rem;
      background: rgba(0,0,0,0.3);
      border-radius: 8px;
      font-style: italic;
    }

    /* Oath/Emphatic Statement */
    .oath-box {
      background: linear-gradient(135deg, rgba(212,175,55,0.15), rgba(212,175,55,0.05));
      border: 2px solid var(--gold);
      border-radius: 12px;
      padding: 2rem;
      margin: 1.5rem 0;
      text-align: center;
    }
    .oath-header {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.1rem;
      color: var(--gold);
      text-transform: uppercase;
      letter-spacing: 0.15em;
      margin-bottom: 1rem;
    }
    .oath-text {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.4rem;
      line-height: 1.8;
      color: var(--cream);
    }
    .oath-text strong {
      color: var(--gold);
    }

    /* Death Toll Counter */
    .death-toll {
      background: linear-gradient(135deg, rgba(153,27,27,0.4), rgba(0,0,0,0.3));
      border: 1px solid rgba(153,27,27,0.6);
      border-radius: 12px;
      padding: 1.5rem;
      text-align: center;
      margin: 1rem 0;
    }
    .death-toll-number {
      font-size: 3.5rem;
      font-weight: 700;
      color: #ef4444;
      font-family: 'Cormorant Garamond', serif;
    }
    .death-toll-label {
      font-size: 1rem;
      color: rgba(255,255,255,0.8);
      margin-top: 0.5rem;
    }
    .death-toll-source {
      font-size: 0.75rem;
      color: rgba(255,255,255,0.5);
      margin-top: 0.5rem;
      font-style: italic;
    }

    /* Learning Objectives Box */
    .learning-objectives {
      background: linear-gradient(135deg, rgba(59,130,246,0.15), rgba(59,130,246,0.05));
      border: 1px solid rgba(59,130,246,0.4);
      border-left: 4px solid #3b82f6;
      border-radius: 0 12px 12px 0;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }
    .learning-objectives-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      font-weight: 700;
      color: #60a5fa;
      margin-bottom: 1rem;
      font-size: 1.1rem;
    }
    .learning-objectives ul {
      padding-left: 1.5rem;
      margin: 0;
    }
    .learning-objectives li {
      margin: 0.5rem 0;
      line-height: 1.5;
      color: rgba(255,255,255,0.9);
    }

    /* Key Takeaways Box */
    .key-takeaways {
      background: linear-gradient(135deg, rgba(34,197,94,0.15), rgba(34,197,94,0.05));
      border: 1px solid rgba(34,197,94,0.4);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }
    .key-takeaways-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      font-weight: 700;
      color: #4ade80;
      margin-bottom: 1rem;
      font-size: 1.1rem;
    }
    .key-takeaways ul {
      padding-left: 1.5rem;
      margin: 0;
    }
    .key-takeaways li {
      margin: 0.5rem 0;
      line-height: 1.5;
    }

    /* Common Mistakes Warning */
    .common-mistakes {
      background: linear-gradient(135deg, rgba(239,68,68,0.15), rgba(239,68,68,0.05));
      border: 1px solid rgba(239,68,68,0.4);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }
    .common-mistakes-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      font-weight: 700;
      color: #f87171;
      margin-bottom: 1rem;
      font-size: 1.1rem;
    }
    .common-mistakes ul {
      padding-left: 1.5rem;
      margin: 0;
    }
    .common-mistakes li {
      margin: 0.5rem 0;
      line-height: 1.5;
    }

    /* Patient Communication Box */
    .patient-communication {
      background: linear-gradient(135deg, rgba(168,85,247,0.15), rgba(168,85,247,0.05));
      border: 1px solid rgba(168,85,247,0.4);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }
    .patient-communication-header {
      font-weight: 700;
      color: #c084fc;
      margin-bottom: 1rem;
      font-size: 1.1rem;
    }
    .dialogue-box {
      background: rgba(0,0,0,0.3);
      border-radius: 8px;
      padding: 1rem;
      margin: 0.75rem 0;
    }
    .dialogue-speaker {
      font-weight: 600;
      color: var(--gold);
      margin-bottom: 0.25rem;
    }
    .dialogue-text {
      font-style: italic;
      line-height: 1.6;
      color: rgba(255,255,255,0.85);
    }

    /* Protagonist Story Box */
    .protagonist-story {
      background: linear-gradient(135deg, rgba(212,175,55,0.1), transparent);
      border: 1px solid rgba(212,175,55,0.3);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }
    .protagonist-name {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.5rem;
      font-weight: 700;
      color: var(--gold);
      margin-bottom: 0.5rem;
    }
    .protagonist-title {
      font-size: 0.9rem;
      color: rgba(255,255,255,0.6);
      margin-bottom: 1rem;
    }
    .protagonist-quote {
      font-style: italic;
      border-left: 3px solid var(--gold);
      padding-left: 1rem;
      margin: 1rem 0;
      color: rgba(255,255,255,0.9);
    }

    /* Legal Disclaimer */
    .legal-disclaimer {
      background: rgba(245,158,11,0.1);
      border: 1px solid rgba(245,158,11,0.3);
      border-radius: 8px;
      padding: 1rem;
      margin: 1rem 0;
      font-size: 0.85rem;
      color: rgba(255,255,255,0.7);
    }
    .legal-disclaimer strong {
      color: var(--amber);
    }

    /* Printable Checklist */
    .printable-checklist {
      background: rgba(255,255,255,0.05);
      border: 2px dashed rgba(255,255,255,0.2);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }
    .printable-checklist-header {
      text-align: center;
      font-weight: 700;
      color: var(--gold);
      margin-bottom: 1rem;
      font-size: 1.1rem;
    }
    .checklist-item {
      display: flex;
      align-items: flex-start;
      gap: 0.75rem;
      padding: 0.5rem 0;
      border-bottom: 1px solid rgba(255,255,255,0.1);
    }
    .checklist-box {
      width: 18px;
      height: 18px;
      border: 2px solid rgba(255,255,255,0.4);
      border-radius: 3px;
      flex-shrink: 0;
      margin-top: 2px;
    }

    /* Additional Patient Communication Styles */
    .communication-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      font-weight: 700;
      color: #c084fc;
      margin-bottom: 1rem;
      font-size: 1.1rem;
    }
    .scenario {
      background: rgba(0,0,0,0.2);
      border-radius: 8px;
      padding: 1rem;
      margin-bottom: 1rem;
      font-style: italic;
    }
    .script-box {
      background: rgba(168,85,247,0.2);
      border-radius: 8px;
      padding: 1rem;
      margin: 1rem 0;
    }
    .script-label {
      font-weight: 600;
      color: #c084fc;
      margin-bottom: 0.5rem;
    }
    .script-text {
      font-size: 1.05rem;
      line-height: 1.7;
      color: rgba(255,255,255,0.95);
    }
    .key-points {
      margin-top: 1rem;
      padding-top: 1rem;
      border-top: 1px solid rgba(168,85,247,0.3);
    }
    .key-points ul {
      padding-left: 1.5rem;
      margin: 0.5rem 0 0 0;
    }

    /* Additional Protagonist Story Styles */
    .protagonist-header {
      margin-bottom: 1rem;
    }
    .protagonist-role {
      font-size: 0.9rem;
      color: rgba(255,255,255,0.6);
    }
    .protagonist-narrative {
      line-height: 1.7;
      margin-bottom: 1rem;
    }
    .protagonist-impact {
      margin-top: 1rem;
      padding-top: 1rem;
      border-top: 1px solid rgba(212,175,55,0.3);
      color: rgba(255,255,255,0.9);
    }

    /* Additional Legal Disclaimer Styles */
    .disclaimer-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      font-weight: 700;
      color: #fbbf24;
      margin-bottom: 0.75rem;
    }
    .disclaimer-text {
      line-height: 1.6;
    }
    .disclaimer-resources {
      margin-top: 1rem;
      padding-top: 0.75rem;
      border-top: 1px solid rgba(245,158,11,0.3);
    }
    .disclaimer-resources ul {
      padding-left: 1.5rem;
      margin: 0.5rem 0 0 0;
    }
    .disclaimer-resources a {
      color: #fbbf24;
    }

    /* Additional Printable Checklist Styles */
    .checklist-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      font-weight: 700;
      color: var(--gold);
      margin-bottom: 0.5rem;
      font-size: 1.2rem;
    }
    .print-instruction {
      color: rgba(255,255,255,0.6);
      font-size: 0.9rem;
      margin-bottom: 1rem;
    }
    .checklist-section {
      margin: 1rem 0;
    }
    .checklist-section h4 {
      color: #60a5fa;
      margin-bottom: 0.5rem;
      font-size: 0.95rem;
    }
    .checklist-section ul {
      list-style: none;
      padding: 0;
      margin: 0;
    }
    .checklist-section li {
      display: flex;
      align-items: flex-start;
      gap: 0.75rem;
      padding: 0.4rem 0;
    }
    .print-btn {
      display: block;
      width: 100%;
      margin-top: 1.5rem;
      padding: 0.75rem;
      background: var(--gold);
      color: #1a1a2e;
      border: none;
      border-radius: 8px;
      font-weight: 600;
      cursor: pointer;
      font-size: 1rem;
    }
    .print-btn:hover {
      background: #e6c847;
    }

    /* Key Takeaways Action Item */
    .action-item {
      margin-top: 1rem;
      padding: 1rem;
      background: rgba(34,197,94,0.2);
      border-radius: 8px;
      border-left: 4px solid #4ade80;
    }

    /* Common Mistakes Header */
    .mistakes-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      font-weight: 700;
      color: #f87171;
      margin-bottom: 1rem;
      font-size: 1.1rem;
    }

    /* Practice Case Styles */
    .practice-case {
      background: linear-gradient(135deg, rgba(6,182,212,0.15), rgba(6,182,212,0.05));
      border: 1px solid rgba(6,182,212,0.4);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }
    .practice-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      font-weight: 700;
      color: #22d3ee;
      margin-bottom: 1rem;
      font-size: 1.1rem;
    }
    .case-scenario {
      background: rgba(0,0,0,0.2);
      border-radius: 8px;
      padding: 1rem;
      margin-bottom: 1rem;
      line-height: 1.6;
    }
    .sample-data {
      margin: 1rem 0;
    }
    .sample-data h4 {
      color: #22d3ee;
      margin-bottom: 0.5rem;
    }
    .data-table {
      width: 100%;
      border-collapse: collapse;
      font-size: 0.9rem;
    }
    .data-table th, .data-table td {
      padding: 0.5rem;
      border: 1px solid rgba(6,182,212,0.3);
      text-align: center;
    }
    .data-table th {
      background: rgba(6,182,212,0.2);
      color: #22d3ee;
      font-weight: 600;
    }
    .practice-questions {
      margin-top: 1rem;
    }
    .practice-questions h4 {
      color: #22d3ee;
      margin-bottom: 0.5rem;
    }
    .practice-questions ol {
      padding-left: 1.5rem;
    }
    .practice-questions li {
      margin: 0.5rem 0;
      line-height: 1.5;
    }
    .answers-reveal {
      margin-top: 1rem;
      background: rgba(0,0,0,0.2);
      border-radius: 8px;
      padding: 1rem;
    }
    .answers-reveal summary {
      cursor: pointer;
      color: #22d3ee;
      font-weight: 600;
    }
    .answers-reveal ol {
      padding-left: 1.5rem;
      margin-top: 0.75rem;
    }

    /* Pre-Assessment Styles */
    .pre-assessment {
      background: linear-gradient(135deg, rgba(249,115,22,0.15), rgba(249,115,22,0.05));
      border: 1px solid rgba(249,115,22,0.4);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }
    .assessment-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      font-weight: 700;
      color: #fb923c;
      margin-bottom: 1rem;
      font-size: 1.1rem;
    }

    /* Redemption Story Styles */
    .redemption-story {
      background: linear-gradient(135deg, rgba(52,211,153,0.15), rgba(52,211,153,0.05));
      border: 1px solid rgba(52,211,153,0.4);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }
    .redemption-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      font-weight: 700;
      color: #34d399;
      margin-bottom: 1rem;
      font-size: 1.1rem;
    }
    .redemption-narrative {
      line-height: 1.7;
      margin-bottom: 1rem;
    }
    .redemption-lesson {
      background: rgba(52,211,153,0.2);
      border-radius: 8px;
      padding: 1rem;
      border-left: 4px solid #34d399;
    }

    /* Real-World Story Styles */
    .story-container {
      background: linear-gradient(135deg, rgba(30,58,95,0.5), rgba(15,15,26,0.7));
      border: 1px solid rgba(212,175,55,0.4);
      border-radius: 16px;
      padding: 2rem;
      margin: 1.5rem 0;
      position: relative;
    }
    .story-container::before {
      content: '';
      position: absolute;
      top: 0;
      left: 0;
      right: 0;
      height: 4px;
      background: linear-gradient(90deg, var(--evidence-red), var(--gold));
      border-radius: 16px 16px 0 0;
    }
    .story-opening {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.6rem;
      font-style: italic;
      color: var(--gold);
      text-align: center;
      padding: 2rem 1.5rem;
      line-height: 1.6;
      border-left: 4px solid var(--evidence-red);
      background: linear-gradient(135deg, rgba(153,27,27,0.15), transparent);
      margin: -2rem -2rem 1.5rem -2rem;
      border-radius: 16px 16px 0 0;
    }
    .stats-box {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
      gap: 1rem;
      background: rgba(124,58,237,0.15);
      border: 1px solid rgba(124,58,237,0.4);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }
    .stats-box-header {
      grid-column: 1 / -1;
      font-weight: 700;
      color: #a78bfa;
      font-size: 1.1rem;
      padding-bottom: 0.75rem;
      border-bottom: 1px solid rgba(124,58,237,0.3);
      margin-bottom: 0.5rem;
      display: flex;
      align-items: center;
      gap: 0.5rem;
    }
    .stat-item {
      text-align: center;
      padding: 1rem;
      background: rgba(0,0,0,0.2);
      border-radius: 8px;
    }
    .stat-value {
      font-size: 1.8rem;
      font-weight: 700;
      color: var(--gold);
      font-family: 'Cormorant Garamond', serif;
    }
    .stat-label {
      font-size: 0.85rem;
      color: rgba(255,255,255,0.7);
      margin-top: 0.25rem;
    }
    .interactive-decision-tree {
      background: linear-gradient(135deg, rgba(245,158,11,0.12), rgba(245,158,11,0.03));
      border: 1px solid rgba(245,158,11,0.4);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }
    .decision-scenario {
      background: rgba(0,0,0,0.3);
      border-radius: 8px;
      padding: 1.25rem;
      margin-bottom: 1.5rem;
      border-left: 4px solid var(--amber);
    }
    .decision-scenario-title {
      font-weight: 700;
      color: var(--amber);
      margin-bottom: 0.5rem;
      font-size: 1.1rem;
    }
    .decision-path {
      margin: 1rem 0;
      padding: 1.25rem;
      border-radius: 8px;
      cursor: pointer;
      transition: all 0.3s ease;
      border: 2px solid transparent;
    }
    .decision-path.path-a {
      background: linear-gradient(135deg, rgba(220,38,38,0.15), rgba(220,38,38,0.05));
      border-color: rgba(220,38,38,0.4);
    }
    .decision-path.path-a:hover {
      background: linear-gradient(135deg, rgba(220,38,38,0.25), rgba(220,38,38,0.1));
      border-color: rgba(220,38,38,0.6);
      transform: translateX(5px);
    }
    .decision-path.path-b {
      background: linear-gradient(135deg, rgba(34,197,94,0.15), rgba(34,197,94,0.05));
      border-color: rgba(34,197,94,0.4);
    }
    .decision-path.path-b:hover {
      background: linear-gradient(135deg, rgba(34,197,94,0.25), rgba(34,197,94,0.1));
      border-color: rgba(34,197,94,0.6);
      transform: translateX(5px);
    }
    .decision-path:focus {
      outline: 3px solid var(--gold);
      outline-offset: 2px;
    }
    .path-header {
      font-weight: 700;
      font-size: 1.05rem;
      margin-bottom: 0.75rem;
      display: flex;
      align-items: center;
      gap: 0.75rem;
    }
    .path-a .path-header { color: #fca5a5; }
    .path-b .path-header { color: #86efac; }
    .path-arrow {
      display: inline-block;
      margin-left: 0.5rem;
      transition: transform 0.2s;
    }
    .decision-path:hover .path-arrow {
      transform: translateX(5px);
    }
    .path-consequence {
      padding-top: 0.75rem;
      border-top: 1px dashed rgba(255,255,255,0.2);
      margin-top: 0.75rem;
      font-size: 0.95rem;
      line-height: 1.6;
    }
    .revelation-box {
      background: linear-gradient(135deg, rgba(212,175,55,0.2), rgba(212,175,55,0.08));
      border: 2px solid var(--gold);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
      text-align: center;
    }
    .revelation-header {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1rem;
      text-transform: uppercase;
      letter-spacing: 0.2em;
      color: var(--gold);
      margin-bottom: 1rem;
    }
    .revelation-text {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.3rem;
      line-height: 1.7;
      color: var(--gold);
      font-style: italic;
    }
    .revelation-detail {
      margin-top: 1rem;
      font-size: 0.95rem;
      color: rgba(255,255,255,0.8);
      font-family: 'Source Sans Pro', sans-serif;
      font-style: normal;
    }
    .story-refrain {
      text-align: center;
      padding: 1.5rem;
      margin: 1.5rem 0;
      background: linear-gradient(90deg, transparent, rgba(212,175,55,0.1), transparent);
      border-top: 1px solid rgba(212,175,55,0.3);
      border-bottom: 1px solid rgba(212,175,55,0.3);
    }
    .story-refrain p {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.4rem;
      font-style: italic;
      color: var(--gold);
      margin: 0;
    }
    .story-timeline {
      position: relative;
      padding-left: 2rem;
      margin: 1.5rem 0;
    }
    .story-timeline::before {
      content: '';
      position: absolute;
      left: 8px;
      top: 0;
      bottom: 0;
      width: 2px;
      background: linear-gradient(180deg, var(--gold), var(--evidence-red), var(--green));
    }
    .timeline-step {
      position: relative;
      padding: 1rem 0 1rem 1.5rem;
    }
    .timeline-step::before {
      content: '';
      position: absolute;
      left: -1.5rem;
      top: 1.25rem;
      width: 12px;
      height: 12px;
      border-radius: 50%;
      background: var(--gold);
      border: 2px solid var(--deep-navy);
    }
    .timeline-step.danger::before { background: var(--evidence-red); }
    .timeline-step.success::before { background: var(--green); }
    .step-label {
      font-weight: 700;
      color: var(--gold);
      font-size: 0.9rem;
      text-transform: uppercase;
      letter-spacing: 0.05em;
      margin-bottom: 0.25rem;
    }
    .step-content {
      line-height: 1.6;
      color: rgba(255,255,255,0.9);
    }

    /* Print styles */
    @media print {
      .course-nav, .progress-bar, .nav-buttons {
        display: none !important;
      }
      .printable-checklist {
        border: 2px solid #333;
        page-break-inside: avoid;
      }
      .checklist-box {
        border: 2px solid #333;
      }
    }

    /* Mobile Responsiveness */
    @media (max-width: 900px) {
      .course-container {
        flex-direction: column;
      }
      .sidebar {
        width: 100%;
        height: auto;
        max-height: 200px;
        border-right: none;
        border-bottom: 1px solid rgba(212,175,55,0.2);
      }
      .module-list {
        display: flex;
        flex-wrap: nowrap;
        overflow-x: auto;
        padding: 0.5rem;
        gap: 0.5rem;
      }
      .module-item {
        flex-shrink: 0;
        padding: 0.5rem 0.75rem;
        border-left: none;
        border-bottom: 3px solid transparent;
      }
      .module-item.active {
        border-left: none;
        border-bottom-color: var(--gold);
      }
      .sidebar-footer {
        padding: 0.5rem 1rem;
      }
      .main-content {
        height: calc(100vh - 200px);
      }
      .slide-container {
        padding: 1rem;
      }
      .rhetoric-question {
        font-size: 1.4rem;
        padding: 1.5rem 1rem;
      }
      .principle-text {
        font-size: 1.4rem;
      }
      .tool-controls {
        flex-direction: column;
      }
      .contrast-box {
        flex-direction: column;
      }
    }

    @media (max-width: 600px) {
      .sidebar {
        max-height: 150px;
      }
      .module-info {
        display: none;
      }
      .module-number {
        width: 32px;
        height: 32px;
        font-size: 0.9rem;
      }
      .slide-title {
        font-size: 1.5rem;
      }
      .case-file-header {
        flex-direction: column;
        align-items: flex-start;
      }
      .decision-branches {
        gap: 0.5rem;
      }
      .decision-branch {
        padding: 0.75rem;
      }
      .data-table {
        font-size: 0.75rem;
      }
      .data-table th, .data-table td {
        padding: 0.25rem;
      }
    }

    /* Floating Glossary Button */
    .floating-glossary {
      position: fixed;
      bottom: 20px;
      right: 20px;
      width: 56px;
      height: 56px;
      border-radius: 50%;
      background: var(--gold);
      color: var(--deep-navy);
      border: none;
      cursor: pointer;
      font-size: 1.5rem;
      box-shadow: 0 4px 12px rgba(0,0,0,0.3);
      z-index: 1000;
      display: flex;
      align-items: center;
      justify-content: center;
      transition: transform 0.2s, box-shadow 0.2s;
    }
    .floating-glossary:hover {
      transform: scale(1.1);
      box-shadow: 0 6px 16px rgba(0,0,0,0.4);
    }
    @media (min-width: 901px) {
      .floating-glossary {
        display: none;
      }
    }

    /* Reading Level Indicator */
    .reading-level {
      display: inline-block;
      padding: 0.25rem 0.75rem;
      background: rgba(124,58,237,0.2);
      border: 1px solid rgba(124,58,237,0.4);
      border-radius: 20px;
      font-size: 0.75rem;
      color: #a78bfa;
      margin-top: 0.5rem;
    }

    /* Module Time Estimate */
    .module-time {
      font-size: 0.65rem;
      color: rgba(255,255,255,0.4);
      margin-top: 0.15rem;
    }

    /* Chart Accessibility Description */
    .chart-description {
      position: absolute;
      left: -9999px;
      width: 1px;
      height: 1px;
      overflow: hidden;
    }
    .chart-description-visible {
      position: static;
      width: auto;
      height: auto;
      background: rgba(0,0,0,0.3);
      padding: 0.75rem;
      margin-top: 0.5rem;
      border-radius: 8px;
      font-size: 0.85rem;
      color: rgba(255,255,255,0.7);
    }

    /* Animation */
    .animate-in {
      animation: fadeSlideIn 0.4s ease-out;
    }
    @keyframes fadeSlideIn {
      from { opacity: 0; transform: translateY(20px); }
      to { opacity: 1; transform: translateY(0); }
    }

    /* ============================================
       ACCESSIBILITY FEATURES
       ============================================ */

    /* Skip to Content Link */
    .skip-link {
      position: absolute;
      top: -100px;
      left: 50%;
      transform: translateX(-50%);
      background: var(--gold);
      color: var(--deep-navy);
      padding: 0.75rem 1.5rem;
      border-radius: 0 0 8px 8px;
      font-weight: 600;
      text-decoration: none;
      z-index: 10000;
      transition: top 0.3s ease;
    }
    .skip-link:focus {
      top: 0;
      outline: 3px solid var(--evidence-red);
      outline-offset: 2px;
    }

    /* Visible Focus States */
    *:focus {
      outline: 2px solid var(--gold);
      outline-offset: 2px;
    }
    *:focus:not(:focus-visible) {
      outline: none;
    }
    *:focus-visible {
      outline: 3px solid var(--gold);
      outline-offset: 2px;
    }
    button:focus-visible,
    .top-bar-btn:focus-visible,
    .module-item:focus-visible {
      outline: 3px solid var(--gold);
      outline-offset: 2px;
      box-shadow: 0 0 0 4px rgba(212, 175, 55, 0.3);
    }
    input:focus-visible,
    textarea:focus-visible,
    select:focus-visible {
      outline: 3px solid var(--gold);
      outline-offset: 0;
      border-color: var(--gold);
    }
    a:focus-visible {
      outline: 3px solid var(--gold);
      outline-offset: 2px;
      text-decoration: underline;
    }

    /* ============================================
       DARK/LIGHT MODE TOGGLE
       ============================================ */

    /* Light Mode Variables */
    .light-mode {
      --navy: #e8e8f0;
      --deep-navy: #f5f5fa;
      --gold: #b8860b;
      --cream: #1a1a2e;
      --detective-blue: #d0dbe8;
      --evidence-red: #dc2626;
    }
    .light-mode .course-container {
      background: #f5f5fa;
    }
    .light-mode .sidebar {
      background: linear-gradient(180deg, #e8eef5 0%, #f5f5fa 100%);
      border-right-color: rgba(184, 134, 11, 0.3);
    }
    .light-mode .sidebar-header {
      background: rgba(0, 0, 0, 0.05);
    }
    .light-mode .main-content {
      background: #ffffff;
    }
    .light-mode .top-bar {
      background: rgba(0, 0, 0, 0.05);
      border-bottom-color: rgba(184, 134, 11, 0.2);
    }
    .light-mode .slide-container {
      background: #ffffff;
    }
    .light-mode .case-file {
      background: linear-gradient(135deg, rgba(208, 219, 232, 0.6), rgba(245, 245, 250, 0.8));
      border-color: rgba(184, 134, 11, 0.4);
    }
    .light-mode .evidence-box {
      background: rgba(220, 38, 38, 0.1);
      border-color: rgba(220, 38, 38, 0.3);
    }
    .light-mode .evidence-box.found {
      background: rgba(22, 163, 74, 0.1);
      border-color: rgba(22, 163, 74, 0.3);
    }
    .light-mode .top-bar-btn {
      background: rgba(0, 0, 0, 0.08);
      border-color: rgba(0, 0, 0, 0.15);
      color: #1a1a2e;
    }
    .light-mode .top-bar-btn:hover {
      background: rgba(0, 0, 0, 0.12);
    }
    .light-mode .glossary-overlay .glossary-panel {
      background: #ffffff;
      border-color: rgba(184, 134, 11, 0.3);
    }
    .light-mode .glossary-search {
      background: #f5f5fa;
      border-color: rgba(0, 0, 0, 0.2);
      color: #1a1a2e;
    }

    /* Theme Toggle Button */
    .theme-toggle {
      position: fixed;
      top: 20px;
      right: 20px;
      width: 44px;
      height: 44px;
      border-radius: 50%;
      background: var(--detective-blue);
      border: 2px solid var(--gold);
      color: var(--gold);
      font-size: 1.2rem;
      cursor: pointer;
      z-index: 1000;
      display: flex;
      align-items: center;
      justify-content: center;
      transition: all 0.3s ease;
      box-shadow: 0 2px 10px rgba(0, 0, 0, 0.3);
    }
    .theme-toggle:hover {
      transform: scale(1.1);
      box-shadow: 0 4px 15px rgba(0, 0, 0, 0.4);
    }
    .light-mode .theme-toggle {
      background: #ffffff;
    }

    /* ============================================
       CERTIFICATE OF COMPLETION
       ============================================ */

    .certificate-overlay {
      position: fixed;
      inset: 0;
      background: rgba(0, 0, 0, 0.9);
      z-index: 10000;
      display: none;
      align-items: center;
      justify-content: center;
      padding: 2rem;
    }
    .certificate-overlay.open {
      display: flex;
    }
    .certificate-container {
      background: linear-gradient(135deg, #fdf6e3 0%, #fff8dc 50%, #fdf6e3 100%);
      border: 8px double var(--gold);
      border-radius: 12px;
      padding: 3rem;
      max-width: 700px;
      width: 100%;
      text-align: center;
      position: relative;
      box-shadow: 0 20px 60px rgba(0, 0, 0, 0.5);
    }
    .certificate-seal {
      position: absolute;
      top: -30px;
      left: 50%;
      transform: translateX(-50%);
      width: 60px;
      height: 60px;
      background: linear-gradient(135deg, var(--gold), #c5a028);
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 1.8rem;
      box-shadow: 0 4px 15px rgba(212, 175, 55, 0.5);
    }
    .certificate-title {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 2.5rem;
      font-weight: 700;
      color: var(--detective-blue);
      margin-top: 1rem;
      text-transform: uppercase;
      letter-spacing: 0.15em;
    }
    .certificate-subtitle {
      font-size: 1rem;
      color: #666;
      margin-bottom: 1.5rem;
    }
    .certificate-body {
      font-size: 1.1rem;
      color: #333;
      line-height: 1.8;
      margin: 1.5rem 0;
    }
    .certificate-name {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 2rem;
      font-weight: 700;
      color: var(--evidence-red);
      border-bottom: 2px solid var(--gold);
      display: inline-block;
      padding: 0 2rem 0.5rem;
      margin: 1rem 0;
    }
    .certificate-date {
      font-size: 0.9rem;
      color: #666;
      margin-top: 1.5rem;
    }
    .certificate-id {
      font-size: 0.75rem;
      color: #999;
      margin-top: 0.5rem;
      font-family: monospace;
    }
    .certificate-actions {
      display: flex;
      gap: 1rem;
      justify-content: center;
      margin-top: 2rem;
    }
    .certificate-btn {
      padding: 0.75rem 1.5rem;
      border-radius: 8px;
      font-weight: 600;
      cursor: pointer;
      transition: all 0.2s;
    }
    .certificate-btn.primary {
      background: var(--gold);
      color: var(--deep-navy);
      border: none;
    }
    .certificate-btn.secondary {
      background: transparent;
      color: #666;
      border: 2px solid #ccc;
    }
    .certificate-btn:hover {
      transform: translateY(-2px);
      box-shadow: 0 4px 12px rgba(0, 0, 0, 0.2);
    }
    .certificate-close {
      position: absolute;
      top: 1rem;
      right: 1rem;
      width: 32px;
      height: 32px;
      border-radius: 50%;
      border: none;
      background: #eee;
      color: #666;
      font-size: 1.2rem;
      cursor: pointer;
    }

    /* Certificate Name Input Modal */
    .name-input-modal {
      position: fixed;
      inset: 0;
      background: rgba(0, 0, 0, 0.8);
      z-index: 10001;
      display: none;
      align-items: center;
      justify-content: center;
    }
    .name-input-modal.open {
      display: flex;
    }
    .name-input-box {
      background: var(--deep-navy);
      border: 2px solid var(--gold);
      border-radius: 12px;
      padding: 2rem;
      max-width: 400px;
      width: 90%;
      text-align: center;
    }
    .name-input-box h3 {
      color: var(--gold);
      margin-bottom: 1rem;
    }
    .name-input-box input {
      width: 100%;
      padding: 0.75rem;
      font-size: 1.1rem;
      border: 2px solid rgba(212, 175, 55, 0.3);
      border-radius: 8px;
      background: rgba(255, 255, 255, 0.1);
      color: var(--cream);
      margin-bottom: 1rem;
    }
    .name-input-box button {
      padding: 0.75rem 2rem;
      background: var(--gold);
      color: var(--deep-navy);
      border: none;
      border-radius: 8px;
      font-weight: 600;
      cursor: pointer;
    }

    /* Reduced Motion */
    @media (prefers-reduced-motion: reduce) {
      *, *::before, *::after {
        animation-duration: 0.01ms !important;
        animation-iteration-count: 1 !important;
        transition-duration: 0.01ms !important;
      }
    }
    .mobile-menu-toggle{display:none;position:fixed;top:12px;left:12px;z-index:1001;background:#1E2761;border:1px solid #D4AF37;color:#D4AF37;width:40px;height:40px;border-radius:8px;font-size:1.2rem;cursor:pointer;align-items:center;justify-content:center;}
    @media(max-width:768px){.mobile-menu-toggle{display:flex;}.sidebar{transform:translateX(-100%);transition:transform 0.3s ease;position:fixed;z-index:1000;height:100vh;}.sidebar.open{transform:translateX(0);}.sidebar-overlay{display:none;position:fixed;inset:0;background:rgba(0,0,0,0.5);z-index:999;}.sidebar-overlay.show{display:block;}}
  </style>
</head>
<body>
<!-- Skip to Content Link (Accessibility) -->
<a class="skip-link" href="#main-content" id="skipLink">Skip to main content</a>
<button aria-expanded="false" aria-label="Toggle navigation menu" class="mobile-menu-toggle" onclick="toggleSidebar()">☰</button>
<div class="sidebar-overlay" onclick="document.querySelector('.sidebar').classList.remove('open');this.classList.remove('show');"></div>
<div class="course-container">
<!-- Sidebar -->
<nav aria-label="Kursnavigation" class="sidebar">
<div class="sidebar-header">
<a href="index.html" onmouseout="this.style.color='rgba(212,175,55,0.7)'" onmouseover="this.style.color='#D4AF37'" style="display:block;font-size:0.7rem;color:rgba(212,175,55,0.7);text-decoration:none;margin-bottom:0.5rem;">← Course Library</a>
<h1>Publication Bias Detective</h1>
<p>Der Beweis, der nie Licht sah</p>
<span class="sidebar-badge">Investigation Unit</span>
</div>
<div class="module-list" id="moduleList"></div>
<div class="sidebar-footer">
<button class="top-bar-btn" onclick="openGlossary()" style="width:100%;margin-bottom:0.5rem;">
          Investigator's Glossary
        </button>
<div class="progress-bar-container">
<div class="progress-label">Case Progress: <span id="progressPercent">0%</span></div>
<div class="progress-bar"><div class="progress-fill" id="progressFill" style="width:0%"></div></div>
</div>
</div>
</nav>
<!-- Main Content -->
<div class="main-content">
<div class="top-bar">
<div>
<span class="module-indicator" id="moduleIndicator">Case File 0</span>
<span class="slide-counter" id="slideCounter">1 / 1</span>
</div>
<div class="top-bar-actions">
<button class="top-bar-btn" id="prevBtn" onclick="prevSlide()">Previous</button>
<button class="top-bar-btn" id="nextBtn" onclick="nextSlide()">Next</button>
</div>
</div>
<div class="slide-container" id="main-content"></div>
</div>
</div>
<!-- Glossary Overlay -->
<div class="glossary-overlay" id="glossaryOverlay">
<div class="glossary-panel">
<div class="glossary-header">
<h3 style="color:var(--gold)">Investigator's Glossary</h3>
<button class="glossary-close" onclick="closeGlossary()">×</button>
</div>
<input class="glossary-search" id="glossarySearch" oninput="filterGlossary()" placeholder="Search terms..." type="text"/>
<div class="glossary-content" id="glossaryContent"></div>
</div>
</div>
<!-- Theme Toggle Button -->
<button aria-label="Toggle dark/light mode" class="theme-toggle" id="themeToggle" onclick="toggleTheme()" title="Toggle dark/light mode">
    🌙
  </button>
<!-- Certificate Overlay -->
<div aria-labelledby="certTitle" class="certificate-overlay" id="certificateOverlay" role="dialog">
<div class="certificate-container" id="certificateContainer">
<button aria-label="Zertifikat schließen" class="certificate-close" onclick="closeCertificate()">×</button>
<div class="certificate-seal">🏆</div>
<h1 class="certificate-title" id="certTitle">Certificate of Completion</h1>
<p class="certificate-subtitle">Publication Bias Detective Training Program</p>
<div class="certificate-body">
<p>Hiermit wird bescheinigt, dass</p>
<div class="certificate-name" id="certName">Investigator Name</div>
<p>den</p>
<p><strong style="color: var(--detective-blue); font-size: 1.2rem;">Publication Bias Detective erfolgreich abgeschlossen hat Kurs</strong></p>
<p>der Nachweis der Kompetenz bei der Identifizierung, Bewertung und Minderung von Publikationsverzerrungen in systematischen Überprüfungen und Metaanalysen.</p>
</div>
<div class="certificate-date" id="certDate">Completed on: January 1, 2025</div>
<div class="certificate-id" id="certId">Certificate ID: PBD-000000</div>
<div class="certificate-actions">
<button class="certificate-btn primary" onclick="printCertificate()">Print Certificate</button>
<button class="certificate-btn secondary" onclick="closeCertificate()">Close</button>
</div>
</div>
</div>
 Namenseingabemodalität für Zertifikat 
<div aria-labelledby="nameInputTitle" class="name-input-modal" id="nameInputModal" role="dialog">
<div class="name-input-box">
<h3 id="nameInputTitle">Congratulations, Investigator!</h3>
<p style="color: rgba(255,255,255,0.7); margin-bottom: 1rem;">Sie haben alle Module abgeschlossen. Geben Sie Ihren Namen für Ihr Zertifikat ein:</p>
<input aria-label="Ihr vollständiger Name" id="investigatorName" placeholder="Ihr vollständiger Name" type="text"/>
<button onclick="generateCertificate()">Generate Certificate</button>
</div>
</div>
<script>
// ============================================================
// SIDEBAR TOGGLE
// ============================================================
function toggleSidebar() {
  var sidebar = document.querySelector('.sidebar');
  var overlay = document.querySelector('.sidebar-overlay');
  var btn = document.querySelector('.mobile-menu-toggle');
  if (sidebar) sidebar.classList.toggle('open');
  if (overlay) overlay.classList.toggle('show');
  if (btn) btn.setAttribute('aria-expanded', btn.getAttribute('aria-expanded') === 'true' ? 'false' : 'true');
}

// ============================================================
// GLOSSARY TERMS
// ============================================================
const glossaryTerms = [
  { term: "Publication Bias", def: "Die Tendenz, dass Studien mit positiven/signifikanten Ergebnissen häufiger veröffentlicht werden als Studien mit negativen/null Ergebnissen, wodurch die Evidenzbasis verzerrt wird." },
  { term: "Funnel Plot", def: "A scatter plot of effect size vs. precision (or sample size). Asymmetry suggests possible publication bias or other small-study effects." },
  { term: "Egger's Test", def: "A statistical test for funnel plot asymmetry. Regresses standardized effect on precision. Significant result (p<0.10) suggests bias." },
  { term: "Begg's Test", def: "Rank correlation test between effect size and variance. Less powerful than Egger's but makes fewer assumptions." },
  { term: "Trimmen und Füllen", def: "Methode, die fehlende Studien schätzt, indem der asymmetrische Teil des Trichters „gestutzt“ wird, die wahre Mitte geschätzt wird und dann unterstellte Studien „aufgefüllt“ werden." },
  { term: "Contour-Enhanced Funnel Plot", def: "Funnel plot with significance contours (p=0.05, 0.01) overlaid. Helps distinguish publication bias from other causes of asymmetry." },
  { term: "File Drawer Problem", def: "Rosenthals Begriff für unveröffentlichte Nullstudien, die in den Schubladen der Forscher „abgelegt“ werden und nie das Licht der Veröffentlichung erblicken." },
  { term: "Fail-Safe N", def: "Number of null studies that would need to exist to reduce a significant meta-analytic result to non-significance. Higher = more robust." },
  { term: "Selection Model", def: "Statistisches Modell, das die Veröffentlichungswahrscheinlichkeit explizit als Funktion des p-Werts oder der Effektgröße modelliert." },
  { term: "P-Curve", def: "Distribution of significant p-values. A right-skewed p-curve (many p<0.025) suggests true effect; left-skewed or flat suggests p-hacking or no effect." },
  { term: "Small-Study Effects", def: "Phenomenon where smaller studies show larger effects. Publication bias is one cause; others include genuine heterogeneity or methodological differences." },
  { term: "Trial Registry", def: "Datenbank, in der Studien vor Beginn registriert werden (z. B. ClinicalTrials.gov). Ermöglicht die Erkennung unveröffentlichter abgeschlossener Studien." },
  { term: "FOIA Request", def: "Aufforderung des Freedom of Information Act, unveröffentlichte Daten von Aufsichtsbehörden wie der FDA zu erhalten." },
  { term: "Outcome Reporting Bias", def: "Selektive Berichterstattung über einige Ergebnisse, andere jedoch nicht innerhalb einer Studie, basierend auf den Ergebnissen." },
  { term: "Spin", def: "Irreführende Berichterstattung, die Ergebnisse positiver darstellt, als die Daten rechtfertigen, auch ohne Datenfälschung." },
  { term: "Grey Literature", def: "Research not published in peer-reviewed journals: dissertations, conference abstracts, government reports, etc." },
  { term: "PET-PEESE", def: "Präzisionseffekttest und Präzisionseffektschätzung mit Standardfehler. Regressionsbasierte Methoden zur Korrektur von Publikationsbias." },
  { term: "3PSM", def: "Three-Parameter Selection Model. Models selection probability as a step function at p=0.05." }
];

// ============================================================
// COURSE MODULES
// ============================================================
const modules = [
  // MODULE 0: THE GATEWAY
  {
    id: 0,
    title: "The Gateway",
    subtitle: "Den Fall öffnen",
    estimatedMinutes: 15,
    slides: [
      {
        type: 'title',
        content: {
          title: "Publication Bias Detective",
          subtitle: "Der Beweis, der nie Licht sah",
          text: "Willkommen, Ermittler. Sie sind dabei, in die verborgene Welt vergrabener Beweise, unterdrückter Gerichtsverfahren und der systematischen Verzerrung der medizinischen Wahrheit vorzudringen."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "PRE-ASSESSMENT: Before we begin, what do you think publication bias typically does to meta-analytic effect estimates?",
          options: [
            { id: 'a', text: "Makes them more accurate by filtering out low-quality studies", correct: false },
            { id: 'b', text: "Inflates them by selectively publishing positive results", correct: true },
            { id: 'c', text: "Has no systematic effect — biases cancel out", correct: false },
            { id: 'd', text: "Deflates them by suppressing the most dramatic findings", correct: false }
          ],
          explanation: "Correct! Publication bias typically INFLATES effect estimates. Positive and statistically significant results are more likely to be published, while negative, null, or inconvenient findings often remain hidden. This creates a systematic overestimate of treatment effects in the published literature. By the end of this course, you'll understand exactly how this happens and what you can do about it."
        }
      },
      {
        type: 'learning-objectives',
        content: {
          intro: "By the end of this module, you will be able to:",
          objectives: [
            "Define publication bias and explain why it occurs",
            "Beschreiben Sie das Ausmaß des Publikationsbias in der Medizin anhand realer Daten",
            "Identify 3 high-profile cases where publication bias caused patient harm",
            "Recognize why systematic reviews without bias assessment are incomplete",
            "Erklären Sie den Unterschied zwischen positiven, negativen und Nullbefunden"
          ]
        }
      },
      {
        type: 'rhetoric',
        content: {
          question: "Haben Sie nicht bedacht, dass von den 74 bei der FDA eingereichten Antidepressivum-Studien in der veröffentlichten Literatur 94 % positiv ausfielen, während die eigenen Aufzeichnungen der FDA nur 51 % positiv zeigten?"
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "CASE ZERO",
          title: "Das Ausmaß des Problems",
          source: "Turner et al., NEJM 2008 – Die Studie, die eine Branche enthüllte",
          timeline: [
            { year: "The Question", text: "Erick Turner, an FDA reviewer turned researcher, asked: What if we could see ALL the antidepressant trials — not just the published ones?", type: "normal" },
            { year: "The Method", text: "He obtained FDA records for 74 trials of 12 antidepressants. Then compared what FDA saw vs. what journals published.", type: "normal" },
            { year: "The Discovery", text: "Of 38 FDA-positive trials: 37 published (97%). Of 36 FDA-negative/questionable trials: only 14 published (39%). And of those 14, 11 were SPUN to appear positive.", type: "buried" },
            { year: "The Impact", text: "Published literature effect size: 0.41. Including unpublished: 0.31. A 32% INFLATION of apparent efficacy. Millions prescribed based on distorted evidence.", type: "revealed" }
          ],
          realData: {
            totalTrials: "74 trials submitted to FDA",
            publishedPositive: "94% appeared positive in literature",
            actualPositive: "Laut FDA waren 51 % positiv",
            effectInflation: "32% overestimate in published literature"
          }
        }
      },
      {
        type: 'content',
        content: {
          title: "Ihr Ermittlungs-Toolkit",
          sections: [
            {
              heading: "Case File 1: The Buried Bodies",
              items: [
                "Reboxetin – Das Medikament, bei dem 74 % der Patientendaten verborgen blieben",
                "Neurontin – Der 430-Millionen-Dollar-Betrug",
                "Vioxx – Die Todesfälle, die bekannt waren, aber nicht erzählt wurden"
              ]
            },
            {
              heading: "Case File 2: The Funnel of Truth",
              items: [
                "Reading funnel plots — the detective's X-ray",
                "Asymmetrie und was sie offenbart",
                "Contour-enhanced plots — seeing significance boundaries"
              ]
            },
            {
              heading: "Case File 3: The Statistical Tests",
              items: [
                "Egger's regression — the mathematical detector",
                "Begg's rank correlation — the non-parametric approach",
                "When tests fail and why"
              ]
            },
            {
              heading: "Akte 4: Die Korrekturmethoden",
              items: [
                "Trimmen und Füllen – Schätzen des Fehlenden",
                "Selection models — modeling the censorship",
                "P-Kurve – die Form der Wahrheit"
              ]
            },
            {
              heading: "Akte 5: Die Jagd",
              items: [
                "Trial registries — finding what was started",
                "FDA- und EMA-Anfragen – die Spur der Regulierungspapiere",
                "Grey literature — the unpublished frontier"
              ]
            }
          ]
        }
      },
      {
        type: 'principle',
        content: {
          number: "I",
          text: "Das Fehlen von Beweisen ist kein Beweis für Abwesenheit – es kann ein Beweis für Unterdrückung sein."
        }
      },
      {
        type: 'key-takeaways',
        content: {
          takeaways: [
            "Publication bias inflates apparent treatment effects by ~30% on average",
            "Die Antidepressivum-Studie von Turner ergab eine Diskrepanz von 94 % gegenüber 51 % zwischen veröffentlichten und tatsächlichen positiven Studien",
            "Es kann nicht davon ausgegangen werden, dass fehlende Daten neutral sind – sie tendieren systematisch zu null/negativen Ergebnissen",
            "Every meta-analysis without bias assessment may be overestimating treatment effects",
            "Publication bias is not random error — it is systematic distortion"
          ],
          actionItem: "Before accepting any meta-analysis conclusion, ask: 'What efforts were made to find unpublished data?'"
        }
      }
    ]
  },

  // MODULE 1: THE BURIED BODIES
  {
    id: 1,
    title: "Die begrabenen Leichen",
    subtitle: "Fallstudien zur Unterdrückung",
    estimatedMinutes: 25,
    slides: [
      {
        type: 'learning-objectives',
        content: {
          intro: "By the end of this module, you will be able to:",
          objectives: [
            "Analyze 3 landmark cases of publication bias and their patient impact",
            "Berechnen Sie den Anteil der verborgenen Daten im Reboxetin-Fall",
            "Erklären Sie die finanziellen und regulatorischen Mechanismen, die eine Unterdrückung ermöglichen",
            "Identifizieren Sie Warnzeichen dafür, dass veröffentlichte Beweise möglicherweise unvollständig sind",
            "Beschreiben Sie die menschlichen Kosten der Beweismittelunterdrückung in Bezug auf Todesfälle und Invalidität"
          ]
        }
      },
      {
        type: 'principle',
        content: {
          number: "I",
          text: "What is hidden shapes belief as powerfully as what is shown."
        }
      },
      {
        type: 'rhetoric',
        content: {
          question: "Haben Sie nicht gesehen, wie Pfizer die Beweise, dass Gabapentin bei den von ihnen propagierten Erkrankungen nicht wirkte, vergrub – und dann 430 Millionen US-Dollar zahlte, als die Leichen exhumiert wurden?"
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "CASE 1A",
          title: "Reboxetin: Die 74-prozentige Lösung",
          source: "Eyding et al., BMJ 2010 — IQWiG's Systematic Investigation",
          timeline: [
            { year: "2000s", text: "Reboxetine marketed as an effective antidepressant. Published trials showed it worked. Doctors prescribed it. Patients took it.", type: "normal" },
            { year: "The Hunt", text: "Das Deutsche Institut für Qualität und Wirtschaftlichkeit (IQWiG) forderte von Pfizer ALLE Studiendaten – veröffentlichte UND unveröffentlichte.", type: "normal" },
            { year: "The Exhumation", text: "They found: 74% of patient data had NEVER been published. 8 trials, 2,256 patients — buried.", type: "buried" },
            { year: "The Truth", text: "Veröffentlichte Daten: Reboxetin deutlich besser als Placebo. ALLE Daten: KEIN signifikanter Unterschied. Die veröffentlichte Literatur war eine kuratierte Lüge.", type: "revealed" },
            { year: "The Verdict", text: "Das IQWiG bewertete den Nutzen von Reboxetin als „nicht belegt“. Es wurde in mehreren Ländern zurückgezogen oder eingeschränkt.", type: "revealed" }
          ],
          realData: {
            publishedPatients: "26 % der veröffentlichten Patientendaten",
            hiddenPatients: "74 % der Patientendaten wurden unterdrückt",
            publishedEffect: "Significant benefit vs placebo",
            trueEffect: "No significant benefit vs placebo",
            hiddenTrials: "8 trials with 2,256 patients never published"
          }
        }
      },
      {
        type: 'statistic-card',
        content: {
          value: "74%",
          label: "der Reboxetin-Patientendaten wurden aus der Veröffentlichung ausgeblendet",
          context: "Die veröffentlichte Literatur basierte auf 26 % der Beweise"
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "CASE 1B",
          title: "Neurontin: Die Off-Label-Maschine",
          source: "Steinman et al., JAMA 2006 + DOJ Settlement 2004",
          timeline: [
            { year: "1994", text: "Gabapentin (Neurontin) approved by FDA for epilepsy. Limited market.", type: "normal" },
            { year: "The Strategy", text: "Parke-Davis/Pfizer promoted it for off-label uses: pain, bipolar, migraine. But trials for these uses were negative.", type: "normal" },
            { year: "The Burial", text: "Interne Dokumente enthüllten: Negative Studien wurden unterdrückt. Positiv aussehende Analysen wurden ausgewählt. Medizinische Autoren haben positive Artikel als Ghostwriter verfasst.", type: "buried" },
            { year: "The Evidence", text: "Eine interne E-Mail: „Wir müssen vorsichtig sein, was wir veröffentlichen … die Daten sehen nicht gut aus.“ Ein weiterer: Entwurf von Veröffentlichungen für Verwendungszwecke, bei denen die Daten „positiv sein sollten“.", type: "buried" },
            { year: "The Settlement", text: "2004: Pfizer paid $430 million in criminal and civil penalties. But by then, Neurontin had generated $2.7 billion in off-label sales.", type: "revealed" }
          ],
          realData: {
            approvedUse: "Epilepsy only",
            offLabelSales: "90 % des Umsatzes wurden Off-Label erzielt",
            settlement: "$430 million (criminal + civil)",
            revenue: "2,7 Milliarden US-Dollar durch Off-Label-Werbung",
            ratio: "6:1 profit to penalty ratio"
          }
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "CASE 1C",
          title: "Vioxx: The Deaths They Knew",
          source: "Krumholz et al., JAMA 2007 + Congressional Testimony",
          timeline: [
            { year: "1999", text: "Vioxx (rofecoxib) launched. Merck's blockbuster painkiller. Marketed as safer for stomach than older NSAIDs.", type: "normal" },
            { year: "2000", text: "VIGOR trial finds 5-fold increase in heart attacks vs. naproxen. Merck's interpretation: Naproxen is cardioprotective. Not: Vioxx is cardiotoxic.", type: "normal" },
            { year: "2000-2004", text: "Internal documents show Merck knew of cardiovascular signal. Training materials taught sales reps to 'DODGE' questions about CV safety.", type: "buried" },
            { year: "The Revelation", text: "APPROVe trial stopped: 2x heart attacks. Vioxx withdrawn. FDA scientist David Graham estimates: 88,000-140,000 excess heart attacks, ~30% fatal.", type: "revealed" },
            { year: "The Reckoning", text: "Merck settles for $4.85 billion. Internal documents revealed systematic suppression of safety signals.", type: "revealed" }
          ],
          realData: {
            yearsOnMarket: "5 years (1999-2004)",
            estimatedHeartAttacks: "88,000-140,000 excess cases",
            estimatedDeaths: "26,000-55,000",
            settlement: "$4.85 billion",
            internalKnowledge: "Cardiovascular signal known internally by 2000"
          }
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "CASE 1D",
          title: "Studie 329: Die Kinder, die sie gefährdeten",
          source: "Jureidini et al., BMJ 2015 — RIAT Reanalysis of GlaxoSmithKline Data",
          timeline: [
            { year: "2001", text: "Studie 329 veröffentlicht in JAACAP. Behauptet: „Paroxetin ist im Allgemeinen gut verträglich und wirksam bei schweren Depressionen bei Jugendlichen.“ Zu den Autoren gehörten prominente Wissenschaftler.", type: "normal" },
            { year: "The Hidden", text: "Interne GSK-Dokumente zeigten: 8 suizidbedingte Ereignisse in der Paroxetin-Gruppe vs. 1 in der Placebo-Gruppe. Das Medikament steigerte das Selbstmordverhalten. Dies wurde in der Veröffentlichung ausgeblendet.", type: "buried" },
            { year: "The Spin", text: "In der veröffentlichten Arbeit wurden suizidale Ereignisse als „emotionale Labilität“ neu klassifiziert. Die Wirksamkeit wurde durch die Umstellung auf nicht vorab festgelegte Ergebnisse behauptet. Der Artikel wurde von einem Ghostwriter verfasst.", type: "buried" },
            { year: "2004", text: "Die FDA gibt eine Black-Box-Warnung für pädiatrische Antidepressiva heraus. GSK verhängte eine Geldstrafe von 3 Milliarden US-Dollar (2012) wegen Betrugs, einschließlich Studie 329. Das Medikament wurde Millionen von Kindern verschrieben.", type: "revealed" },
            { year: "2015", text: "RIAT reanalysis using actual trial data: 'Paroxetine is neither safe nor effective.' The opposite of the original conclusion. Same data, honest analysis.", type: "revealed" }
          ],
          realData: {
            originalClaim: "Wirksam und gut verträglich",
            realityAfterReanalysis: "Neither safe nor effective",
            suicidalEvents: "8 in paroxetine vs 1 in placebo",
            settlement: "$3 billion (GSK total fraud settlement)",
            childrenExposed: "Millions prescribed worldwide before warning"
          }
        }
      },
      {
        type: 'death-toll',
        content: {
          number: "26,000–55,000",
          label: "Estimated excess deaths from Vioxx alone",
          source: "FDA scientist David Graham's congressional testimony, 2004"
        }
      },
      {
        type: 'oath',
        content: {
          header: "Nach den Beweisen, die sie begraben haben",
          text: "By the trials that were hidden, and the patients who were harmed —<br><strong>the cost of suppression is measured in lives.</strong><br><br>Every buried study is a betrayal. Every spin is a deception.<br>The detective does not look away. The detective counts the cost."
        }
      },
      {
        type: 'contrast',
        content: {
          title: "Zwei Wege im Angesicht des Negativen Daten",
          darkSide: {
            header: "Der Weg der Verschleierung",
            items: [
              "Die negativen Prüfungen verbergen",
              "Die Sprache verdrehen ('emotionale Labilität', nicht 'selbstmörderisch')",
              "Ghostwrite favorable papers",
              "Promote off-label use despite evidence",
              "Pay the fine as cost of doing business"
            ],
            consequence: "Result: Reboxetine prescribed as effective (it wasn't). Vioxx killed tens of thousands. Study 329 endangered children."
          },
          lightSide: {
            header: "Der Weg von Transparenz",
            items: [
              "Publish all trials regardless of outcome",
              "Report adverse events accurately",
              "Unabhängigen Datenzugriff ermöglichen",
              "Folgen Sie den Beweisen, nicht dem Markt",
              "Accept reduced profits for patient safety"
            ],
            consequence: "Result: Doctors can make informed decisions. Patients receive treatments that actually work. Trust in medicine is preserved."
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          title: "Das Dilemma des Gutachters",
          situation: "You're conducting a meta-analysis of a pain medication. You find 12 published trials — all positive, effect size d=0.45. A colleague mentions rumors of unpublished negative trials. The manufacturer won't share data. What do you do?",
          nodes: [
            {
              id: 'start',
              question: "Sie haben 12 positive veröffentlichte Studien. Fahren Sie mit der Metaanalyse fort?",
              branches: [
                { id: 'a', text: "Ja – veröffentlichen Sie mit den verfügbaren Daten und beachten Sie Einschränkungen", nextNode: 'publish' },
                { id: 'b', text: "Suchen Sie nach unveröffentlichten Daten, bevor Sie fortfahren", nextNode: 'hunt' },
                { id: 'c', text: "Apply statistical tests for publication bias", nextNode: 'test' }
              ]
            },
            {
              id: 'publish',
              type: 'outcome',
              consequence: 'bad',
              title: "Die Reboxetine-Wiederholung",
              text: "Your meta-analysis shows strong efficacy (d=0.45). Guidelines cite it. Prescriptions increase. Two years later, regulatory investigation reveals 8 unpublished negative trials. True effect: d=0.15, non-significant. Your published meta-analysis contributed to patients receiving ineffective treatment.",
              realCase: "Das ist genau das, was mit Reboxetin passiert ist. Mehrere veröffentlichte Metaanalysen zeigten einen Nutzen – bis das IQWiG die unveröffentlichten Daten erhielt und der Effekt verschwand."
            },
            {
              id: 'hunt',
              question: "Sie durchsuchen ClinicalTrials.gov und finden 6 abgeschlossene Studien ohne veröffentlichte Ergebnisse. Sie kontaktieren Trialisten und stellen FOIA-Anträge. Was passiert?",
              branches: [
                { id: 'd', text: "Sie erhalten 4 von 6 Studiendatensätzen – 3 sind negativ", nextNode: 'found' },
                { id: 'e', text: "Anfragen abgelehnt oder ignoriert – Sie haben keine neuen Daten", nextNode: 'blocked' }
              ]
            },
            {
              id: 'found',
              type: 'outcome',
              consequence: 'good',
              title: "Die Wahrheit kommt ans Licht",
              text: "Including the unpublished data: effect drops to d=0.22, barely significant. Your meta-analysis reports BOTH estimates, notes the discrepancy, and warns about likely publication bias. Clinicians can make informed decisions. Your work prevents another reboxetine.",
              realCase: "Das hat Turner mit Antidepressiva gemacht und Eyding mit Reboxetin – Erhalt regulatorischer Daten, um das wahre Bild zu enthüllen."
            },
            {
              id: 'blocked',
              question: "Sie können keine unveröffentlichten Daten erhalten. Ihr Funnel-Plot sieht verdächtig aus. Was melden Sie?",
              branches: [
                { id: 'f', text: "Melden Sie den Effekt, aber mit starken Vorbehalten und einer voreingenommenen Bewertung", nextNode: 'cautious' },
                { id: 'g', text: "Use trim-and-fill to estimate adjusted effect", nextNode: 'adjust' }
              ]
            },
            {
              id: 'cautious',
              type: 'outcome',
              consequence: 'neutral',
              title: "Der ehrliche Unbekannte",
              text: "You report: 'Published trials suggest d=0.45, but funnel plot asymmetry and registry search indicate likely missing negative trials. We located 6 unpublished trials that could not be obtained. True effect is likely smaller.' GRADE assessment: downgrade for publication bias. You've flagged the problem even without solving it.",
              realCase: "GRADE erlaubt ausdrücklich eine Herabstufung bei vermuteter Publikationsverzerrung. Transparenz über Unsicherheit ist wertvoller als falsche Präzision."
            },
            {
              id: 'adjust',
              type: 'outcome',
              consequence: 'neutral',
              title: "Die statistische Korrektur",
              text: "Trim-and-fill imputes 5 missing studies. Adjusted effect: d=0.28. You report both estimates with explanation. Caveat: Trim-and-fill assumes publication bias is the ONLY cause of asymmetry, and doesn't recover the actual missing data. It's an approximation, not a solution.",
              realCase: "Trim-and-Fill wird häufig verwendet, weist jedoch Einschränkungen auf. Es kann zu einer Über- oder Unterkorrektur kommen. Auswahlmodelle sind möglicherweise genauer, erfordern jedoch Annahmen über den Auswahlmechanismus."
            },
            {
              id: 'test',
              question: "Egger's test: p=0.03 (significant asymmetry). Begg's test: p=0.08 (borderline). Funnel plot shows gap in bottom-left. What do you conclude?",
              branches: [
                { id: 'h', text: "Publication bias is confirmed — adjust the estimate", nextNode: 'confirmed' },
                { id: 'i', text: "Tests sind suggestiv, aber nicht endgültig – untersuchen Sie weiter", nextNode: 'investigate' }
              ]
            },
            {
              id: 'confirmed',
              type: 'outcome',
              consequence: 'bad',
              title: "Die übermütige Schlussfolgerung",
              text: "You state 'publication bias confirmed' and apply trim-and-fill. But Egger's test has high false positive rate with few studies and high heterogeneity. The asymmetry might be due to genuine effect modification (smaller trials in sicker patients). You've made a statistical inference that requires clinical verification.",
              realCase: "Funnel plot asymmetry has many causes beyond publication bias: heterogeneity, methodological differences in small studies, true biology. Tests can't distinguish these."
            },
            {
              id: 'investigate',
              type: 'outcome',
              consequence: 'good',
              title: "Die umfassende Bewertung",
              text: "You use contour-enhanced funnel plots: missing studies are in non-significant regions (suggests publication bias, not heterogeneity). You check if smaller studies differ methodologically (they don't). You search registries (find unpublished trials). You report: 'Multiple lines of evidence suggest publication bias' with GRADE downgrade. Full transparency, appropriate uncertainty.",
              realCase: "Modern guidance recommends multiple approaches: visual assessment, statistical tests, registry searches, and clinical judgment. No single method is sufficient."
            }
          ]
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "CASE 1E",
          title: "Avandia: The 83,000 Heart Attacks",
          source: "Nissen & Wolski, NEJM 2007 + Senate Finance Committee Investigation",
          timeline: [
            { year: "1999", text: "Rosiglitazone (Avandia) approved for diabetes. GlaxoSmithKline's blockbuster drug.", type: "normal" },
            { year: "Das versteckte Signal", text: "Bis 2000, GSKs interne Metaanalyse zeigte ein um 30 % erhöhtes Risiko für Herzereignisse. Sie gaben weitere Analysen in Auftrag – alle zeigten das gleiche Signal. KEINE wurden veröffentlicht.", type: "buried" },
            { year: "2007", text: "Cardiologist Steven Nissen obtains 42 trial datasets through legal discovery. His meta-analysis: 43% increased MI risk (OR 1.43, p=0.03). Published in NEJM.", type: "revealed" },
            { year: "The Toll", text: "FDA estimates: 83,000 excess heart attacks from 1999-2007. GSK had known since 2000. Seven years of silence. Seven years of prescriptions.", type: "revealed" },
            { year: "The Reckoning", text: "GSK zahlt 3 Milliarden US-Dollar Vergleich (2012). Avandia eingeschränkt. Aber der Schaden war angerichtet – und die veröffentlichte Literatur hatte ihn verschwiegen.", type: "revealed" }
          ],
          realData: {
            approvalYear: "1999",
            internalSignalYear: "2000",
            publicRevelationYear: "2007",
            yearsOfSuppression: "7 years",
            estimatedExcessMIs: "83,000",
            settlement: "$3 billion"
          }
        }
      },
      {
        type: 'rhetoric',
        content: {
          question: "Haben Sie nicht daran gedacht, dass ein Unternehmen SIEBEN JAHRE lang wusste, dass sein Medikament Herzinfarkte verursacht – und nichts sagte? Dass 83.000 Herzen geschädigt wurden, während die Beweise in Unternehmensakten lagen?"
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "CASE 1F",
          title: "Der DECREASE-Betrug: Als die Daten erfunden wurden",
          source: "Erasmus MC Investigation 2012 + Bouri et al. BMJ 2014 Reanalysis",
          timeline: [
            { year: "Background", text: "Don Poldermans war vor der Operation der weltweit führende Experte für Betablocker. Seine DECREASE-Studien zeigten eine dramatische Reduzierung der Sterblichkeit. Aufgrund seiner Arbeit wurden weltweit Richtlinien geändert.", type: "normal" },
            { year: "The Suspicion", text: "Andere Forscher konnten seine Ergebnisse nicht reproduzieren. Seine Effektgrößen waren unglaublich groß. Datenmuster schienen zu sauber.", type: "normal" },
            { year: "2012", text: "Untersuchung des Erasmus Medical Center: Poldermans hat in mehreren Studien Daten erfunden. Er hat Patienten erfunden. Er hat Ergebnisse gefälscht.", type: "buried" },
            { year: "The Reanalysis", text: "Bouri et al. reanalyzed all beta-blocker trials EXCLUDING Poldermans' data. Without his studies: NO mortality benefit, possible HARM. Guidelines had been based on fraud.", type: "revealed" },
            { year: "The Cost", text: "European guidelines caused an estimated 10,000 excess deaths per year by recommending routine beta-blockers. Based on fabricated evidence.", type: "revealed" }
          ],
          realData: {
            fraudulentTrials: "DECREASE I, II, IV",
            originalClaim: "34% mortality reduction",
            truthWithoutFraud: "No benefit, possible harm",
            estimatedAnnualDeaths: "~10,000 excess deaths/year in Europe",
            guidelineImpact: "ESC guidelines changed worldwide practice"
          }
        }
      },
      {
        type: 'death-toll',
        content: {
          number: "10,000/year",
          label: "Estimated excess deaths in Europe from guidelines based on DECREASE fraud",
          source: "Bouri et al., Heart 2014"
        }
      },
      {
        type: 'decision-tree',
        content: {
          title: "Der Scheideweg des Whistleblowers",
          situation: "You're a junior researcher at a pharmaceutical company. You've discovered that your company has 5 unpublished trials showing the drug increases cardiovascular events. The drug is already approved and generating $2 billion/year. Your supervisor tells you to focus on other projects and 'let the medical affairs team handle regulatory issues.' What do you do?",
          nodes: [
            {
              id: 'start',
              question: "Sie haben Beweise für versteckten Schaden gefunden. Ihre Karriere steht auf dem Spiel. Was machst du?",
              branches: [
                { id: 'a', text: "Stay silent — it's above your pay grade", nextNode: 'silent' },
                { id: 'b', text: "Report internally through compliance channels", nextNode: 'internal' },
                { id: 'c', text: "Become a whistleblower — contact FDA or journalists", nextNode: 'whistleblow' }
              ]
            },
            {
              id: 'silent',
              type: 'outcome',
              consequence: 'bad',
              title: "Das Gewicht der Stille",
              text: "Du schweigst. Das Medikament wird weiterhin verkauft. Es kommt weiterhin zu Herzinfarkten. Jahre später kommt die Wahrheit durch einen Rechtsstreit ans Licht. Sie haben gelesen, dass Tausende zu Schaden kamen. Du wusstest es. Du hast nichts gesagt. Das Geld, das Sie verdient haben, war Blutgeld. Die von Ihnen geschützte Karriere basierte auf Komplizenschaft.",
              realCase: "Viele Pharmamitarbeiter wussten von Vioxx, Avandia und anderen Skandalen. Die meisten blieben stumm. Einige sagten später aus, dass die Schuld sie nie verlassen habe."
            },
            {
              id: 'internal',
              question: "Sie reichen einen internen Compliance-Bericht ein. Wochen vergehen. Der Compliance-Beauftragte dankt Ihnen und sagt: „Die Angelegenheit wird bearbeitet.“ Was tun Sie als Nächstes?",
              branches: [
                { id: 'd', text: "Trust the process — compliance will handle it", nextNode: 'trust' },
                { id: 'e', text: "Folgen Sie nach und fordern Sie Beweise für Maßnahmen", nextNode: 'followup' },
                { id: 'f', text: "Document everything and prepare external escalation", nextNode: 'document' }
              ]
            },
            {
              id: 'trust',
              type: 'outcome',
              consequence: 'bad',
              title: "Die falsche Zusicherung",
              text: "Es ändert sich nichts. Monate später werden Sie still und heimlich in eine andere Abteilung versetzt. Die Droge geht weiter. Sie erfahren, dass „Compliance-Handhabung“ eine rechtliche Prüfung der Verteidigung zukünftiger Rechtsstreitigkeiten bedeutet und nicht die Frage, wie Patienten geschützt werden können. Ihr Bericht wurde eingereicht – und neben den Studien begraben.",
              realCase: "Interne Compliance schützt oft das Unternehmen, nicht die Patienten. Cheryl Eckard von GSK meldete jahrelang intern Produktionsprobleme, bevor sie zur Whistleblowerin des Bundes wurde."
            },
            {
              id: 'followup',
              type: 'outcome',
              consequence: 'neutral',
              title: "Die Papierspur",
              text: "Sie fordern Besprechungsnotizen, Aktionspunkte und behördliche Unterlagen. Ihnen wird gesagt, dass es sich hierbei um „privilegierte Informationen“ handele. Ihre Beharrlichkeit fällt auf – nicht positiv. Sie werden als „kein Teamplayer“ bezeichnet. Aber Sie haben einen Datensatz erstellt. Wenn der Skandal schließlich ans Licht kommt, werden Ihre dokumentierten Bedenken zu Beweisen.",
              realCase: "Documentation protects whistleblowers legally. Peter Rost at Pfizer kept meticulous records that later proved invaluable in legal proceedings."
            },
            {
              id: 'document',
              type: 'outcome',
              consequence: 'good',
              title: "Der vorbereitete Weg",
              text: "You keep copies of everything. You consult a whistleblower attorney. You understand the False Claims Act and qui tam provisions. When internal channels fail, you're ready. Your documentation becomes the foundation for a federal case. You face retaliation — but you're protected by law, and you sleep at night.",
              realCase: "Successful whistleblowers like Cheryl Eckard and John Kopchinski prepared extensively before going external. Eckard received $96 million; Kopchinski received $51 million."
            },
            {
              id: 'whistleblow',
              question: "You decide to go external. But how?",
              branches: [
                { id: 'g', text: "Contact a journalist at a major newspaper", nextNode: 'journalist' },
                { id: 'h', text: "Reichen Sie eine Qui-Tam-Klage unter Verschluss und Dokumentation ein", nextNode: 'quitam' },
                { id: 'i', text: "Report directly to FDA's MedWatch", nextNode: 'fda' }
              ]
            },
            {
              id: 'journalist',
              type: 'outcome',
              consequence: 'neutral',
              title: "Die öffentliche Enthüllung",
              text: "Ein Journalist ermittelt. Die Geschichte bricht. Aber ohne rechtlichen Schutz wird man sofort entlassen. Das Unternehmen behauptet, Sie hätten die Vertraulichkeit verletzt. Es droht ein teurer Rechtsstreit. Die Wahrheit kommt ans Licht – aber Ihre Karriere und Ihre Finanzen sind zerstört. Journalismus entlarvt, schützt den Entlarvenden jedoch nicht.",
              realCase: "Many whistleblowers who went to media first faced devastating retaliation. Legal protection requires following specific procedures."
            },
            {
              id: 'quitam',
              type: 'outcome',
              consequence: 'good',
              title: "Der geschützte Weg",
              text: "A qui tam lawyer files under seal. The government investigates with your evidence. Years later, the case resolves: the company pays billions, patients are warned, and you receive 15-25% of the recovery. The process was long and stressful, but you're protected by law and rewarded for integrity.",
              realCase: "Durch den False Claims Act wurden seit 1986 über 70 Milliarden US-Dollar eingezogen. Ein großer Teil davon entfällt auf Arzneimittelfälle. Whistleblower beteiligen sich an Wiedereinziehungen."
            },
            {
              id: 'fda',
              type: 'outcome',
              consequence: 'neutral',
              title: "Die Regulatory Route",
              text: "FDA nimmt Ihren Bericht ernst. Sie fordern Unterlagen vom Unternehmen an. Die Anwälte des Unternehmens stehen auf. Der Prozess dauert Jahre. Schließlich wird dem Etikett eine Warnung hinzugefügt. Aber Sie haben keinen finanziellen Schutz, keinen rechtlichen Schutz. Sie haben das Richtige getan – aber das System hat Sie nicht davor geschützt.",
              realCase: "Die FDA verlässt sich auf freiwillige Meldungen und hat nur begrenzte Durchsetzungsbefugnisse. David Graham, ein FDA-Wissenschaftler, sah sich wegen seiner Vioxx-Analyse mit internen Vergeltungsmaßnahmen konfrontiert."
            }
          ]
        }
      },
      {
        type: 'legal-disclaimer',
        content: {
          text: "This educational content about whistleblowing is provided for informational purposes only and does NOT constitute legal advice. Whistleblower protections vary SIGNIFICANTLY by country, jurisdiction, employer type (government vs. private), and type of misconduct. The consequences of disclosure can be severe, including termination, blacklisting, and personal liability. INTERNATIONAL NOTE: The resources below are primarily US-focused. Many countries have different (often weaker) protections. EU Directive 2019/1937 provides baseline protections in Europe, but implementation varies. BEFORE taking any action on suspected misconduct, consult with a qualified attorney who specializes in whistleblower protection law in YOUR jurisdiction.",
          resources: [
            { name: "Government Accountability Project (US)", url: "https://whistleblower.org/" },
            { name: "National Whistleblower Center (US)", url: "https://www.whistleblowers.org/" },
            { name: "OSHA Whistleblower Protection Program (US)", url: "https://www.osha.gov/whistleblower" },
            { name: "Whistleblower Network News (International)", url: "https://whistleblowersblog.org/" },
            { name: "EU Whistleblower Directive Info", url: "https://ec.europa.eu/info/aid-development-cooperation-fundamental-rights/your-rights-eu/whistleblower-protection_en" }
          ]
        }
      },
      {
        type: 'contrast',
        content: {
          title: "Two Scientists Discover Hidden Harm",
          darkSide: {
            header: "Der stille Zeuge",
            items: [
              "Sieht die unveröffentlichten Studien",
              "Raises concern once, is dismissed",
              "Accepts 'it's being handled'",
              "Focuses on other projects",
              "Jahre später liest er von den Todesfällen",
              "Lebt mit dem Wissen, was sie sind nicht gemacht"
            ],
            consequence: "Result: Career preserved. Conscience damaged. When the scandal breaks, they weren't part of the cover-up — but they weren't part of the solution either."
          },
          lightSide: {
            header: "Die anhaltende Stimme",
            items: [
              "Sees the same unpublished trials",
              "Documents everything meticulously",
              "Escalates through proper channels",
              "When channels fail, consults attorney",
              "Files protected disclosure",
              "Faces retaliation but persists"
            ],
            consequence: "Result: Career disrupted but rebuilt. Patients protected. Years later, receives recognition and compensation. Sleeps soundly knowing they acted when it mattered."
          }
        }
      },
      {
        type: 'clinical-guide',
        content: {
          title: "Red Flags for Publication Bias",
          items: [
            "ALLE veröffentlichten Studien sind positiv (insbesondere hinsichtlich der subjektiven Ergebnisse)",
            "Effect sizes are implausibly large compared to mechanism",
            "Industry-sponsored trials have larger effects than independent trials",
            "Conference abstracts never became full publications",
            "Registered trials on ClinicalTrials.gov have no published results",
            "Ergebnisse wurden auf Konferenzen vorgestellt und sind dann „verschwunden“",
            "Internal documents (litigation, FOIA) reveal suppressed trials",
            "Funnel plot shows asymmetric gap in bottom-left quadrant"
          ]
        }
      },
      {
        type: 'cycle-return',
        content: {
          principle: "Das Verborgene prägt den Glauben genauso stark wie das, was gezeigt wird. Die erste Aufgabe des Detektivs besteht darin, zu wissen, dass etwas verborgen ist."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Wie viel Prozent der Patientendaten wurden im Reboxetin-Fall nie veröffentlicht?",
          options: [
            { id: 'a', text: "26%", correct: false },
            { id: 'b', text: "51%", correct: false },
            { id: 'c', text: "74%", correct: true },
            { id: 'd', text: "94%", correct: false }
          ],
          explanation: "74 % der Patientendaten aus Reboxetin-Studien wurden nie veröffentlicht. Nur 26 % schafften es in die veröffentlichte Literatur. Als das IQWiG alle Daten erhielt, verschwand die scheinbare Wirksamkeit des Arzneimittels. Dieser Fall zeigt, warum unveröffentlichte Daten wichtiger sind als veröffentlichte Datenmengen."
        }
      },
      {
        type: 'protagonist-story',
        content: {
          name: "Dr. Erick Turner",
          role: "FDA Reviewer turned Whistleblower Researcher",
          narrative: "As an FDA medical reviewer, Erick Turner saw something troubling: antidepressant trials submitted to the FDA often had different results than what appeared in published journals. After leaving the FDA, he conducted the landmark 2008 study comparing FDA records to published literature for 74 antidepressant trials. What he found shocked medicine: while published literature suggested 94% of trials were positive, FDA records showed only 51% were truly positive.",
          quote: "Die Literatur sah aus, als käme sie vom Lake Wobegon, wo alle Kinder überdurchschnittlich gut sind.",
          impact: "Seine in NEJM veröffentlichte Studie hat unser Verständnis von Publikationsbias grundlegend verändert. Es lieferte den klarsten Beweis dafür, dass in veröffentlichter medizinischer Literatur die Wirksamkeit von Behandlungen systematisch übertrieben wird."
        }
      },
      {
        type: 'key-takeaways',
        content: {
          takeaways: [
            "Reboxetine case: 74% of patient data hidden, drug approval revoked when full data emerged",
            "Vioxx case: 88,000-140,000 excess heart attacks, company knew early",
            "Paroxetine Study 329: Suicide risk hidden, ghostwritten, led to $3 billion settlement",
            "Financial incentives powerfully drive selective publication",
            "Regulatory submissions often tell a different story than published papers"
          ],
          actionItem: "Suchen Sie nach jedem Medikament, das Sie regelmäßig verschreiben, nach FDA-Bewertungen oder Zulassungsdokumenten vergleichen – was die Aufsichtsbehörden gesehen haben, mit dem, wurde veröffentlicht."
        }
      }
    ]
  },

  // MODULE 2: THE FUNNEL OF TRUTH
  {
    id: 2,
    title: "Der Trichter der Wahrheit",
    subtitle: "Visual Detection",
    estimatedMinutes: 20,
    slides: [
      {
        type: 'learning-objectives',
        content: {
          intro: "By the end of this module, you will be able to:",
          objectives: [
            "Explain the statistical principles behind funnel plot asymmetry",
            "Interpret funnel plots and identify patterns suggesting publication bias",
            "Distinguish between small-study effects and true publication bias",
            "Verwenden Sie interaktive Funnel-Plot-Tools, um Ihre eigenen zu beurteilen Metaanalysen",
            "Recognize limitations and confounders of funnel plot interpretation"
          ]
        }
      },
      {
        type: 'principle',
        content: {
          number: "II",
          text: "Der Trichter enthüllt, was der Wald verbirgt – die Form dessen, was veröffentlicht wurde, und den Schatten dessen, was nicht veröffentlicht wurde."
        }
      },
      {
        type: 'rhetoric',
        content: {
          question: "Haben Sie nicht gesehen, wie ein symmetrischer Trichterplot erklärt: „Die Veröffentlichung war allen Ergebnissen gerecht“ – während ein asymmetrischer Trichter flüstert: „Jemand hat ausgewählt, was Sie wollten.“ siehe'?"
        }
      },
      {
        type: 'content',
        content: {
          title: "Die Logik des Trichters",
          sections: [
            {
              heading: "Why a Funnel Shape?",
              items: [
                "Large studies (top): precise estimates, cluster tightly around true effect",
                "Small studies (bottom): imprecise, scatter widely around true effect",
                "Wenn ALLE Studien unabhängig von den Ergebnissen veröffentlicht werden: symmetrische Streuung",
                "Wenn NUR signifikante Ergebnisse veröffentlicht werden: asymmetrische Streuung"
              ]
            },
            {
              heading: "Reading the X-Axis (Effect Size)",
              items: [
                "Horizontal position shows each study's effect estimate",
                "Pooled estimate typically shown as vertical line",
                "Der Abstand vom Zentrum zeigt die Abweichung von Durchschnitt"
              ]
            },
            {
              heading: "Lesen der Y-Achse (Präzision)",
              items: [
                "Standard error (inverted: 0 at top, larger SE at bottom)",
                "OR sample size (larger at top)",
                "OR precision (1/SE, larger at top)",
                "Top = more precise = more confident estimates"
              ]
            }
          ]
        }
      },
      {
        type: 'tool-funnel',
        content: {
          id: 'funnel-basic',
          title: "Interactive Funnel Plot",
          description: "Untersuchen Sie, wie Publikationsbias die Trichterform verzerrt. Schalten Sie die Voreingenommenheit ein/aus, um den Effekt zu sehen."
        }
      },
      {
        type: 'content',
        content: {
          title: "Asymmetrie: Der Fingerabdruck der Voreingenommenheit",
          sections: [
            {
              heading: "Die fehlende Ecke",
              items: [
                "Bottom-left gap: Small, non-significant, negative studies missing",
                "Dies ist das klassische Muster der Publikationsverzerrung",
                "Kleine Studien mit Nullergebnissen → weggelegt, nie veröffentlicht",
                "Large studies published regardless (too big to bury)"
              ]
            },
            {
              heading: "But Asymmetry Has Other Causes",
              items: [
                "TRUE HETEROGENEITY: Small studies in sicker patients → larger effects (real)",
                "METHODOLOGICAL DIFFERENCES: Small studies less rigorous → inflated effects",
                "CHANCE: With few studies, asymmetry can occur randomly",
                "ARTEFACT: Some effect measures (OR) create asymmetry naturally"
              ]
            }
          ]
        }
      },
      {
        type: 'tool-contour',
        content: {
          id: 'contour-funnel',
          title: "Contour-Enhanced Funnel Plot",
          description: "Contours show significance boundaries. If missing studies fall in non-significant regions, publication bias is likely. If they fall in significant regions, other explanations apply."
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "CASE 2A",
          title: "The HRT Reversal: When Observation Deceived",
          source: "WHI Trial, JAMA 2002 + Decades of Observational Studies",
          timeline: [
            { year: "1980s-90s", text: "Beobachtungsstudien zeigten übereinstimmend: Frauen unter HRT hatten ein um 40–50 % GERINGERES Risiko für Herzerkrankungen. Metaanalysen bestätigten es. In den Leitlinien wird eine HRT zum Schutz des Herzens empfohlen.", type: "normal" },
            { year: "The Logic", text: "Warum sollte es nicht funktionieren? Östrogen verbessert die Lipidprofile. Die Biologie machte Sinn. Die konsistenten Beobachtungsdaten haben es „bewiesen“.", type: "normal" },
            { year: "2002", text: "Women's Health Initiative (WHI) – die erste große randomisierte Studie – wurde vorzeitig abgebrochen. HRT ERHÖHTE kardiovaskuläre Ereignisse um 29 %. Das Gegenteil von dem, was alle glaubten.", type: "revealed" },
            { year: "The Explanation", text: "Healthy user bias: Women who took HRT were healthier, more educated, more health-conscious. The 'protection' was confounding, not causation. And unpublished negative observational studies? Nobody looked for them.", type: "revealed" }
          ],
          realData: {
            observationalEstimate: "40-50% risk reduction",
            rctResult: "29% risk INCREASE",
            discrepancy: "Complete reversal",
            yearsOfWrongPractice: "20+ years",
            cause: "Healthy user bias + possible publication bias in observational studies"
          }
        }
      },
      {
        type: 'rhetoric',
        content: {
          question: "Haben Sie nicht gesehen, wie die medizinische Gemeinschaft zwanzig Jahre lang geglaubt hat – mit „starken Beweisen“ –, dass eine Hormontherapie das Herz schützt? Und wie zeigte eine einzige randomisierte Studie, dass die Beobachtung sie alle getäuscht hatte?"
        }
      },
      {
        type: 'oath',
        content: {
          header: "Nach Aussage des Trichters",
          text: "The funnel plot does not lie — <strong>but it can be misread.</strong><br><br>Asymmetry is a witness, not a verdict.<br>It testifies that something is unusual.<br>It does not testify WHY.<br><br>The detective who sees asymmetry and cries 'bias!'<br>is no better than the one who sees symmetry and cries 'truth!'<br><br><strong>Both must investigate. Both must verify. Both must doubt.</strong>"
        }
      },
      {
        type: 'decision-tree',
        content: {
          title: "Das Dilemma des Zeitschriftenredakteurs",
          situation: "You're the editor of a major medical journal. A researcher submits a well-conducted trial showing NO effect of a popular supplement on cognitive function (null result, p=0.67). Three positive trials have been published elsewhere. The methods are rigorous. The sample size is adequate. Your reviewers are split — some say 'not novel enough,' others say 'important null finding.' What do you do?",
          nodes: [
            {
              id: 'start',
              question: "Ein strenger Nullversuch trifft auf Ihrem Schreibtisch ein. Was ist Ihre Entscheidung?",
              branches: [
                { id: 'a', text: "Ablehnen – Nullergebnisse sind für unsere Zeitschrift nicht aufregend genug", nextNode: 'reject' },
                { id: 'b', text: "Accept — null findings are scientifically important", nextNode: 'accept' },
                { id: 'c', text: "Request additional analyses to find 'something interesting'", nextNode: 'fish' }
              ]
            },
            {
              id: 'reject',
              type: 'outcome',
              consequence: 'bad',
              title: "Die voreingenommene Entscheidung",
              text: "You reject the null study. The researcher, demoralized, files it away. The published literature now contains 3 positive trials and 0 negative trials. Future meta-analysts will see only the positives. Your decision — multiplied across thousands of editors — IS publication bias. You didn't suppress evidence maliciously. You just found it boring.",
              realCase: "Studien zeigen, dass Nullergebnisse mit einer um 50 % geringeren Wahrscheinlichkeit veröffentlicht werden. Als Grund geben die meisten Zeitschriftenredakteure „Mangel an Neuheit“ an. Der kumulative Effekt verzerrt die Evidenzbasis."
            },
            {
              id: 'accept',
              type: 'outcome',
              consequence: 'good',
              title: "Die gegenkulturelle Wahl",
              text: "You accept the null study with an editorial on the importance of publishing negative results. Meta-analysts now have a more complete picture: 3 positive trials and 1 negative. The effect estimate shrinks. Clinicians make better-informed decisions. You've contributed to truth — even though it won't boost your impact factor.",
              realCase: "PLOS ONE und andere Zeitschriften begrüßen jetzt ausdrücklich Nullergebnisse. Einige Fachzeitschriften konzentrieren sich auf negative Ergebnisse. Die Kultur verändert sich langsam."
            },
            {
              id: 'fish',
              type: 'outcome',
              consequence: 'bad',
              title: "Die p-Hacking-Einladung",
              text: "You ask: 'Did you check subgroups? Any secondary outcomes significant?' The researcher re-analyzes. In men over 65 with baseline cognitive impairment, there's a hint of effect (p=0.04). The paper is revised to emphasize this 'finding.' You've published — but you've also taught the researcher that fishing for significance is how to get published.",
              realCase: "Diese Dynamik – Redakteure fordern „interessante“ Neuanalysen – ist ein wesentlicher Treiber für p-Hacking und selektive Berichterstattung. Es entstehen falsch-positive Ergebnisse, die wie echte Ergebnisse aussehen."
            }
          ]
        }
      },
      {
        type: 'contrast',
        content: {
          title: "Two Funnels, Two Truths",
          darkSide: {
            header: "Der Trichter, der symmetrisch erschien",
            items: [
              "15 studies form a beautiful symmetric cone",
              "Egger's test: p=0.45 (not significant)",
              "Schlussfolgerung: „Keine Hinweise auf Publikationsbias“",
              "BUT: Registry search not performed",
              "ABER: Alle Studien wurden von der Industrie finanziert",
              "BUT: 8 registered trials have no published results"
            ],
            consequence: "Der Trichter sah sauber aus, weil die unveröffentlichten Studien nie veröffentlicht wurden geplottet. Abwesenheit in der Grafik ≠ Abwesenheit von der Realität."
          },
          lightSide: {
            header: "Der Trichter, der asymmetrisch erschien",
            items: [
              "12 Studien zeigen klare Asymmetrie",
              "Egger's test: p=0.02 (significant)",
              "Initial conclusion: 'Publication bias!'",
              "ABER: Kleine Studien wurden an kranken Patienten durchgeführt",
              "BUT: Larger effects in severe disease is expected",
              "BUT: Stratified analysis shows no bias within severity groups"
            ],
            consequence: "Der Trichter wirkte aufgrund echter Heterogenität voreingenommen. Die Asymmetrie war biologischer Natur, nicht Unterdrückung. Die Untersuchung hat die Wahrheit ans Licht gebracht."
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          title: "Interpreting Funnel Asymmetry",
          situation: "Ihr Trichterdiagramm zeigt eine deutliche Asymmetrie – unten links fehlen Studien. Sie haben 15 Studien in Ihrer Metaanalyse. Wie interpretieren Sie das?",
          nodes: [
            {
              id: 'start',
              question: "Sie sehen eine Funnel-Plot-Asymmetrie mit fehlenden kleinen negativen Studien. Was ist Ihre Interpretation?",
              branches: [
                { id: 'a', text: "Publication bias is confirmed — small negative studies weren't published", nextNode: 'bias_confirmed' },
                { id: 'b', text: "Check where missing studies fall relative to significance contours", nextNode: 'contours' },
                { id: 'c', text: "Untersuchen Sie, ob sich kleine Studien systematisch von großen unterscheiden", nextNode: 'heterogeneity' }
              ]
            },
            {
              id: 'bias_confirmed',
              type: 'outcome',
              consequence: 'bad',
              title: "Die voreilige Schlussfolgerung",
              text: "You conclude publication bias without considering alternatives. But asymmetry can have multiple causes. If small studies enrolled sicker patients (common in proof-of-concept trials), larger effects are EXPECTED. Your 'bias' may be biology. Always consider: Is there a clinical reason small studies might differ?",
              realCase: "Sterne et al. (BMJ 2011) dokumentierte, dass „Effekte kleiner Studien“ ein besserer Begriff als „Publikationsbias“ ist, da die Ursachen vielfältig sind."
            },
            {
              id: 'contours',
              question: "You add contour enhancement. Missing studies fall clearly in the p>0.05 region (non-significant). What does this suggest?",
              branches: [
                { id: 'd', text: "Publication bias is the most likely explanation", nextNode: 'bias_likely' },
                { id: 'e', text: "Could still be heterogeneity — need more investigation", nextNode: 'more_check' }
              ]
            },
            {
              id: 'bias_likely',
              type: 'outcome',
              consequence: 'good',
              title: "Die fundierte Bewertung",
              text: "Contour-enhanced plots show the 'missing' studies would have been non-significant. This pattern specifically suggests publication bias — studies weren't published BECAUSE they weren't significant. This doesn't prove bias exists, but it's the most parsimonious explanation. Report this finding with appropriate caveats.",
              realCase: "Peters et al. (JAMA 2008) introduced contour-enhanced funnel plots specifically to distinguish publication bias from heterogeneity."
            },
            {
              id: 'more_check',
              type: 'outcome',
              consequence: 'good',
              title: "Die gründliche Untersuchung",
              text: "You're right to be cautious. You also: (1) Check if small studies used different interventions/populations, (2) Run Egger's test (p=0.02), (3) Search registries for unpublished trials (find 3), (4) Compare industry vs. independent funding. Multiple lines of evidence strengthen your conclusion.",
              realCase: "Cochrane empfiehlt, sich nicht auf eine einzelne Methode zu verlassen. Visuelle, statistische und empirische (Registrierungssuche) Ansätze sollten kombiniert werden."
            },
            {
              id: 'heterogeneity',
              question: "You examine study characteristics. Small studies enrolled patients from specialty clinics; large studies enrolled from primary care. Severity differs. What now?",
              branches: [
                { id: 'f', text: "Dies erklärt die Asymmetrie – es ist Heterogenität, keine Verzerrung", nextNode: 'heterogeneity_explains' },
                { id: 'g', text: "Beides könnte wahr sein – Subgruppenanalyse UND Verzerrungsbewertung erforderlich", nextNode: 'both_true' }
              ]
            },
            {
              id: 'heterogeneity_explains',
              type: 'outcome',
              consequence: 'neutral',
              title: "Die Klinik Erläuterung",
              text: "Specialty clinics enroll sicker patients who may respond more to treatment (higher baseline = more room to improve). The 'asymmetry' reflects genuine effect modification, not suppression. You should do subgroup analysis by setting and report effects separately. The funnel wasn't lying — you were asking it the wrong question.",
              realCase: "In Studien zu Interventionen auf der Intensivstation zeigen kleinere monozentrische Studien häufig größere Effekte als multizentrische Studien – keine Verzerrung, sondern Unterschiede zwischen Fallmischungen."
            },
            {
              id: 'both_true',
              type: 'outcome',
              consequence: 'good',
              title: "Die nuancierte Wahrheit",
              text: "Heterogeneity AND publication bias can coexist. You stratify by setting and STILL see asymmetry within strata. You report: 'Effect modification by setting accounts for SOME asymmetry; residual asymmetry suggests possible publication bias.' You've separated the explainable from the suspicious.",
              realCase: "Diese mehrschichtige Analyse ist der Goldstandard. Erklären Sie zunächst, was klinisch möglich ist, und beurteilen Sie dann die verbleibende Asymmetrie auf Verzerrungen."
            }
          ]
        }
      },
      {
        type: 'clinical-guide',
        content: {
          title: "Funnel Plot Interpretation Checklist",
          items: [
            "LOOK: Is there asymmetry? Which direction? Which corner is 'missing'?",
            "CONTOUR: Do missing studies fall in significant or non-significant regions?",
            "COUNT: Do you have at least 10 studies? (Fewer = unreliable assessment)",
            "CHECK: Do small and large studies differ systematically (population, setting, quality)?",
            "TEST: Run Egger's test — but remember it's suggestive, not definitive",
            "SEARCH: Are there unpublished registered trials?",
            "VERGLEICHEN: Unterscheiden sich von der Industrie geförderte Studien von unabhängigen?",
            "REPORT: Describe the assessment process, not just the conclusion"
          ]
        }
      },
      {
        type: 'cycle-return',
        content: {
          principle: "Der Trichter enthüllt, was der Wald verbirgt. Lernen Sie, seine Form zu lesen – aber denken Sie daran, dass Asymmetrie ein Fingerabdruck ist, der mehreren Verdächtigen gehören kann."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "In a contour-enhanced funnel plot, if 'missing' studies would fall in the p>0.05 (non-significant) region, this most strongly suggests:",
          options: [
            { id: 'a', text: "Heterogenität zwischen Studien", correct: false },
            { id: 'b', text: "Publication bias — non-significant studies weren't published", correct: true },
            { id: 'c', text: "Die Metaanalyse enthält zu wenige Studien", correct: false },
            { id: 'd', text: "Das Effektmaß ist ungeeignet", correct: false }
          ],
          explanation: "When missing studies fall in non-significant regions, it suggests they weren't published BECAUSE they weren't significant — the hallmark of publication bias. If missing studies fell in significant regions, other explanations (heterogeneity, different populations) would be more likely. Contour enhancement helps make this distinction."
        }
      },
      {
        type: 'key-takeaways',
        content: {
          takeaways: [
            "Trichterdiagramme sollten symmetrisch sein WENN keine Publikationsverzerrung vorliegt (größere Studien gruppiert, kleinere Studien verteilt)",
            "Contour-enhanced funnel plots add significance regions to help distinguish bias from heterogeneity",
            "Missing studies in non-significant regions strongly suggest publication bias",
            "Missing studies in significant regions suggest other explanations (heterogeneity, true effect variation)",
            "Visual inspection is subjective — always combine with statistical tests"
          ],
          actionItem: "Üben Sie das Lesen von Trichterdiagrammen mit dem interaktiven Tool. Beginnen Sie mit der Identifizierung des Lückenmusters – wohin würden fehlende Studien fallen?"
        }
      }
    ]
  },

  // MODULE 3: THE STATISTICAL TESTS
  {
    id: 3,
    title: "The Tests",
    subtitle: "Statistical Detection",
    estimatedMinutes: 30,
    slides: [
      {
        type: 'learning-objectives',
        content: {
          intro: "By the end of this module, you will be able to:",
          objectives: [
            "Berechnen und interpretieren Sie Eggers Regressionstest für Funnel-Plot-Asymmetrie",
            "Explain when to use Begg's test vs Egger's test",
            "Recognize the limitations of statistical tests with <10 studies",
            "Interpret discordant test results (Egger's positive, Begg's negative)",
            "Apply appropriate thresholds (p<0.10) and understand why they differ from conventional p<0.05"
          ]
        }
      },
      {
        type: 'principle',
        content: {
          number: "III",
          text: "Das Auge ahnt, aber der Test quantifiziert. Doch kein Test kann erkennen, was wirklich passiert ist – nur das, was die Daten vermuten lassen."
        }
      },
      {
        type: 'rhetoric',
        content: {
          question: "Haben Sie nicht darüber nachgedacht, dass Eggers Regression die komplexe Frage nach versteckten Beweisen auf einen einzigen p-Wert reduziert – kraftvoll, aber gefährlich, suggestiv, aber nicht schlüssig?"
        }
      },
      {
        type: 'content',
        content: {
          title: "Egger's Regression Test",
          sections: [
            {
              heading: "The Logic",
              items: [
                "Regress effect size (standardized by SE) against precision (1/SE)",
                "If NO bias: intercept should be near zero",
                "If bias toward positive results: positive intercept",
                "Die Steigung spiegelt den wahren zugrunde liegenden Effekt wider."
              ]
            },
            {
              heading: "The Equation",
              items: [
                "Effect/SE = intercept + slope × (1/SE)",
                "Test whether intercept differs from 0",
                "Significant p-value (typically p<0.10) suggests asymmetry",
                "More liberal threshold (0.10 vs 0.05) because test has low power"
              ]
            },
            {
              heading: "Limitations",
              items: [
                "Low power with <10 studies — may miss real bias",
                "High false positive rate with heterogeneity",
                "Assumes linear relationship between effect and precision",
                "Different variants exist (Egger, Peters, Harbord) for different outcomes"
              ]
            }
          ]
        }
      },
      {
        type: 'tool-egger',
        content: {
          id: 'egger-test',
          title: "Egger's Test Calculator",
          description: "Geben Sie Studiendaten ein, um Eggers Regressionstest für den Trichterplot zu berechnen Asymmetrie."
        }
      },
      {
        type: 'content',
        content: {
          title: "Begg's Rank Correlation",
          sections: [
            {
              heading: "The Method",
              items: [
                "Correlate effect size ranks with variance ranks",
                "Uses Kendall's tau correlation",
                "If NO bias: no correlation (tau near 0)",
                "If bias: positive correlation (large effects with large variance)"
              ]
            },
            {
              heading: "Vergleich mit Eggers",
              items: [
                "Less powerful than Egger's (rank-based loses information)",
                "But makes fewer parametric assumptions",
                "Better for non-normally distributed effects",
                "Often reported alongside Egger's for completeness"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Harbord's Test for Binary Outcomes",
          sections: [
            {
              heading: "Warum ein anderer Test für Binärdaten?",
              items: [
                "Egger's test has inflated Type I error with binary outcomes (OR, RR)",
                "Die Beziehung zwischen Effekt und Präzision ist für Verhältnisse mathematisch eingeschränkt",
                "Harbords Test verwendet punktzahlbasierte Statistiken, die Folgendes berücksichtigen Dies",
                "Peters' test is an alternative using sample size rather than SE"
              ]
            },
            {
              heading: "When to Use Harbord's vs Egger's",
              items: [
                "BINARY outcomes (OR, RR, RD): Use Harbord's or Peters' test",
                "CONTINUOUS outcomes (MD, SMD): Use Egger's test",
                "SURVIVAL outcomes (HR): Harbord's or modified tests",
                "Regel: Passen Sie den Test an Ihr Wirkungsmaß an"
              ]
            },
            {
              heading: "Peters' Test (Alternative)",
              items: [
                "Regress effect on 1/n (inverse sample size) instead of SE",
                "Less prone to false positives than Egger's for OR",
                "Recommended by Cochrane for meta-analyses of odds ratios",
                "Similar interpretation: significant intercept suggests asymmetry"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Newer Alternatives: Doi Plot and LFK Index",
          sections: [
            {
              heading: "Doi Plot",
              items: [
                "Plots Z-scores against a normal quantile (|Z|) axis",
                "Creates an asymmetric pattern that's easier to read than funnel plots",
                "Große Asymmetrie: offensichtliche Abweichung von der Linie",
                "More sensitive to asymmetry patterns than traditional funnel"
              ]
            },
            {
              heading: "LFK Index",
              items: [
                "Quantifies Doi plot asymmetry as a single number",
                "LFK > 1 or < -1: Minor asymmetry",
                "LFK > 2 or < -2: Major asymmetry",
                "Provides objective measure rather than relying on visual assessment"
              ]
            },
            {
              heading: "When to Use",
              items: [
                "Consider as supplement to funnel plot + Egger's",
                "Particularly useful when visual assessment is ambiguous",
                "Available in some meta-analysis software (R metafor, Stata)",
                "Not yet universally adopted — mention if used"
              ]
            }
          ]
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "CASE 3A",
          title: "When Tests Disagree: The Statin Example",
          source: "Naci et al., BMJ 2013 — Meta-analysis of statins for mortality",
          timeline: [
            { year: "The Data", text: "29 trials of statins vs placebo/usual care for all-cause mortality. Forest plot shows significant benefit (RR 0.86). Funnel plot shows... some asymmetry.", type: "normal" },
            { year: "Egger's Test", text: "p = 0.12. Not significant at 0.10 threshold. Suggests no publication bias.", type: "normal" },
            { year: "Begg's Test", text: "p = 0.08. Borderline significant. Suggests possible publication bias.", type: "normal" },
            { year: "The Dilemma", text: "Tests disagree. Visual inspection shows some gap in bottom-left. What to conclude?", type: "buried" },
            { year: "The Resolution", text: "Authors report BOTH tests, note discordance, state 'some evidence of small-study effects.' Transparency > certainty.", type: "revealed" }
          ],
          realData: {
            eggerP: "p = 0.12 (not significant)",
            beggP: "p = 0.08 (borderline)",
            studies: "29 trials",
            visualAssessment: "Mild asymmetry visible",
            conclusion: "Unsicher – mit Vorbehalten gemeldet"
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          title: "Interpreting Discordant Tests",
          situation: "Your meta-analysis has 18 studies. Egger's test: p=0.04 (significant). Begg's test: p=0.21 (not significant). Visual inspection shows mild asymmetry. Your funnel has moderate heterogeneity (I²=55%). What do you conclude?",
          nodes: [
            {
              id: 'start',
              question: "Eggers ist signifikant, Beggs nicht, visuell zeigt leichte Asymmetrie. Was ist Ihre Interpretation?",
              branches: [
                { id: 'a', text: "Egger's is more powerful — publication bias is present", nextNode: 'egger_rules' },
                { id: 'b', text: "Tests stimmen nicht überein – Beweise sind nicht schlüssig", nextNode: 'inconclusive' },
                { id: 'c', text: "Check if heterogeneity could explain the discordance", nextNode: 'heterogeneity' }
              ]
            },
            {
              id: 'egger_rules',
              type: 'outcome',
              consequence: 'bad',
              title: "The Oversimplification",
              text: "While Egger's IS more powerful, it's also more prone to false positives when heterogeneity exists. Your I²=55% is substantial. The 'asymmetry' Egger's detected may be effect modification, not bias. Concluding 'bias present' without addressing heterogeneity is premature.",
              realCase: "Sterne et al. zeigte, dass Eggers Test die Typ-I-Fehlerraten erhöht hat, wenn Heterogenität vorliegt. Der Test erkennt Asymmetrie, nicht speziell Voreingenommenheit."
            },
            {
              id: 'inconclusive',
              type: 'outcome',
              consequence: 'neutral',
              title: "Die ehrliche Bewertung",
              text: "You report: 'Evidence for publication bias is mixed. Egger's test was significant (p=0.04) but Begg's was not (p=0.21). Visual asymmetry is mild. In the presence of moderate heterogeneity (I²=55%), these tests have limited reliability. We cannot confidently assess publication bias.' This is honest but unhelpful for decision-making.",
              realCase: "Viele Metaanalysen erreichen diesen unbequemen Mittelweg. Transparenz über Unsicherheit ist wertvoll, aber die Leser brauchen Orientierung."
            },
            {
              id: 'heterogeneity',
              question: "Sie recherchieren weiter. Kleine Studien stammten aus Asien (verschiedene Bevölkerungsgruppen), große Studien aus Europa/USA. Der Schweregrad der Erkrankung war je nach Region unterschiedlich. Was nun?",
              branches: [
                { id: 'd', text: "Heterogenität erklärt die Asymmetrie – es ist kein Publikationsbias", nextNode: 'explained' },
                { id: 'e', text: "Führen Sie eine stratifizierte Analyse nach Region durch und testen Sie innerhalb von Schichten", nextNode: 'stratify' }
              ]
            },
            {
              id: 'explained',
              type: 'outcome',
              consequence: 'good',
              title: "Die klinische Einsicht",
              text: "The apparent 'asymmetry' reflects genuine regional differences in populations and disease. Asian populations had more severe disease (baseline risk 25% vs 15%), explaining larger effects in smaller trials. This is heterogeneity, not suppression. You report this finding — it's clinically important and explains the discordant tests.",
              realCase: "In cardiovascular trials, regional differences in baseline risk routinely cause heterogeneity that can mimic publication bias on funnel plots."
            },
            {
              id: 'stratify',
              type: 'outcome',
              consequence: 'good',
              title: "Die geschichtete Beurteilung",
              text: "Within Asian studies (8 trials): no asymmetry, Egger p=0.45. Within European studies (10 trials): no asymmetry, Egger p=0.38. The POOLED asymmetry was confounded by region. Publication bias is now considered unlikely — the heterogeneity between regions created the apparent funnel asymmetry.",
              realCase: "Stratified funnel plots (by subgroup) can reveal that apparent bias is actually confounding by a third variable."
            }
          ]
        }
      },
      {
        type: 'clinical-guide',
        content: {
          title: "Statistical Test Interpretation Guide",
          items: [
            "SAMPLE SIZE: With <10 studies, tests have very low power — don't trust a negative result",
            "CONCORDANCE: If Egger's, Begg's, AND visual all agree, confidence is higher",
            "HETEROGENEITY: High I² inflates false positives for Egger's — interpret cautiously",
            "WIRKUNGSMESSUNG: Verwenden Sie den Peters-Test für OR (bessere Eigenschaften als der Egger-Test für binäre Ergebnisse)",
            "REPORT BOTH: Always report Egger's AND visual assessment, note any discordance",
            "THRESHOLD: p<0.10 is conventional (not 0.05) because of low power",
            "NEVER CONCLUDE 'NO BIAS': A non-significant test doesn't prove absence of bias"
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "When Publication Bias Is Less of a Concern",
          sections: [
            {
              heading: "Anzeichen, die die Besorgnis verringern",
              items: [
                "HARD OUTCOMES: Mortality, hospitalization — harder to manipulate or spin than 'quality of life'",
                "LARGE TRIALS: Fewer small studies means less selective publishing opportunity",
                "PROSPECTIVE REGISTRATION: All trials registered before starting, with pre-specified outcomes",
                "INDEPENDENT REPLICATION: Non-industry trials confirm industry findings",
                "SYMMETRIC FUNNEL: Visual inspection shows no gap, tests negative, registry search finds no missing trials"
              ]
            },
            {
              heading: "Die ausgewogene Perspektive",
              items: [
                "Not every asymmetric funnel means suppression",
                "Not every meta-analysis of drug trials is biased",
                "Publication bias is ONE threat to validity — consider others too",
                "Das Ziel ist eine genaue Beurteilung, nicht ein Maximum Skepsis"
              ]
            }
          ]
        }
      },
      {
        type: 'contrast',
        content: {
          title: "Two Meta-Analyses: Different Risk Profiles",
          darkSide: {
            header: "HIGH RISK for Publication Bias",
            items: [
              "Subjective outcome (pain scores, depression scales)",
              "All trials industry-funded",
              "Multiple small trials, few large confirmatory",
              "No prospective registration",
              "Asymmetric funnel, all published trials positive",
              "Registry shows unpublished completed trials"
            ],
            consequence: "Interpretation: Treat effect estimates with high suspicion. Apply corrections, search for unpublished data, downgrade GRADE for bias."
          },
          lightSide: {
            header: "LOW RISK for Publication Bias",
            items: [
              "Objective outcome (all-cause mortality)",
              "Mix of industry and government-funded trials",
              "Includes large multicenter confirmatory trials",
              "Most trials prospectively registered",
              "Symmetrischer Trichter, Mischung aus positiven und Null-Ergebnissen",
              "Registry search finds no missing completed trials"
            ],
            consequence: "Interpretation: Publication bias is a lesser concern (not zero, but modest). Focus assessment on other biases: allocation concealment, attrition, etc."
          }
        }
      },
      {
        type: 'cycle-return',
        content: {
          principle: "The eye suspects, but the test quantifies. Yet remember: the test detects asymmetry, not bias. Asymmetry is a clue; bias is a conclusion that requires judgment."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Your meta-analysis has 8 studies. Egger's test gives p=0.23. You should conclude:",
          options: [
            { id: 'a', text: "No publication bias is present", correct: false },
            { id: 'b', text: "Ein Publikationsbias kann vorhanden sein oder auch nicht – der Test hat mit 8 Studien eine geringe Aussagekraft", correct: true },
            { id: 'c', text: "Die Metaanalyse ist gültig und unvoreingenommen", correct: false },
            { id: 'd', text: "You need to use Begg's test instead", correct: false }
          ],
          explanation: "With only 8 studies, Egger's test has very low power to detect publication bias even when it exists. A non-significant result does NOT mean no bias — it means the test couldn't detect it. Cochrane recommends at least 10 studies for meaningful interpretation of these tests. You should report the test result but not over-interpret a negative finding."
        }
      },
      {
        type: 'common-mistakes',
        content: {
          mistakes: [
            { mistake: "Concluding 'no bias' from non-significant test", correction: "Non-significant tests may lack power — especially with <10 studies. Say 'insufficient evidence to detect bias.'" },
            { mistake: "Ignoring heterogeneity when interpreting Egger's", correction: "Hohe I²-Erhöhungen falsch positive Quote für Egger's. Prüfen Sie auf Störfaktoren, bevor Sie zu einer Verzerrung kommen." },
            { mistake: "Only using one test", correction: "Report Egger's AND visual assessment. Note concordance or discordance. Neither alone is sufficient." },
            { mistake: "Using standard p<0.05 threshold", correction: "Convention uses p<0.10 for publication bias tests because of low power. Adjust your interpretation." }
          ]
        }
      },
      {
        type: 'key-takeaways',
        content: {
          takeaways: [
            "Egger's test: regression-based, more powerful but sensitive to heterogeneity",
            "Begg's test: rank-based, less powerful but more robust to distributional assumptions",
            "Use p<0.10 threshold (not 0.05) due to low power of these tests",
            "With <10 studies, tests have very limited value — rely more on visual assessment and external evidence",
            "Discordant tests often indicate heterogeneity is confounding the assessment"
          ],
          actionItem: "For your next meta-analysis, plan to report: visual funnel plot, Egger's test with p-value, sample size, and heterogeneity (I²) to contextualize findings."
        }
      }
    ]
  },

  // MODULE 4: THE CORRECTION
  {
    id: 4,
    title: "The Correction",
    subtitle: "Anpassung der Verzerrung",
    estimatedMinutes: 35,
    slides: [
      {
        type: 'learning-objectives',
        content: {
          intro: "By the end of this module, you will be able to:",
          objectives: [
            "Wenden Sie die Trim-and-Fill-Methode an, interpretieren Sie sie und verstehen Sie ihre Annahmen",
            "Explain PET-PEESE regression and when it outperforms Trim-and-Fill",
            "Verwenden Sie das Fail-Safe N, um die Robustheit zu bewerten (mit geeigneten Vorbehalte)",
            "Beschreiben Sie Auswahlmodelle (Copas, 3PSM) und ihre Rolle bei der Sensitivitätsanalyse",
            "Wählen Sie geeignete Korrekturmethoden basierend auf Datenmerkmalen"
          ]
        }
      },
      {
        type: 'principle',
        content: {
          number: "IV",
          text: "Um abzuschätzen, was verborgen war, muss man Schatten erraten – notwendig, aber verwechseln Sie die Schätzung niemals mit der Wahrheit."
        }
      },
      {
        type: 'rhetoric',
        content: {
          question: "Haben Sie nicht darüber nachgedacht, dass Trim-and-Fill Studien „unterstellt“, die möglicherweise nie existiert haben – eine statistische Vermutung, keine Wiederherstellung vergrabener Beweise?"
        }
      },
      {
        type: 'content',
        content: {
          title: "Trim-and-Fill-Methode",
          sections: [
            {
              heading: "The Logic",
              items: [
                "1. TRIM: Entfernen Sie die extremsten kleinen Studien von der asymmetrischen Seite",
                "2. SCHÄTZUNG: Berechnen Sie den gepoolten Effekt aus den verbleibenden (symmetrischen) Studien.",
                "3. FILL: Add imputed mirror-image studies to create symmetry",
                "4. RE-ESTIMATE: Calculate adjusted pooled effect including imputed studies"
              ]
            },
            {
              heading: "The Assumption",
              items: [
                "Asymmetry is ENTIRELY due to suppression of small negative studies",
                "Der „wahre“ Trichter wäre symmetrisch um den wahren Effekt.",
                "Fehlende Studien sind Spiegelbilder der beobachteten asymmetrischen Studien"
              ]
            },
            {
              heading: "The Limitations",
              items: [
                "If asymmetry is due to heterogeneity (not bias), trim-and-fill OVERCORRECTS",
                "Imputierte Studien sind fiktiv – sie repräsentieren möglicherweise keine echten, unveröffentlichten Studien.",
                "Stellt tatsächlich fehlende Daten nicht wieder her, sondern schätzt nur, was sie möglicherweise anzeigen.",
                "Performance varies; can under- or over-correct depending on true mechanism"
              ]
            }
          ]
        }
      },
      {
        type: 'tool-trimfill',
        content: {
          id: 'trim-fill-tool',
          title: "Visualisierung zum Trimmen und Füllen",
          description: "Sehen Sie, wie Trim-and-Fill fehlende Studien imputiert und die gepoolten Daten anpasst Effekt."
        }
      },
      {
        type: 'content',
        content: {
          title: "PET-PEESE: Precision-Effect Testing",
          sections: [
            {
              heading: "What is PET-PEESE?",
              items: [
                "An alternative to trim-and-fill that estimates bias-corrected effects via regression",
                "PET = Precision-Effect Test: regress effect on SE, intercept estimates bias-corrected effect",
                "PEESE = Precision-Effect Estimate with Standard Error: regress effect on SE², better when true effect exists",
                "Two-step conditional estimator: Use PET to test if effect exists, then PEESE to estimate it"
              ]
            },
            {
              heading: "Der zweistufige Prozess",
              items: [
                "STEP 1 (PET): Regress effect sizes on standard errors (effect = β₀ + β₁×SE)",
                "If PET intercept β₀ is significant (p<0.10): True effect likely exists → use PEESE",
                "STEP 2 (PEESE): Regress effect sizes on variance (effect = β₀ + β₁×SE²)",
                "PEESE intercept provides bias-corrected effect estimate",
                "Wenn PET nicht signifikant: Keine Evidenz für einen echten Effekt jenseits der Verzerrung schließen"
              ]
            },
            {
              heading: "Vorteile gegenüber Trim-and-Fill",
              items: [
                "Better performance in simulations when publication bias is moderate to severe",
                "Provides explicit test of whether true effect exists after accounting for bias",
                "Less assumption-dependent than selection models",
                "Works with meta-regression framework — can include moderators"
              ]
            },
            {
              heading: "Limitations",
              items: [
                "Erfordert mehr als 10 Studien für Zuverlässigkeit Schätzungen",
                "Assumes linear relationship between effect and SE/variance",
                "Can over-correct when heterogeneity explains small-study effects",
                "PET can have low power to detect true effects"
              ]
            }
          ]
        }
      },
      {
        type: 'tool-petpeese',
        content: {
          id: 'pet-peese-tool',
          title: "PET-PEESE Calculator",
          description: "Geben Sie Ihre Metaanalysedaten ein, um PET- und PEESE-Bias-korrigierte Schätzungen zu berechnen."
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "CASE 4A",
          title: "Trim-and-Fill vs Reality: The Antidepressant Test",
          source: "Turner et al. NEJM 2008 — Comparing estimate to FDA truth",
          timeline: [
            { year: "The Opportunity", text: "Turner verfügte über BEIDE: veröffentlichte Literatur UND das vollständige Studienregister der FDA. Dies ermöglichte einen seltenen Test: Schätzt Trim-and-Fill die unveröffentlichten Daten richtig?", type: "normal" },
            { year: "Published Only", text: "Meta-analysis of published trials: effect size = 0.41 (strongly effective)", type: "normal" },
            { year: "Trim-and-Fill", text: "Applied to published data: imputes 6 studies, adjusted effect = 0.34. A 17% reduction.", type: "normal" },
            { year: "FDA Truth", text: "Including ALL FDA trials (published + unpublished): effect size = 0.31. True reduction was 24%.", type: "revealed" },
            { year: "The Verdict", text: "Trim-and-Fill hat die Verzerrung UNTERSCHÄTZT. Es hat etwas korrigiert, aber nicht genug. Besser als nichts, aber kein Ersatz für tatsächliche Daten.", type: "revealed" }
          ],
          realData: {
            publishedEffect: "d = 0.41",
            trimFillEffect: "d = 0.34 (17% reduction)",
            trueEffect: "d = 0.31 (24% reduction)",
            trimFillAccuracy: "~70 % der Verzerrung korrigiert"
          }
        }
      },
      {
        type: 'content',
        content: {
          title: "Selection Models",
          sections: [
            {
              heading: "The Concept",
              items: [
                "Explicitly model the PROBABILITY of publication",
                "P(published) depends on p-value, effect direction, or statistical significance",
                "Auswahlfunktionsparameter aus den beobachteten Daten schätzen",
                "Adjust effect estimate accounting for estimated selection"
              ]
            },
            {
              heading: "Common Selection Models",
              items: [
                "3PSM: Three-parameter selection model — step function at p=0.05",
                "Copas model: Continuous selection probability based on effect and variance",
                "Weight-function models: Flexible specification of selection weights"
              ]
            },
            {
              heading: "Vorteile gegenüber Trim-and-Fill",
              items: [
                "Explicitly models the selection mechanism",
                "Can accommodate more complex selection patterns",
                "Stellt Unsicherheitsintervalle bereit, die die Auswahlunsicherheit berücksichtigen"
              ]
            },
            {
              heading: "Disadvantages",
              items: [
                "Erfordert Annahmen über die Auswahl Funktion",
                "Kann bei wenigen Studien instabil sein",
                "Multiple models can give different answers"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "P-Curve Analysis",
          sections: [
            {
              heading: "The Logic",
              items: [
                "Examine the DISTRIBUTION of significant p-values (p<0.05)",
                "If true effect exists: p-curve should be RIGHT-SKEWED (many p<0.01)",
                "If no effect + selective reporting: p-curve is FLAT or LEFT-SKEWED",
                "If p-hacking: spikes just below 0.05"
              ]
            },
            {
              heading: "Interpretation",
              items: [
                "Rechtsschiefe p-Kurve: Beleg für wahre Wirkung",
                "Flat p-curve: Suggests no true effect (or underpowered studies)",
                "Left-skewed: Suggests selective reporting or p-hacking",
                "Spike at 0.04-0.05: Classic p-hacking signature"
              ]
            }
          ]
        }
      },
      {
        type: 'tool-pcurve',
        content: {
          id: 'pcurve-tool',
          title: "P-Curve Analyzer",
          description: "Geben Sie p-Werte aus bedeutenden Studien ein, um den Beweiswert zu bewerten."
        }
      },
      {
        type: 'content',
        content: {
          title: "Fail-Safe N (Rosenthal Methode)",
          sections: [
            {
              heading: "The Concept",
              items: [
                "Wie viele unveröffentlichte Nullstudien müssten vorhanden sein, damit Ihr Ergebnis nicht signifikant ist?",
                "Wenn die Zahl groß ist, ist das Ergebnis „robust“ gegenüber Publikationsverzerrungen.",
                "Wenn die Zahl gering ist, könnten ein paar Aktenladenstudien Ihr Ergebnis zunichte machen Schlussfolgerung"
              ]
            },
            {
              heading: "The Formula",
              items: [
                "N = (ΣZ / 1.645)² - k, where k = number of studies",
                "Alternatively: N = k × (mean Z / 1.645)² - k",
                "Rule of thumb: N > 5k + 10 suggests robustness"
              ]
            },
            {
              heading: "Limitations (Important!)",
              items: [
                "Assumes missing studies have EXACTLY zero effect (unrealistic)",
                "Doesn't account for systematic bias in effect direction",
                "Can give misleadingly large N when effects are inflated",
                "Moderne Methoden (Auswahlmodelle, Trim-and-Fill) werden bevorzugt"
              ]
            }
          ]
        }
      },
      {
        type: 'tool-failsafe',
        content: {
          id: 'failsafe-tool',
          title: "Fail-Safe N Calculator",
          description: "Berechnen Sie, wie viele Nullstudien vorhanden sein müssten, um Ihr metaanalytisches Ergebnis zu annullieren."
        }
      },
      {
        type: 'contrast',
        content: {
          title: "Two Approaches to Bias Correction",
          darkSide: {
            header: "Der übermütige Analyst",
            items: [
              "Runs trim-and-fill once",
              "Reports adjusted estimate as 'true effect'",
              "Ignores model assumptions",
              "Discordant wird zurückgewiesen Methoden",
              "Claims bias has been 'corrected'"
            ],
            consequence: "Result: False precision. Readers believe the adjusted number. If assumptions wrong, they're misled. The overconfidence perpetuates poor practice."
          },
          lightSide: {
            header: "Der bescheidene Analyst",
            items: [
              "Runs multiple methods (trim-fill, selection models, PET-PEESE)",
              "Reports a RANGE of plausible effects",
              "States assumptions explicitly",
              "Notes when methods disagree (that's informative!)",
              "Acknowledges uncertainty in all corrections"
            ],
            consequence: "Ergebnis: Ehrliche Unsicherheit. Die Leser sehen die Grenzen. Entscheidungsträger verstehen das Risiko. Die Wissenschaft schreitet durch anerkannte Einschränkungen voran."
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          title: "Auswahl einer Korrekturmethode",
          situation: "Your meta-analysis shows significant funnel asymmetry (Egger p=0.02). You want to estimate a bias-adjusted effect. Which method should you use?",
          nodes: [
            {
              id: 'start',
              question: "Sie haben eine wahrscheinliche Publikationsverzerrung festgestellt. Wie passen Sie Ihre Schätzung an?",
              branches: [
                { id: 'a', text: "Use trim-and-fill — it's the most widely recognized", nextNode: 'trimfill' },
                { id: 'b', text: "Use a selection model — it models the mechanism", nextNode: 'selection' },
                { id: 'c', text: "Melden Sie die nicht angepasste Schätzung mit Vorbehalten – Korrekturen sind unzuverlässig", nextNode: 'noadjust' }
              ]
            },
            {
              id: 'trimfill',
              question: "Trim-and-Fill imputiert 4 Studien. Der angepasste Effekt sinkt von OR 0,65 auf OR 0,78. Melden Sie dies als den „wahren“ Effekt?",
              branches: [
                { id: 'd', text: "Ja – die angepasste Schätzung korrigiert die Verzerrung", nextNode: 'overclaim' },
                { id: 'e', text: "Report both estimates as sensitivity analysis", nextNode: 'sensitivity' }
              ]
            },
            {
              id: 'overclaim',
              type: 'outcome',
              consequence: 'bad',
              title: "Die falsche Gewissheit",
              text: "Trim-and-Fill korrigiert einen VERMUSSTEN Mechanismus. Wenn die Asymmetrie teilweise auf Heterogenität (nicht auf Voreingenommenheit) beruhte, haben Sie überkorrigiert. Wenn es sich um eine starke Verzerrung handelte, haben Sie unterkorrigiert. Die Darstellung der angepassten Schätzung als „Wahrheit“ führt zu falscher Präzision. Sie wissen nicht, welches Szenario zutrifft.",
              realCase: "Die Antidepressivum-Analyse von Turner zeigte, dass Trim-and-Fill nur etwa 70 % des tatsächlichen Bias erfasste – immer noch eine beträchtliche Restinflation."
            },
            {
              id: 'sensitivity',
              type: 'outcome',
              consequence: 'good',
              title: "Das ehrliche Sortiment",
              text: "Sie berichten: „Unbereinigt ODER 0,65 (0,55–0,77).“ Trim-and-Fill angepasst ODER 0,78 (0,65–0,94). Der wahre Effekt liegt wahrscheinlich in diesem Bereich.' Sie haben die Unsicherheit angemessen vermittelt. Leser können erkennen, dass Schlussfolgerungen empfindlich auf Verzerrungsannahmen reagieren.",
              realCase: "Dieser Ansatz – unbereinigt und angepasst als Grenzen meldend – wird von mehreren Methodikern empfohlen."
            },
            {
              id: 'selection',
              question: "Sie führen ein 3-Parameter-Auswahlmodell aus. Es ergibt sich ein OR von 0,82 (0,68–0,99), was auf eine stärkere Verzerrung als beim Trimmen und Füllen hindeutet. Ein Copas-ergibtModell OR 0,75 (0,60–0,93), was weniger bedeutet. Was machst du?",
              branches: [
                { id: 'f', text: "Mitteln Sie die Modelle", nextNode: 'average' },
                { id: 'g', text: "Report all models as sensitivity analyses showing range of plausible adjustments", nextNode: 'range' }
              ]
            },
            {
              id: 'average',
              type: 'outcome',
              consequence: 'bad',
              title: "Die falsche Synthese",
              text: "Durch die Mittelung von Modellen mit unterschiedlichen Annahmen erhalten Sie nicht „die Wahrheit“, sondern eine Zahl, die möglicherweise keiner aussagekräftigen Größe entspricht. Die Modelle stimmen nicht überein, da sie unterschiedliche Annahmen treffen. Die Meinungsverschiedenheit IST die Information, nicht etwas, das weggemittelt werden kann.",
              realCase: "Modellmittelung bei der Bias-Korrektur kann bei richtiger Gewichtung angemessen sein, aber die einfache Mittelung von Punktschätzungen verschleiert die Modellunsicherheit, die das wichtigste Ergebnis ist."
            },
            {
              id: 'range',
              type: 'outcome',
              consequence: 'good',
              title: "Das vollständige Bild",
              text: "You report: 'Adjustments range from OR 0.75 (Copas) to OR 0.82 (3PSM). All adjusted estimates remain significant but are attenuated from the unadjusted OR 0.65. We cannot determine which selection model best represents the true mechanism, but results suggest the unadjusted estimate is inflated by approximately 15-25%.'",
              realCase: "Diese transparente Berichterstattung über Modellunsicherheit folgt Best Practices für Sensitivitätsanalyse."
            },
            {
              id: 'noadjust',
              type: 'outcome',
              consequence: 'neutral',
              title: "Die konservative Wahl",
              text: "You report the unadjusted effect with a clear warning: 'Funnel plot asymmetry suggests publication bias (Egger p=0.02). The reported effect (OR 0.65) is likely inflated. Bias-adjusted estimates vary depending on assumptions. Interpret with caution.' This is honest but may frustrate readers wanting a 'corrected' number.",
              realCase: "Einige Methodologen argumentieren, dass dies der einzig vertretbare Ansatz ist – Korrekturen sind zu modellabhängig, um zuverlässig zu sein."
            }
          ]
        }
      },
      {
        type: 'clinical-guide',
        content: {
          title: "Bias Correction Best Practices",
          items: [
            "Behaupten Sie NIEMALS, dass eine angepasste Schätzung der „wahre“ Effekt ist – es ist eine Sensitivität Analyse",
            "REPORT BOTH: Original estimate AND adjusted estimate(s) as bounding scenarios",
            "TRY MULTIPLE METHODS: If they all agree, more confidence; if they disagree, that's important",
            "TATSÄCHLICHE DATEN SUCHEN: Registersuchen und FOIA sind besser als statistische Korrekturen",
            "CONSIDER THE MECHANISM: Is asymmetry likely bias, heterogeneity, or both?",
            "STATE ASSUMPTIONS: Make clear what assumptions each correction method requires",
            "DOWNGRADE GRADE: If substantial bias likely, reduce certainty regardless of adjustment"
          ]
        }
      },
      {
        type: 'cycle-return',
        content: {
          principle: "Um abzuschätzen, was verborgen war, muss man Schatten erraten. Statistische Korrekturen sind Werkzeuge zur Sensitivitätsanalyse, nicht zur Wiederherstellung der Wahrheit. Der einzig sichere Weg zur Wahrheit besteht darin, die tatsächlich verborgenen Daten zu finden."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Trimmen und Füllen passt Ihren gepoolten Effekt von OR 0,60 auf OR 0,75 an. Was können Sie daraus schließen?",
          options: [
            { id: 'a', text: "Der wahre Effekt beträgt OR 0,75", correct: false },
            { id: 'b', text: "Der wahre Effekt liegt irgendwo zwischen OR 0,60 und OR 0,75", correct: false },
            { id: 'c', text: "Wenn der Publikationsbias die Ursache für die Asymmetrie ist, liegt der Effekt möglicherweise näher bei OR 0,75, aber diese Korrektur ist es unsicher", correct: true },
            { id: 'd', text: "Die Metaanalyse ist unzuverlässig und sollte nicht veröffentlicht werden", correct: false }
          ],
          explanation: "Trim-and-fill provides a plausible adjustment IF publication bias is the true cause of asymmetry AND IF the missing studies would be mirror-images of observed studies. These are strong assumptions. The adjusted estimate is a sensitivity analysis, not a definitive correction. Turner's comparison showed trim-and-fill only partially corrected for actual bias."
        }
      },
      {
        type: 'patient-communication',
        content: {
          scenario: "Ein Patient fragt nach einem neuen Medikament. Sie wissen, dass eine aktuelle Metaanalyse dies unterstützt, aber Sie sind sich der Bedenken bezüglich der Publikationsverzerrung bewusst.",
          script: "The research generally supports this medication, but I want to be honest with you — studies with positive results are more likely to get published than negative ones. The overall evidence suggests benefit, but the true effect might be somewhat smaller than the published studies show. Based on your specific situation, I think the potential benefits still outweigh the risks, but let's monitor closely and adjust if needed.",
          keyPoints: [
            "Acknowledge uncertainty without causing undue alarm",
            "Explain publication bias in accessible terms",
            "Frame in context of patient's individual risk-benefit",
            "Emphasize shared decision-making and monitoring"
          ]
        }
      },
      {
        type: 'key-takeaways',
        content: {
          takeaways: [
            "Trim-and-Fill unterstellt spiegelbildliche Studien – korrigiert etwa 70 % der Verzerrungen in Validierungsstudien",
            "PET-PEESE uses regression to estimate bias-corrected effects — two-step conditional estimator",
            "Selection models (3PSM, Copas) explicitly model publication probability — more flexible but complex",
            "P-curve analyzes distribution of p-values to detect p-hacking or evidential value",
            "Alle Korrekturen sind Sensitivitätsanalysen, keine Wahrheitswiederherstellung – es ist immer besser, tatsächliche Daten zu finden"
          ],
          actionItem: "Für Sie Führen Sie bei der nächsten Metaanalyse sowohl Trim-and-Fill als auch PET-PEESE als Sensitivitätsanalysen durch. Melden Sie beides zusammen mit Ihrer Hauptschätzung."
        }
      }
    ]
  },

  // MODULE 5: THE HUNT
  {
    id: 5,
    title: "The Hunt",
    subtitle: "Versteckte Beweise finden",
    estimatedMinutes: 25,
    slides: [
      {
        type: 'learning-objectives',
        content: {
          intro: "By the end of this module, you will be able to:",
          objectives: [
            "Durchsuchen Sie ClinicalTrials.gov und andere Register nach unveröffentlichten Studien",
            "File FOIA requests and navigate regulatory document access",
            "Bewerten Sie die Qualität und Benutzerfreundlichkeit grauer Literaturquellen",
            "Contact trialists systematically to request unpublished data",
            "Build a comprehensive search strategy that goes beyond published literature"
          ]
        }
      },
      {
        type: 'principle',
        content: {
          number: "V",
          text: "Better to find one buried study than to impute ten imaginary ones."
        }
      },
      {
        type: 'rhetoric',
        content: {
          question: "Haben Sie nicht gesehen, wie das geht? ClinicalTrials.gov zeichnet auf, was BEGONNEN wurde – und ein Vergleich mit dem, was VERÖFFENTLICHT wurde, zeigt den Friedhof der aufgegebenen Ergebnisse?"
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "CASE 5A",
          title: "The Registry Detective: Ross's Investigation",
          source: "Ross et al., JAMA 2009 — Tracking trials from registration to publication",
          timeline: [
            { year: "The Method", text: "Ross identified all trials registered on ClinicalTrials.gov in 2002. Followed them for 5 years. Did they get published?", type: "normal" },
            { year: "The Findings", text: "Of 677 registered trials, only 46% published within 5 years. Positive trials: 61% published. Negative/null trials: 34% published.", type: "buried" },
            { year: "The Gap", text: "Industry-funded trials: 40% published. NIH-funded: 56%. Academic non-profit: 56%. Industry was worst at publishing.", type: "buried" },
            { year: "The Implication", text: "Register legen offen, welche Veröffentlichungszahlen fehlen. Die für Ärzte sichtbare Evidenzbasis beträgt weniger als die Hälfte der vorhandenen Evidenzbasis.", type: "revealed" }
          ],
          realData: {
            registered: "677 trials in 2002",
            published5yr: "46% published within 5 years",
            positivePublished: "61%",
            negativePublished: "34%",
            industryPublished: "40%",
            academicPublished: "56%"
          }
        }
      },
      {
        type: 'content',
        content: {
          title: "Trial Registry Searching",
          sections: [
            {
              heading: "Key Registries",
              items: [
                "ClinicalTrials.gov — Largest, US-based, required for many trials",
                "ISRCTN — International, especially European trials",
                "EU Clinical Trials Register — European Medicines Agency database",
                "WHO ICTRP — Search portal for multiple registries worldwide",
                "Disease-specific registries (e.g., oncology, cardiovascular)"
              ]
            },
            {
              heading: "Worauf Sie achten sollten",
              items: [
                "ABGESCHLOSSENE Studien ohne veröffentlichte Ergebnisse",
                "Trials where 'completion date' was years ago",
                "Trials listed as 'terminated' — why?",
                "Discrepancies: registered primary outcome ≠ published primary outcome"
              ]
            },
            {
              heading: "Search Strategy",
              items: [
                "Search your drug/intervention in registry",
                "Filter nach abgeschlossenen/abgebrochenen Studien",
                "Querverweis auf Ihre Metaanalyse: welche Studien haben Sie verpasst?",
                "Kontaktieren Sie Trialisten für unveröffentlichte Daten"
              ]
            }
          ]
        }
      },
      {
        type: 'tool-registry',
        content: {
          id: 'registry-tracker',
          title: "Registry Gap Finder",
          description: "Compare registered vs. published trials to identify potentially missing studies."
        }
      },
      {
        type: 'rhetoric',
        content: {
          question: "Haben Sie nicht bedacht, dass von allen jemals begonnenen Studien fast die HÄLFTE nie veröffentlicht wird? Dass auf dem Friedhof der Wissenschaft so viele Studien liegen wie in der Bibliothek?"
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "CASE 5B",
          title: "AllTrials: Die Bewegung zum Öffnen der Tresore",
          source: "AllTrials Campaign + Goldacre, Bad Pharma, 2012",
          timeline: [
            { year: "2012", text: "Ben Goldacre veröffentlicht „Bad Pharma“. Dokumentiert systematische Unterdrückung in der gesamten Branche. Fordert Transparenz.", type: "normal" },
            { year: "2013", text: "AllTrials campaign launches: 'All trials registered, all results reported.' Within months, 85,000 individuals and 600 organizations sign on.", type: "normal" },
            { year: "The Resistance", text: "Industry initially resists. Argues: proprietary data, competitive advantage, patient privacy. But pressure mounts.", type: "buried" },
            { year: "2015", text: "EMA verabschiedet Richtlinie 0070: Daten aus klinischen Studien werden veröffentlicht. GSK verpflichtet sich zur Weitergabe von Testdaten. Das Blatt beginnt sich zu wenden.", type: "revealed" },
            { year: "The Progress", text: "ClinicalTrials.gov verlangt nun eine Ergebnisberichterstattung innerhalb eines Jahres. Aber die Durchsetzung ist schwach. Im Jahr 2023 melden etwa 30 % der Studien immer noch nicht rechtzeitig Ergebnisse.", type: "revealed" }
          ],
          realData: {
            campaignSignatures: "85,000+ individuals, 600+ organizations",
            currentCompliance: "~70% of trials report results within required timeframe",
            remainingGap: "~30% still don't comply",
            enforcement: "Limited — fines rarely applied",
            progress: "Significant but incomplete"
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          title: "Der versteinerte Forscher",
          situation: "You're conducting a Cochrane review. You've identified 5 unpublished industry trials on ClinicalTrials.gov. You've emailed the company three times over 6 months. No response. The company's published trials show strong efficacy. You strongly suspect the unpublished trials are negative. What do you do?",
          nodes: [
            {
              id: 'start',
              question: "Das Unternehmen gibt keine Daten weiter. Wie gehen Sie vor?",
              branches: [
                { id: 'a', text: "Veröffentlichen Sie die Rezension nur mit veröffentlichten Daten", nextNode: 'publish_incomplete' },
                { id: 'b', text: "Escalate — formal data request through Cochrane", nextNode: 'escalate' },
                { id: 'c', text: "Try alternative routes — FOIA, EMA, litigation documents", nextNode: 'alternatives' }
              ]
            },
            {
              id: 'publish_incomplete',
              type: 'outcome',
              consequence: 'bad',
              title: "Die unvollständige Wahrheit",
              text: "Your review shows strong efficacy based on published trials. But you know 5 unpublished trials exist. You mention them in 'Limitations' but proceed anyway. Your review is cited by guidelines. The drug is widely adopted. Years later, when the unpublished data emerges, your review is discredited. You contributed to the distortion you were trying to assess.",
              realCase: "Mehrere Cochrane-Reviews wurden dafür kritisiert, dass sie trotz bekannter unveröffentlichter Studien fortfahren. Der Druck zur Veröffentlichung kann die wissenschaftliche Vorsicht außer Kraft setzen."
            },
            {
              id: 'escalate',
              question: "Sie eskalieren über die offiziellen Kanäle von Cochrane. Das Unternehmen antwortet mit „Zusammenfassungsdaten“, jedoch nicht mit individuellen Patientendaten. Die Zusammenfassung zeigt „ähnliche Ergebnisse wie veröffentlichte Studien“. Vertrauen Sie ihm?",
              branches: [
                { id: 'd', text: "Accept the summary — it's better than nothing", nextNode: 'accept_summary' },
                { id: 'e', text: "Fordern Sie vollständige Daten oder dokumentieren Sie die Ablehnung", nextNode: 'demand_full' }
              ]
            },
            {
              id: 'accept_summary',
              type: 'outcome',
              consequence: 'neutral',
              title: "Der begrenzte Sieg",
              text: "You include the company's summary data. It shows modest effects, smaller than published trials. Your review now has more data — but you can't verify the company's summary. You note: 'Unpublished data provided by manufacturer; individual patient data not available for independent analysis.' You've documented the limitation transparently.",
              realCase: "Viele Bewertungen akzeptieren zusammenfassende Daten von Herstellern. Es ist besser als nichts, aber eine unabhängige Überprüfung ist nicht möglich."
            },
            {
              id: 'demand_full',
              type: 'outcome',
              consequence: 'good',
              title: "Die dokumentierte Ablehnung",
              text: "The company refuses full data. You document every request, every refusal. Your review states: 'Manufacturer declined to provide individual patient data for 5 trials despite repeated requests. Summary data offered but not independently verifiable. Published evidence may overestimate efficacy.' This transparency is scientifically honest and puts the burden where it belongs.",
              realCase: "Cochranes Tamiflu-Review dokumentierte jahrelange Ablehnungen von Roche. Diese Dokumentation trug schließlich zum regulatorischen Druck zur Datenfreigabe bei."
            },
            {
              id: 'alternatives',
              question: "Sie reichen einen FOIA-Antrag bei der FDA ein. Sechs Monate später erhalten Sie klinische Studienberichte mit einigen Korrekturen. Was finden Sie?",
              branches: [
                { id: 'f', text: "Unveröffentlichte Studien waren in der Tat negativ – Ihr Verdacht wurde bestätigt", nextNode: 'confirmed_negative' },
                { id: 'g', text: "Unveröffentlichte Studien waren positiv – Sie hatten zu Unrecht vermutet", nextNode: 'wrong_suspicion' }
              ]
            },
            {
              id: 'confirmed_negative',
              type: 'outcome',
              consequence: 'good',
              title: "Die Wahrheit wiederhergestellt",
              text: "The FDA data reveals: 3 of 5 unpublished trials showed no significant effect. Combined with published trials, the pooled effect drops from d=0.45 to d=0.22. Your review now reflects reality, not marketing. You've demonstrated why persistence in data hunting matters. The extra 6 months of work prevented years of overestimation.",
              realCase: "Das ist genau das, wurde Turner bei Antidepressiva gefunden, der Jefferson mit Tamiflu herausgefunden hatte. Die Beharrlichkeit hat sich ausgezahlt."
            },
            {
              id: 'wrong_suspicion',
              type: 'outcome',
              consequence: 'neutral',
              title: "Die ehrliche Beruhigung",
              text: "The FDA data shows the unpublished trials were actually positive, similar to published results. Your suspicion was wrong. But you've now verified this independently. Your review is STRONGER because you checked. You report: 'Unpublished trials obtained via FOIA; results consistent with published trials.' Skepticism that's verified is still valuable skepticism.",
              realCase: "Nicht jede unveröffentlichte Studie ist negativ. Aber der einzige Weg, dies herauszufinden, besteht darin, die Daten zu erhalten. Eine Verifizierung lohnt sich immer."
            }
          ]
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "CASE 5D",
          title: "Der FOIA-Weg: Beschaffung von FDA-Daten",
          source: "Mehrere Fälle – Lernen von Turner, Jureidini und anderen",
          timeline: [
            { year: "The Problem", text: "Hersteller übermitteln vollständige Studiendaten an die FDA. Die FDA ist jedoch nicht verpflichtet, dies zu veröffentlichen. Die meisten Daten bleiben vertraulich.", type: "normal" },
            { year: "The Strategy", text: "Freedom of Information Act (FOIA) requests can pry open FDA files. Request clinical study reports (CSRs), medical reviews, statistical reviews.", type: "normal" },
            { year: "The Reality", text: "FOIA-Anfragen dauern 6–24 Monate. Daten werden häufig geschwärzt. Aber hartnäckige Nachfrager haben wichtige unveröffentlichte Daten aufgedeckt.", type: "normal" },
            { year: "Turner's Approach", text: "Turner erhielt von der FDA Arzneimittelzulassungspakete für 12 Antidepressiva. Diese enthielten ALLE eingereichten Studiendaten – veröffentlichte und unveröffentlichte. Dies ermöglichte seine bahnbrechende NEJM-Studie.", type: "revealed" },
            { year: "The Lesson", text: "Regulierungsdaten sind der Goldstandard. Es wurde erfasst, was zur Genehmigung eingereicht und nicht selektiv veröffentlicht wurde.", type: "revealed" }
          ],
          realData: {
            typicalFOIAtime: "6-24 months",
            successRate: "Variable — depends on request specificity",
            dataQuality: "CSRs contain far more detail than publications",
            alternatives: "EMA provides some data proactively; Canada, Australia have similar processes"
          }
        }
      },
      {
        type: 'content',
        content: {
          title: "Grey Literature Sources",
          sections: [
            {
              heading: "Conference Abstracts",
              items: [
                "Many studies present at conferences but never publish in full",
                "Durchsuchen Sie Konferenzberichte zu Ihrem Thema",
                "Positive und negative Ergebnisse können sowohl auf Konferenzen erscheinen",
                "Watch out: abstracts may have limited data quality"
              ]
            },
            {
              heading: "Dissertationen und Abschlussarbeiten",
              items: [
                "ProQuest Dissertations — extensive database",
                "OpenDOAR — repository search",
                "Studenten veröffentlichen möglicherweise Nullergebnisse, die dies nicht tun würden Überleben Sie die Peer-Review",
                "Often contain pilot studies or unpublished substudies"
              ]
            },
            {
              heading: "Regulatory Documents",
              items: [
                "FDA approval packages (drugs.fda.gov)",
                "EMA public assessment reports (ema.europa.eu)",
                "NICE technology appraisals (UK)",
                "PBAC public summary documents (Australia)"
              ]
            },
            {
              heading: "Litigation Documents",
              items: [
                "Drug litigation (Vioxx, Neurontin, SSRIs) unsealed internal documents",
                "Drug Industry Document Archive (DIDA) at UCSF",
                "PLoS Medicine often publishes analyses of litigation documents"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          title: "Das Dilemma der fehlenden Daten",
          situation: "Your meta-analysis finds 15 published trials. A registry search reveals 8 more completed trials with no publications. You contact the trialists: 3 respond with 'negative results, not interesting enough to publish.' 5 don't respond. What do you do?",
          nodes: [
            {
              id: 'start',
              question: "You've found 8 unpublished trials. How do you proceed?",
              branches: [
                { id: 'a', text: "Fahren Sie mit den 15 veröffentlichten Studien fort – unveröffentlichte Daten sind nicht verfügbar", nextNode: 'ignore' },
                { id: 'b', text: "Versuchen Sie mehr, die unveröffentlichten Daten zu erhalten", nextNode: 'pursue' },
                { id: 'c', text: "Report both analyses: with 15 trials, and with imputation for the 8 missing", nextNode: 'dual' }
              ]
            },
            {
              id: 'ignore',
              type: 'outcome',
              consequence: 'bad',
              title: "Die vorsätzliche Blindheit",
              text: "Sie WISSEN jetzt, dass es 8 unveröffentlichte Studien gibt und mindestens 3 wahrscheinlich negativ sind. Durch die Veröffentlichung nur der 15 veröffentlichten Studien wird die Voreingenommenheit aufrechterhalten. Sie haben den Friedhof identifiziert, sind aber weggegangen. Ihre Metaanalyse wird die Wirksamkeit überschätzen und möglicherweise den Patienten schaden.",
              realCase: "Gutachter, die unveröffentlichte Studien identifizieren und diese dann ignorieren, können nicht behaupten, dass sie nichts wissen. Best Practice erfordert die Dokumentation dieser Versuche und ihrer wahrscheinlichen Auswirkungen."
            },
            {
              id: 'pursue',
              question: "Sie senden Folge-E-Mails an Nicht-Antwortende. Sie reichen FOIA-Anträge für zwei Studien ein, die von der FDA reguliert wurden. Sie suchen nach Konferenzzusammenfassungen. Was erhalten Sie?",
              branches: [
                { id: 'd', text: "Vollständige Daten für 2 Studien, Konferenzzusammenfassungen für 3 weitere", nextNode: 'partial' },
                { id: 'e', text: "Nothing after 6 months of effort", nextNode: 'nothing' }
              ]
            },
            {
              id: 'partial',
              type: 'outcome',
              consequence: 'good',
              title: "Die erweiterte Evidenzbasis",
              text: "You now have 17 trials with full data + 3 with abstract-level data. Primary analysis uses 17. Sensitivity analysis adds 3 abstract-level estimates. You report: 'Of 23 known trials, 15 were published. We obtained data for 5 additional trials (3 negative). Effect reduced from 0.45 to 0.34.' You've documented the bias and partially corrected it.",
              realCase: "Dieser Aufwand – Kontaktaufnahme mit Trialisten, FOIA, Konferenzrecherchen – gilt als Best Practice für Cochrane-Reviews zu wichtigen Fragen."
            },
            {
              id: 'nothing',
              type: 'outcome',
              consequence: 'neutral',
              title: "Der dokumentierte Fehler",
              text: "You've exhausted reasonable options. Your review reports: 'We identified 8 unpublished completed trials (33% of known evidence base). Despite multiple contacts and FOIA requests, data could not be obtained. Three trialists confirmed negative results. Our effect estimate is likely inflated.' This is transparent and appropriately cautious.",
              realCase: "Die Dokumentation fehlgeschlagener Versuche, Daten zu erhalten, ist wertvoll – es macht Leser auf Voreingenommenheit aufmerksam und erstellt eine Aufzeichnung für zukünftige Forscher."
            },
            {
              id: 'dual',
              type: 'outcome',
              consequence: 'neutral',
              title: "Der Sensitivitätsansatz",
              text: "You report published analysis (15 trials, effect=0.45) and a 'worst case' sensitivity analysis assuming the 8 missing trials had null effects (23 trials, effect=0.28). This bounds the plausible effect. You note: 'True effect likely lies between these estimates, probably closer to lower bound given evidence that missing trials had negative results.'",
              realCase: "Sensitivitätsanalyse für fehlende Daten ist ein gültiger Ansatz, aber es sollte beachtet werden, dass es sich dabei um eine Simulation und nicht um eine Datenwiederherstellung handelt."
            }
          ]
        }
      },
      {
        type: 'clinical-guide',
        content: {
          title: "Der Beweis Jäger-Checkliste",
          items: [
            "REGISTRIES: Search ClinicalTrials.gov, ISRCTN, WHO ICTRP for completed unpublished trials",
            "CONTACT TRIALISTS: Email corresponding authors of missing trials — many will share data",
            "REGULATORY DATA: FOIA requests to FDA, EMA public assessment reports",
            "CONFERENCES: Search society meeting abstracts (often on Embase)",
            "DISSERTATIONS: ProQuest, institutional repositories",
            "LITIGATION: Drug Industry Document Archive for specific drugs",
            "DOCUMENT EVERYTHING: Record what you searched, what you found, what you couldn't get",
            "LÜCKEN MELDEN: Auch fehlgeschlagene Suchvorgänge sind informativ – melden Sie die fehlenden Studien, die Sie gefunden haben"
          ]
        }
      },
      {
        type: 'contrast',
        content: {
          title: "Zwei Forscher stehen vor den gleichen fehlenden Daten",
          darkSide: {
            header: "Forscher A: Der Pragmatiker",
            items: [
              "Finds 8 unpublished trials on registry",
              "Sends one email to each trialist",
              "Waits 2 weeks, gets no response",
              "Fahrt mit veröffentlichten Daten fort nur",
              "Reports 'comprehensive search performed'"
            ],
            consequence: "Result: Meta-analysis published showing strong effect (d=0.45). Guidelines cite it. Two years later, unpublished trials surface showing true effect d=0.22. Guidelines have to be revised."
          },
          lightSide: {
            header: "Forscher B: Der Detektiv",
            items: [
              "Finds same 8 unpublished trials",
              "Sends 3 follow-up emails over 3 months",
              "Files FOIA requests for FDA-regulated trials",
              "Searches conference abstracts manually",
              "Obtains 5 of 8 datasets (3 negative)"
            ],
            consequence: "Result: Meta-analysis published showing modest effect (d=0.28) with full transparency about missing data. Guidelines cite conservative estimate. No future revision needed."
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          title: "Das Dilemma des Richtlinienautors",
          situation: "You're writing clinical guidelines for a treatment. The meta-analysis shows benefit (OR 0.70, p=0.001), but Egger's test is significant (p=0.03) and you've identified 6 unpublished trials on registries. The treatment is already widely used. What do you recommend?",
          nodes: [
            {
              id: 'start',
              question: "Die Beweise zeigen Wirksamkeit, aber wahrscheinliche Publikationsverzerrung. Was steht in Ihrer Leitlinie?",
              branches: [
                { id: 'a', text: "Strong recommendation — the meta-analysis shows clear benefit", nextNode: 'strong' },
                { id: 'b', text: "Bedingte Empfehlung mit Vorbehalten bezüglich Bias-Bedenken", nextNode: 'conditional' },
                { id: 'c', text: "Warten Sie auf weitere Beweise – aktuelle Beweise sind unzuverlässig", nextNode: 'await' }
              ]
            },
            {
              id: 'strong',
              type: 'outcome',
              consequence: 'bad',
              title: "Die überzogene Richtlinie",
              text: "Ihre starke Empfehlung sorgt für eine breite Akzeptanz. Aber der wahre Effekt (einschließlich unveröffentlichter Daten) ist viel schwächer als veröffentlichte Beweise vermuten lassen. Patienten erhalten eine Behandlung mit geringem Nutzen, aber echtem Schaden. Wenn die Wahrheit ans Licht kommt, wird die Glaubwürdigkeit Ihrer Leitlinie beschädigt.",
              realCase: "Dieses Muster spielte sich bei Tamiflu ab – starke Leitlinienempfehlungen basierend auf voreingenommenen veröffentlichten Beweisen, Milliardenausgaben für Vorräte, dann zeigte die vollständige Datenanalyse von Cochrane nur minimalen Nutzen."
            },
            {
              id: 'conditional',
              question: "Sie schreiben eine bedingte Empfehlung. Wie kommunizieren Sie die Unsicherheit?",
              branches: [
                { id: 'd', text: "Note 'low certainty evidence' using GRADE, mention bias concerns briefly", nextNode: 'grade' },
                { id: 'e', text: "Full transparency: report both published and bias-adjusted estimates, explain missing trials", nextNode: 'transparent' }
              ]
            },
            {
              id: 'grade',
              type: 'outcome',
              consequence: 'neutral',
              title: "Der Standardansatz",
              text: "You downgrade for publication bias per GRADE. Your recommendation reads: 'Conditional recommendation, low certainty evidence.' But many readers don't understand what this means. Clinicians may still interpret it as 'probably works.' The nuance is lost.",
              realCase: "Studien zeigen, dass GRADE-Sicherheitsbewertungen oft falsch interpretiert werden. „Geringe Sicherheit“ kommuniziert den Grad der Besorgnis nicht angemessen."
            },
            {
              id: 'transparent',
              type: 'outcome',
              consequence: 'good',
              title: "Die vollständig informierte Richtlinie",
              text: "Your guideline states: 'Published trials suggest OR 0.70. However, we identified 6 unpublished trials and funnel plot asymmetry suggests the true effect may be weaker. Adjusted estimates range from OR 0.70-0.85. Until full data are available, benefits should not be overstated.' Clinicians can make informed decisions.",
              realCase: "Dieser transparente Ansatz wird zunehmend empfohlen. In den PRISMA-P-Leitlinien 2023 liegt der Schwerpunkt auf der Berichterstattung über alle Bias-Bewertungen und deren Auswirkungen."
            },
            {
              id: 'await',
              type: 'outcome',
              consequence: 'neutral',
              title: "Die konservative Haltung",
              text: "Your guideline states: 'Insufficient evidence due to likely publication bias.' But the treatment is already widely used. Clinicians continue prescribing without guidance. Your conservative stance may be scientifically correct but practically unhelpful. Sometimes imperfect guidance is better than no guidance.",
              realCase: "Es besteht ein Spannungsverhältnis zwischen dem Warten auf perfekte Beweise und der Bereitstellung zeitnaher Leitlinien. Der Schlüssel liegt in transparenter Ungewissheitskommunikation, nicht im Schweigen."
            }
          ]
        }
      },
      {
        type: 'oath',
        content: {
          header: "Der Eid des Beweisjägers",
          text: "I will not stop at the published literature.<br><strong>I will search the registries, contact the trialists, petition the regulators.</strong><br><br>I will document my search — what I found and what I could not find.<br>For the studies I cannot obtain are as important as those I can.<br><br>The buried evidence has a voice.<br><strong>I will be the one who listens.</strong>"
        }
      },
      {
        type: 'cycle-return',
        content: {
          principle: "Es ist besser, eine vergrabene Studie zu finden, als zehn imaginäre zu unterstellen. Der Detektiv, der das Register durchsucht, ist hundert wert, der nur Statistiken erstellt."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "You find that 40% of registered trials for your intervention have no published results 5 years after completion. This most likely indicates:",
          options: [
            { id: 'a', text: "Die Versuche laufen noch.", correct: false },
            { id: 'b', text: "Die Ergebnisse waren negativ oder uninteressant und wurden nicht veröffentlicht.", correct: true },
            { id: 'c', text: "Die Registerinformationen sind falsch.", correct: false },
            { id: 'd', text: "Die Versuche wurden unter anderem veröffentlicht Namen", correct: false }
          ],
          explanation: "Ross et al. found that non-publication 5 years after trial completion is strongly associated with negative/null results. Positive trials are published faster and more often. While some explanation (name changes, delayed publication) may apply to individual trials, systematic non-publication at this rate indicates publication bias. The published literature for this intervention is likely inflated."
        }
      },
      {
        type: 'protagonist-story',
        content: {
          name: "Dr. Tom Jefferson",
          role: "Cochrane-Forscher und Evidence Hunter",
          narrative: "Tom Jefferson spent years trying to get the complete clinical trial data for Tamiflu (oseltamivir). Despite Roche's claims of efficacy, when Jefferson and the Cochrane team finally obtained the full clinical study reports (35,000+ pages) through regulatory requests and persistent advocacy, they found the drug's benefits were far more modest than published papers suggested, and harms were understated.",
          quote: "Wir mussten 67 separate Anträge bei Aufsichtsbehörden in mehreren Ländern einreichen. Das Unternehmen hat uns auf Schritt und Tritt bekämpft. Aber die Daten, die wir nicht sehen sollten, erzählten eine ganz andere Geschichte als die Daten, die sie veröffentlicht hatten.",
          impact: "Die Cochrane-Oseltamivir-Überprüfung änderte die weltweiten Lagerempfehlungen und löste eine Reform der Transparenz klinischer Studien aus. Es hat sich gezeigt, dass eine anhaltende Evidenzsuche den etablierten medizinischen Konsens zunichte machen kann."
        }
      },
      {
        type: 'key-takeaways',
        content: {
          takeaways: [
            "ClinicalTrials.gov und WHO ICTRP offenbaren, wurde begonnen und wurde veröffentlicht",
            "FOIA/EMA-Anfragen können auf vollständige klinische Studienberichte zugreifen (nicht nur auf Fachzeitschriftenzusammenfassungen)",
            "Kontaktieren Sie Studienärzte direkt – die Rücklaufquote liegt bei ca. 50 % auf Nachfrage höflich für unveröffentlichte Daten",
            "Grey literature (conference abstracts, dissertations, regulatory documents) contains valuable hidden evidence",
            "Dokumentieren Sie Ihre Suchstrategie – was Sie nicht finden konnten, ist genauso wichtig wie das, was Sie gefunden haben"
          ],
          actionItem: "Fügen Sie vor Ihrer nächsten systematischen Überprüfung „Registrierungssuche“ und „Kontakt zum Trialisten“ als obligatorische Schritte in Ihr Protokoll ein. Budgetieren Sie Zeit für behördliche Anfragen."
        }
      }
    ]
  },

  // MODULE 6: THE CAPSTONE
  {
    id: 6,
    title: "The Capstone",
    subtitle: "Integration",
    estimatedMinutes: 30,
    slides: [
      {
        type: 'learning-objectives',
        content: {
          intro: "By the end of this module, you will be able to:",
          objectives: [
            "Integrieren Sie alle Methoden zur Erkennung von Publikationsbias in eine kohärente Bewertung",
            "Wenden Sie die fünf Prinzipien des Publication Bias Detective an",
            "Make ethical decisions when encountering evidence of suppression",
            "Vermitteln Sie Patienten und Kollegen Unsicherheit über Publikationsbias",
            "Entwickeln Sie einen persönlichen Aktionsplan zur Bekämpfung von Publikationsbias in Ihrem Unternehmen Arbeit"
          ]
        }
      },
      {
        type: 'title',
        content: {
          title: "The Capstone",
          subtitle: "Die vollständige Untersuchung",
          text: "Sie haben gelernt, das Verborgene zu sehen, das Verdächtige zu testen, die Schätzung anzupassen und die Verschütteten zu jagen. Bringen Sie nun diese Fähigkeiten zusammen."
        }
      },
      {
        type: 'content',
        content: {
          title: "Die fünf Prinzipien des Publication Bias Detective",
          sections: [
            {
              heading: "I. Das Abwesenheitsprinzip",
              items: ["Das Fehlen von Beweisen ist kein Beweis für Abwesenheit – es kann ein Beweis für Unterdrückung sein."]
            },
            {
              heading: "II. Das Sichtbarkeitsprinzip",
              items: ["What is hidden shapes belief as powerfully as what is shown."]
            },
            {
              heading: "III. Das Asymmetrieprinzip",
              items: ["Der Trichter enthüllt, was der Wald verbirgt – die Form dessen, was veröffentlicht wurde, und den Schatten dessen, was nicht veröffentlicht wurde."]
            },
            {
              heading: "IV. Das Unsicherheitsprinzip",
              items: ["Das Auge ahnt, aber der Test quantifiziert. Doch kein Test kann erkennen, was wirklich passiert ist – nur das, was die Daten vermuten lassen."]
            },
            {
              heading: "V. Das Wiederherstellungsprinzip",
              items: ["Better to find one buried study than to impute ten imaginary ones."]
            }
          ]
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "FINAL CASE",
          title: "Die vollständige Untersuchung: Oseltamivir (Tamiflu)",
          source: "Jefferson et al., Cochrane 2014 – The 4-Year Battle for Hidden Data",
          timeline: [
            { year: "2009", text: "Cochrane begins review of neuraminidase inhibitors (Tamiflu, Relenza). Published trials suggest efficacy. Governments stockpile $billions worth.", type: "normal" },
            { year: "The Suspicion", text: "Anmerkung der Cochrane-Autoren: 60 % der Patientendaten stammten von unveröffentlichten Herstellern Versuche. Veröffentlichte Artikel wurden von Ghostwritern verfasst. Datenanfragen abgelehnt.", type: "normal" },
            { year: "2009-2012", text: "BMJ-Kampagne: „Open Data.“ Wiederholte Anfragen an Roche nach klinischen Studienberichten. Jahrelange Ablehnungen und Verhandlungen.", type: "buried" },
            { year: "2013", text: "EMA grants access to regulatory documents. Roche finally releases 77 clinical study reports — 22,000 pages.", type: "revealed" },
            { year: "The Truth", text: "Vollständige Daten zeigten: Tamiflu reduzierte die Symptomdauer um ~17 Stunden (nicht „Tage“). Keine Hinweise auf eine Lungenentzündungsprävention (der beanspruchte Krankenhausnutzen). Erhöhte Übelkeit/Erbrechen. WHO stuft von „wesentlich“ auf „komplementär“ herab.", type: "revealed" }
          ],
          realData: {
            publishedClaim: "Reduziert Lungenentzündungen und Krankenhausaufenthalte",
            fullDataReality: "Keine Beweise für die Prävention von Lungenentzündungen",
            symptomBenefit: "~17 hours symptom reduction",
            harms: "Increased nausea, vomiting, headache",
            stockpileWaste: "Billions in government stockpiles of overstated benefit"
          }
        }
      },
      {
        type: 'statistic-card',
        content: {
          value: "4 Years",
          label: "um klinische Studienberichte zu erhalten, die öffentlich hätten sein sollen",
          context: "The delay cost billions in misallocated pandemic preparedness"
        }
      },
      {
        type: 'decision-tree',
        content: {
          title: "Reading a Meta-Analysis: The Bias Detective's Checklist",
          situation: "A colleague sends you a meta-analysis showing that a new intervention significantly reduces mortality (OR 0.65, 95% CI 0.52-0.81, p<0.001). They want to change clinical practice based on this. Before agreeing, what do you check?",
          nodes: [
            {
              id: 'start',
              question: "Die Metaanalyse zeigt beeindruckend Ergebnisse. Was ist Ihre erste Frage?",
              branches: [
                { id: 'a', text: "Wie viele Studien wurden eingeschlossen?", nextNode: 'studies' },
                { id: 'b', text: "Wurde der Publikationsbias bewertet?", nextNode: 'bias_check' },
                { id: 'c', text: "Wurden Studienregister nach unveröffentlichten Studien durchsucht?", nextNode: 'registry' }
              ]
            },
            {
              id: 'studies',
              question: "Die Metaanalyse umfasst 8 Studien. Was bedeutet das für die Bias-Bewertung?",
              branches: [
                { id: 'd', text: "Too few for reliable Egger's test — visual assessment only", nextNode: 'few_studies' },
                { id: 'e', text: "Enough for full bias assessment", nextNode: 'wrong_enough' }
              ]
            },
            {
              id: 'few_studies',
              type: 'outcome',
              consequence: 'good',
              title: "Die Einschränkung wurde richtig identifiziert",
              text: "With only 8 studies, statistical tests for publication bias (Egger's, Begg's) have very low power. A non-significant test does NOT mean no bias. You should rely more on: (1) Visual funnel plot assessment, (2) Registry searches for unpublished trials, (3) Assessment of whether all studies are positive (suspicious). Statistical tests can neither confirm nor rule out bias.",
              realCase: "Die Leitlinien von Cochrane besagen, dass Tests für Funnel-Plot-Asymmetrie nicht verwendet werden sollten, wenn weniger als 10 Studien vorhanden sind."
            },
            {
              id: 'wrong_enough',
              type: 'outcome',
              consequence: 'bad',
              title: "Overconfident in Tests",
              text: "8 Studien liegen unter dem empfohlenen Minimum von 10 für den Egger-Test. Da es so wenige Studien gibt, weist der Test eine hohe Falsch-Negativ-Rate auf – er übersieht oft echte Voreingenommenheit. Die Schlussfolgerung „keine Verzerrung“ aus einem nicht signifikanten Test mit 8 Studien ist nicht gerechtfertigt. Sie müssen andere Methoden verwenden.",
              realCase: "Simulationen zeigen, dass Eggers Test bei 10 Studien nur eine Aussagekraft von ca. 50 % hat, um moderate Verzerrungen zu erkennen, und bei weniger Studien sogar noch weniger."
            },
            {
              id: 'bias_check',
              question: "The methods section says 'Publication bias was assessed using Egger's test (p=0.34)'. What's your concern?",
              branches: [
                { id: 'f', text: "Gut – sie haben auf Verzerrungen getestet und keine gefunden", nextNode: 'false_assurance' },
                { id: 'g', text: "A non-significant test doesn't prove no bias — what else did they do?", nextNode: 'deeper' }
              ]
            },
            {
              id: 'false_assurance',
              type: 'outcome',
              consequence: 'bad',
              title: "Die falsche Zusicherung",
              text: "A non-significant Egger's test does NOT prove absence of bias. It means the test failed to detect asymmetry — which could be because there's no bias, OR because the test lacked power, OR because bias exists but isn't reflected in asymmetry. You need additional information: funnel plot inspection, registry search, assessment of study characteristics.",
              realCase: "Viele Metaanalysen geben nur den p-Wert von Egger ohne Trichter an Plots oder Registersuchen. Dies ist für eine Voreingenommenheitsbewertung nicht ausreichend."
            },
            {
              id: 'deeper',
              type: 'outcome',
              consequence: 'good',
              title: "Der angemessene Skeptizismus",
              text: "You ask the right follow-up questions: Did they search trial registries? Did they show the funnel plot? Did they compare industry vs. independent trials? Did they contact authors of conference abstracts that never became papers? A single statistical test is the minimum, not the full assessment.",
              realCase: "Best practice includes: visual funnel plot, statistical tests, registry search, comparison by funding source, and contact with trialists."
            },
            {
              id: 'registry',
              type: 'outcome',
              consequence: 'good',
              title: "Die erste Frage des Detektivs",
              text: "Registry searches are the most direct way to identify missing evidence. You check: Did the authors search ClinicalTrials.gov? Did they report how many registered trials had no published results? Did they try to obtain unpublished data? If they didn't search registries, the bias assessment is incomplete regardless of statistical tests.",
              realCase: "Turners bahnbrechende Studie zeigte, dass Registersuchen wesentliche unveröffentlichte Beweise identifizieren können, die statistische Tests nicht erkennen können."
            }
          ]
        }
      },
      {
        type: 'contrast',
        content: {
          title: "Two Readers of the Same Meta-Analysis",
          darkSide: {
            header: "Der unkritische Leser",
            items: [
              "Sees: 'OR 0.65, p<0.001, significant'",
              "Checks: 'Egger's p=0.34, no bias detected'",
              "Concludes: 'Strong evidence, change practice'",
              "Skips: Funnel plot, registry section, limitations",
              "Tells colleagues: 'The meta-analysis proves it works'"
            ],
            consequence: "Ergebnis: Übernimmt eine Behandlung basierend auf überhöhten Beweisen. Später erfuhr man, dass unveröffentlichte Studien keine Wirkung zeigten. Muss den Patienten erklären, warum die „bewährte“ Behandlung ihnen nicht geholfen hat."
          },
          lightSide: {
            header: "Der Publikationsbias-Detektiv",
            items: [
              "Sees same numbers, asks: 'What's missing?'",
              "Examines funnel plot: 'Gap in bottom-left'",
              "Checks registry search: 'None reported'",
              "Notes: 'All 8 trials industry-funded, all positive'",
              "Tells colleagues: 'Likely inflated, await independent data'"
            ],
            consequence: "Result: Maintains appropriate uncertainty. When full data emerge showing weaker effect, no surprise. Patients received honest communication about uncertainty from the start."
          }
        }
      },
      {
        type: 'oath',
        content: {
          header: "Von den Patienten, die den Beweisen vertrauten",
          text: "For every inflated effect size, there was a patient who expected more benefit than they received.<br><br>For every buried negative trial, there was a patient who received a treatment that did not work.<br><br>For every spin, there was a doctor who believed what they read.<br><br><strong>The detective remembers: Numbers are not abstractions. They guide treatment. They shape lives.</strong><br><br>Vigilance in evidence assessment is not pedantry — it is care."
        }
      },
      {
        type: 'case-file',
        content: {
          caseNumber: "MEMORIAL CASE",
          title: "Die Gesichter hinter den Zahlen",
          source: "Multiple sources — The Human Cost of Publication Bias",
          timeline: [
            { year: "Reboxetine", text: "Patienten nahmen ein Medikament ein, das auftauchte in Veröffentlichungen wirksam, zeigte jedoch in den vollständigen Daten keinen Nutzen. Jahrelange Behandlung mit Placeboeffekt und Nebenwirkungen, obwohl es bessere Optionen gab.", type: "buried" },
            { year: "Vioxx", text: "26.000–55.000 zusätzliche Todesfälle. Herzinfarkte bei Menschen, die ihrem Arzt vertrauten, die der veröffentlichten Literatur vertrauten, der das Sicherheitssignal fehlte.", type: "buried" },
            { year: "Study 329", text: "Kindern wurde Paroxetin auf der Grundlage eines von Ghostwritern verfassten Papiers verabreicht, in dem Sicherheit behauptet wurde. Suizidale Ereignisse nahmen um das Achtfache zu, dies blieb jedoch verborgen. Heranwachsende wurden durch einen Artikel geschädigt, der gelogen hat.", type: "buried" },
            { year: "DECREASE", text: "~10.000 Todesfälle pro Jahr in Europa aufgrund von Richtlinien, die auf gefälschten Daten basieren. Patienten erhielten vor der Operation Betablocker, weil ein betrügerischer Forscher die Beweise erfunden hatte.", type: "buried" },
            { year: "Avandia", text: "83.000 zusätzliche Herzinfarkte. Sieben Jahre lang verschreiben, obwohl das Unternehmen das kardiovaskuläre Risiko kannte. Die veröffentlichte Literatur zeigte nichts Falsches.", type: "buried" }
          ],
          realData: {
            totalEstimatedDeaths: "100.000+ aus Fällen allein in diesem Kurs",
            commonThread: "Veröffentlichte Beweise, die systematisch unvollständig waren",
            responsibility: "Distributed — companies, journals, regulators, researchers",
            prevention: "Vigilant detection, transparency demands, systematic searching"
          }
        }
      },
      {
        type: 'death-toll',
        content: {
          number: "100,000+",
          label: "Konservative Schätzung der Todesfälle aus den in diesem Kurs behandelten Fällen",
          source: "Vioxx (26-55k) + DECREASE (~10k/yr × several years) + Avandia (unknown fraction of 83k MIs) + others"
        }
      },
      {
        type: 'decision-tree',
        content: {
          title: "Der nächste Schritt: Was werden Sie? Tun?",
          situation: "Sie haben diesen Kurs abgeschlossen. Sie können jetzt Publikationsbias erkennen, testen, anpassen und nach versteckten Beweisen suchen. Aber Wissen ohne Handeln verändert sich nichts. Was werden Sie mit dem, was Sie gelernt haben, machen?",
          nodes: [
            {
              id: 'start',
              question: "Sie haben die Fähigkeiten des Publikationsbias-Detektivs erlernt. Wie werden Sie sie nutzen?",
              branches: [
                { id: 'a', text: "In my own research — I'll be more vigilant about bias in literature I read", nextNode: 'personal' },
                { id: 'b', text: "As a reviewer — I'll demand better bias assessment in papers I review", nextNode: 'reviewer' },
                { id: 'c', text: "As an advocate — I'll push for transparency in my institution/field", nextNode: 'advocate' }
              ]
            },
            {
              id: 'personal',
              question: "Sie verpflichten sich zu persönlicher Wachsamkeit. Wie werden Sie dies umsetzen?",
              branches: [
                { id: 'd', text: "Check funnel plots and bias assessments in every meta-analysis I read", nextNode: 'personal_good' },
                { id: 'e', text: "Search registries when making treatment decisions based on published evidence", nextNode: 'personal_great' }
              ]
            },
            {
              id: 'personal_good',
              type: 'outcome',
              consequence: 'good',
              title: "Der informierte Verbraucher",
              text: "You become a critical reader of evidence. When a meta-analysis claims strong effects, you check: How many studies? Funnel plot shape? Registry search? This protects your patients from inflated claims. One alert clinician at a time, the distortion loses power.",
              realCase: "Individuelle Wachsamkeit ist wichtig. Wenn mehr Leser die Reboxetin-Metaanalysen in Frage gestellt hätten, wäre das Medikament möglicherweise früher unter die Lupe genommen worden."
            },
            {
              id: 'personal_great',
              type: 'outcome',
              consequence: 'good',
              title: "Der aktive Ermittler",
              text: "Bevor Sie die Praxis wechseln, durchsuchen Sie selbst ClinicalTrials.gov. Sie finden unveröffentlichte Studien, die Metaanalysen übersehen haben. Sie senden den Trialisten eine E-Mail, um Daten anzufordern. Sie werden zu dem Detektiv, zu dem Sie dieser Kurs ausgebildet hat. Ihre Patienten werden auf der Grundlage der vollständigen Evidenz und nicht nur des veröffentlichten Teils betreut.",
              realCase: "Clinicians who check registries before adopting new treatments are rare but invaluable. They catch problems before guidelines do."
            },
            {
              id: 'reviewer',
              question: "Als Peer-Reviewer können Sie gestalten, was veröffentlicht wird. Was benötigen Sie?",
              branches: [
                { id: 'f', text: "Demand funnel plots and Egger's tests in all meta-analyses", nextNode: 'reviewer_minimum' },
                { id: 'g', text: "Require registry searches and documentation of unpublished trials", nextNode: 'reviewer_thorough' }
              ]
            },
            {
              id: 'reviewer_minimum',
              type: 'outcome',
              consequence: 'neutral',
              title: "Der statistische Gatekeeper",
              text: "Sie benötigen in jeder von Ihnen überprüften Metaanalyse eine Bias-Bewertung. Autoren fügen jetzt Trichterdiagramme hinzu. Aber ohne Registrierungssuchen erkennen statistische Tests nur einen Bruchteil des Problems. Sie haben die Mindestlatte höher gelegt – ein sinnvoller Beitrag –, aber das tiefere Problem bleibt bestehen.",
              realCase: "Many journals now require bias assessment. Compliance has improved. But quality of assessment varies widely."
            },
            {
              id: 'reviewer_thorough',
              type: 'outcome',
              consequence: 'good',
              title: "Der gründliche Torwächter",
              text: "You require: (1) Registry search with documentation of found/not found trials, (2) Contact attempts with trialists, (3) Comparison of published vs. registry-reported outcomes, (4) GRADE assessment incorporating bias risk. You reject meta-analyses that claim 'no publication bias' based on Egger's test alone. Standards rise.",
              realCase: "Die Standards von Cochrane haben die Messlatte für systematische Übersichten weltweit höher gelegt. Einzelne Prüfer, die hohe Standards durchsetzen, führen zu systemischen Veränderungen."
            },
            {
              id: 'advocate',
              question: "Sie möchten auf systemische Transparenz drängen. Worauf werden Sie Ihre Interessenvertretung konzentrieren?",
              branches: [
                { id: 'h', text: "Unterstützen Sie AllTrials und die obligatorische Ergebnisberichterstattung", nextNode: 'advocate_policy' },
                { id: 'i', text: "Push my institution to adopt data sharing policies", nextNode: 'advocate_local' },
                { id: 'j', text: "Schulen Sie andere – geben Sie diese Fähigkeiten an Kollegen und Studenten weiter", nextNode: 'advocate_teach' }
              ]
            },
            {
              id: 'advocate_policy',
              type: 'outcome',
              consequence: 'good',
              title: "Der Policy Advocate",
              text: "Sie unterzeichnen AllTrials. Sie schreiben an Gesetzgeber zum Thema Prozesstransparenz. Sie unterstützen die Durchsetzung der FDAAA. Sie sind eine Stimme unter Tausenden – aber Tausende von Stimmen schaffen politischen Willen. Das Gesetz von 2007, das die Ergebnisberichterstattung vorschreibt, wurde verabschiedet, weil Befürworter dies forderten. Die nächste Verbesserung braucht Sie.",
              realCase: "AllTrials hat über 90.000 Unterschriften gesammelt und die EMA-Richtlinien beeinflusst. Einzelne Stimmen bündeln sich zu politischer Kraft."
            },
            {
              id: 'advocate_local',
              type: 'outcome',
              consequence: 'good',
              title: "Der institutionelle Champion",
              text: "You push your hospital/university to require data sharing for all trials conducted there. You advocate for pre-registration policies. You work with the IRB to include transparency requirements. One institution at a time, the culture shifts. When everyone around you expects transparency, suppression becomes harder.",
              realCase: "Viele akademische medizinische Zentren erfordern jetzt eine Vorregistrierung und Ergebnisberichterstattung. Diese Richtlinien sind aus interner Interessenvertretung hervorgegangen."
            },
            {
              id: 'advocate_teach',
              type: 'outcome',
              consequence: 'good',
              title: "The Multiplier",
              text: "You teach this course to your residents. You present at grand rounds. You write blog posts explaining funnel plots. Every person you train becomes another detective. The skills spread exponentially. One teacher creates hundreds of vigilant readers. This is how paradigms shift — one learner at a time, until critical mass is reached.",
              realCase: "Die evidenzbasierte Medizinbewegung verbreitete sich durch die Lehre. Das Bewusstsein für Publikationsbias verbreitet sich in gleicher Weise. Sie können es beschleunigen."
            }
          ]
        }
      },
      {
        type: 'contrast',
        content: {
          title: "Two Futures",
          darkSide: {
            header: "Die Zukunft der anhaltenden Stille",
            items: [
              "Researchers continue hiding negative trials",
              "Journals continue rejecting null results",
              "Meta-analyses continue to inflate effects",
              "Guidelines continue to be based on incomplete evidence",
              "Patients continue receiving treatments that don't work",
              "Das nächste Vioxx passiert und das nächste und das nächste"
            ],
            consequence: "Die Zukunft, wenn sich nichts ändert. Der Kreislauf aus Unterdrückung und Schaden geht weiter. Das Wissen über Publikationsbias bleibt akademisch und nicht umsetzbar."
          },
          lightSide: {
            header: "Die Zukunft der wachsamen Erkennung",
            items: [
              "Detectives check every meta-analysis for bias",
              "Reviewers demand registry searches before acceptance",
              "Clinicians verify evidence before changing practice",
              "Advocates push for transparency at every level",
              "Teachers spread the skills of detection",
              "Die Kosten der Unterdrückung steigen, bis sie den Nutzen übersteigen"
            ],
            consequence: "Die Zukunft, wenn SIE handeln. Jeder Detektiv, jeder Rezensent, jeder Anwalt verschiebt das Gleichgewicht. Der Publikationsbias wird schwieriger, riskanter und weniger profitabel. Die Wahrheit findet Licht."
          }
        }
      },
      {
        type: 'oath',
        content: {
          header: "Die endgültige Verpflichtung",
          text: "I have learned to see what is hidden.<br>I have learned to test my suspicions.<br>I have learned to hunt for buried evidence.<br><br><strong>I will not let this knowledge remain unused.</strong><br><br>I will check the funnels. I will search the registries.<br>I will ask the questions no one wants asked.<br>I will document what I find and what I cannot find.<br><br><strong>I will be the detective the evidence needs.</strong>"
        }
      },
      {
        type: 'principle',
        content: {
          number: "OATH",
          text: "I will not accept the published literature as truth without investigation.\n\nI will look for what is hidden as carefully as I examine what is shown.\n\nI will test my suspicions statistically, but never mistake the test for certainty.\n\nI will hunt for buried evidence rather than impute imaginary studies.\n\nI will report what I find and what I cannot find — both are evidence.\n\nI will remember that behind every missing study are patients whose treatment was decided on incomplete evidence."
        }
      },
      {
        type: 'rhetoric',
        content: {
          question: "Und wenn Sie das alles gelernt haben – wenn Sie die Asymmetrie des Trichters sehen, das Flüstern der statistischen Tests hören und wie ein Detektiv durch Archive durch Register jagen können – was werden Sie mit diesem Wissen anfangen? Wirst du schweigen oder wirst du sprechen?"
        }
      },
      {
        type: 'cycle-return',
        content: {
          principle: "Du bist gekommen, um die Erkennung zu lernen. Sie gehen mit dem Wissen, dass die Erkennung nur der Anfang ist. Der Detektiv, der die Wahrheit findet, muss auch darum kämpfen, sie ans Licht zu bringen. Der Beweis, der nie Licht erblickte, kann nur heilen, wenn man ihn ans Tageslicht bringt."
        }
      },
      {
        type: 'redemption-story',
        content: {
          title: "Johnson & Johnson's DePuy Hip Implant Recall",
          narrative: "Not all stories of hidden data end in regulatory punishment. In 2010, Johnson & Johnson voluntarily recalled its DePuy ASR hip replacement system after internal analysis revealed higher-than-expected failure rates. While critics noted the recall came late (after ~93,000 implants), the company ultimately shared its internal data, funded revision surgeries, and established a patient monitoring registry. The DePuy case shows that companies CAN choose transparency when internal evidence shows harm — and that this path, while costly, is less destructive than prolonged concealment.",
          lesson: "Transparenz nach der Entdeckung eines Schadens ist zwar unvollkommen, begrenzt aber den Schaden und beginnt, Vertrauen wiederherzustellen. Der Kontrast zu Vioxx (wo Merck angeblich jahrelang Daten verschwiegen hat) zeigt zwei mögliche Reaktionen der Unternehmen auf unbequeme Beweise. Beide sind kostspielig, aber eines bewahrt die wissenschaftliche Integrität."
        }
      },
      {
        type: 'practice-case',
        content: {
          title: "Anwenden Ihrer Fähigkeiten",
          scenario: "You're reviewing a meta-analysis of a new diabetes drug. The authors report OR = 0.65 (95% CI: 0.52-0.81) for cardiovascular events, based on 12 trials. They state 'Egger's test was non-significant (p=0.34), indicating no publication bias.' The funnel plot shows slight asymmetry in the lower-left. Registry search shows 18 trials were registered for this drug.",
          data: {
            headers: ["Study", "Effect (log OR)", "SE", "Published"],
            rows: [
              ["ADVANCE-1", "-0.52", "0.15", "Yes"],
              ["CARDIO-2", "-0.48", "0.18", "Yes"],
              ["SAFE-3", "-0.35", "0.22", "Yes"],
              ["TRIAL-4", "-0.61", "0.12", "Yes"],
              ["MULTI-5", "-0.28", "0.25", "Yes"],
              ["PILOT-6", "-0.41", "0.20", "Yes"],
              ["REG-7 to REG-18", "???", "???", "No (6 registered, no results)"]
            ]
          },
          questions: [
            "What concerns does the registry search raise?",
            "Warum ist der nicht signifikante Egger-Test NICHT beruhigend?",
            "Was würden Sie empfehlen, bevor Sie diese Effektschätzung akzeptieren?"
          ],
          answers: [
            "18 registered trials but only 12 published = 33% missing. This gap strongly suggests selective publication. The 6 missing trials likely had less favorable results.",
            "Egger-Test hat eine geringe Leistung mit 12 Studien. Ein nicht signifikantes Ergebnis schließt eine Verzerrung nicht aus – es bedeutet, dass der Test sie nicht erkennen konnte. Es liegt eine visuelle Asymmetrie vor. Die Kombination aus visueller Asymmetrie + Registrierungslücke ist besorgniserregender als Eggers Test beruhigend ist.",
            "Kontaktieren Sie die Forscher der 6 unveröffentlichten Studien. Stellen Sie Anfragen für regulatorische Daten. Führen Sie Trim-and-Fill und PET-PEESE als Sensitivitätsanalysen durch. Herabstufung der Sicherheit bei der GRADE-Bewertung. Akzeptieren Sie die Punktschätzung NICHT als zuverlässig."
          ]
        }
      },
      {
        type: 'printable-checklist',
        content: {
          title: "Publication Bias Assessment Checklist",
          sections: [
            {
              heading: "1. Visual Assessment",
              items: [
                "Examine funnel plot for symmetry",
                "Note location of any gaps (significance regions?)",
                "Check if small studies cluster on one side",
                "Consider contour-enhanced funnel if available"
              ]
            },
            {
              heading: "2. Statistical Tests",
              items: [
                "Report Egger's test with p-value (threshold: p<0.10)",
                "Note number of studies (tests unreliable with <10)",
                "Report Begg's test if available",
                "Check if visual and statistical findings agree"
              ]
            },
            {
              heading: "3. Registry Search",
              items: [
                "Search ClinicalTrials.gov for intervention",
                "Search WHO ICTRP for international trials",
                "Compare registered vs. published trial count",
                "Document completion dates of unpublished trials"
              ]
            },
            {
              heading: "4. Additional Investigation",
              items: [
                "Kontaktieren Sie Trialisten für unveröffentlichte Daten",
                "Search conference abstracts and grey literature",
                "Check regulatory documents (FDA, EMA)",
                "Compare published outcomes to registered outcomes"
              ]
            },
            {
              heading: "5. Sensitivity Analysis",
              items: [
                "Run trim-and-fill and report adjusted estimate",
                "Führen Sie PET-PEESE durch, wenn mehr als 10 Studien verfügbar sind",
                "Calculate Fail-Safe N as heuristic",
                "Consider selection model if appropriate"
              ]
            },
            {
              heading: "6. Interpretation & Reporting",
              items: [
                "Document all searches (dates, terms, results)",
                "Melden Sie, was NICHT gefunden wurde und was nicht.",
                "Adjust GRADE certainty based on bias assessment",
                "State conclusions cautiously if bias suspected"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Reporting Standards: PRISMA-PB and PROSPERO",
          sections: [
            {
              heading: "PRISMA Extension for Publication Bias (PRISMA-PB)",
              items: [
                "Checklistenpunkt 15: Beschreiben Sie die Methoden, die zur Bewertung des Risikos einer Verzerrung aufgrund fehlender Studien verwendet werden Ergebnisse",
                "Checklist item 22: Present assessments of risk of bias due to missing results",
                "Requires explicit statement about registry searches conducted",
                "Muss die Anzahl der gefundenen Studien im Vergleich zur Anzahl eingeschlossener Studien mit Begründung angeben"
              ]
            },
            {
              heading: "PROSPERO Registration",
              items: [
                "Registrieren Sie Ihre systematische Überprüfung, BEVOR Sie mit der Suche beginnen",
                "Geben Sie Ihre Publikationsbias-Bewertungsmethoden vorab an",
                "Prevents selective reporting of bias assessments (ironic!)",
                "Available free at: crd.york.ac.uk/prospero"
              ]
            },
            {
              heading: "GRADE Assessment for Publication Bias",
              items: [
                "Rate DOWN one level if publication bias strongly suspected",
                "Consider: funnel asymmetry, registry gaps, industry funding pattern",
                "Document reasoning in GRADE evidence profile",
                "Even with bias-corrected estimates, uncertainty warrants downgrade"
              ]
            }
          ]
        }
      },
      {
        type: 'patient-communication',
        content: {
          scenario: "Ein Patient möchte ein Medikament absetzen, nachdem er online gelesen hat, dass Studien „versteckt“ waren oder „voreingenommen“.",
          script: "I understand your concern — you've read that some studies may not have been published, and that's a real issue in medicine. Let me explain what we know: while publication bias can inflate how well drugs appear to work, it doesn't mean treatments don't work at all. For your medication specifically, we have [X evidence]. The benefits we've seen in your case — [specific improvements] — are real. Let's review together whether continuing makes sense for you, but I wouldn't recommend stopping abruptly based on general concerns about bias.",
          keyPoints: [
            "Validate the concern — publication bias IS real",
            "Distinguish between inflated effects vs. no effects",
            "Ground discussion in patient's specific experience",
            "Avoid dismissing patient's research efforts",
            "Offer shared decision-making, not paternalism"
          ]
        }
      },
      {
        type: 'patient-communication',
        content: {
          scenario: "Ein Kollege empfiehlt eine neue Behandlung basierend auf einer Metaanalyse. Sie bemerken, dass das Trichterdiagramm asymmetrisch ist und das Register fehlende Studien anzeigt.",
          script: "Thanks for sharing this — it's an interesting option. I took a look at the meta-analysis and noticed a few things that give me pause. The funnel plot shows some asymmetry in the lower-left, and when I checked ClinicalTrials.gov, I found [X] registered trials that don't appear in the analysis. That pattern often indicates publication bias. The effect might be real, but probably smaller than the 40% reduction they report. Want to look at the registry data together? I think we should be cautious about changing our practice based on this until we understand what's missing.",
          keyPoints: [
            "Führen Sie mit Wertschätzung, nicht mit Kritik",
            "Seien Sie konkret, was Sie herausgefunden haben (keine vage Skepsis)",
            "Bieten Sie an, Beweise gemeinsam zu prüfen (kollaborativ)",
            "Sagen Sie es nicht „Die Studie ist falsch“ – sagen Sie „Die Wirkung könnte übertrieben sein“",
            "Suggest appropriate caution, not rejection"
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Questions Patients Can Ask Their Doctor",
          sections: [
            {
              heading: "Über Behandlungsnachweise",
              items: [
                "Wie viele Studien unterstützen diese Behandlung? Wurden sie alle veröffentlicht?",
                "Hat das Pharmaunternehmen die Studien finanziert? Gab es unabhängige Studien?",
                "Basiert diese Empfehlung auf einer systematischen Überprüfung? Wurde auf Publikationsbias geprüft?",
                "Wie hoch ist die für die Behandlung erforderliche Anzahl? Basiert das auf allen Studien oder nur auf veröffentlichten?"
              ]
            },
            {
              heading: "About Uncertainty",
              items: [
                "Wie überzeugt sind Sie von dieser Empfehlung?",
                "Könnte der Nutzen geringer sein, als die Studien vermuten lassen?",
                "Gibt es Behandlungen mit besserer Evidenzqualität?",
                "What would change your recommendation?"
              ]
            },
            {
              heading: "Über Shared Entscheidungsfindung",
              items: [
                "Welche Möglichkeiten habe ich angesichts der Unsicherheit?",
                "Was würden Sie tun, wenn Sie in meiner Situation wären?",
                "Can we try this and reassess in [timeframe]?",
                "Worauf sollte ich achten, damit wir wissen, dass es nicht funktioniert?"
              ]
            }
          ]
        }
      },
      {
        type: 'quiz',
        content: {
          question: "POST-ASSESSMENT: A meta-analysis shows Drug X reduces mortality by 35% (OR 0.65, p<0.001). Egger's test is non-significant (p=0.28) with 8 studies. Registry shows 12 trials were registered. What's your assessment?",
          options: [
            { id: 'a', text: "Starke Beweise – signifikante Wirkung und kein Publikationsbias festgestellt", correct: false },
            { id: 'b', text: "Uncertain — Egger's test underpowered, registry gap concerning, effect may be inflated", correct: true },
            { id: 'c', text: "Invalid — the meta-analysis should be rejected entirely", correct: false },
            { id: 'd', text: "More studies needed before any conclusion", correct: false }
          ],
          explanation: "Correct! Multiple red flags here: (1) Egger's test with only 8 studies has very low power — non-significant doesn't mean no bias; (2) 12 registered trials but only 8 published = 33% missing, suggesting selective publication; (3) The 35% effect may be inflated. You should: search for the 4 missing trials, run sensitivity analyses (trim-and-fill, PET-PEESE), and interpret with caution. Compare your answer to the pre-assessment — you've learned to see beyond p-values!"
        }
      },
      {
        type: 'key-takeaways',
        content: {
          takeaways: [
            "The Five Principles: Absence, Visibility, Asymmetry, Uncertainty, Action",
            "Erkennung allein reicht nicht aus – Beweise müssen umgesetzt und geteilt werden",
            "Every role matters: reader, reviewer, advocate, teacher",
            "Systemic change happens through accumulated individual actions",
            "The detective who finds truth must also fight to make it known"
          ],
          actionItem: "Before leaving this course, choose ONE concrete action: will you check funnel plots, demand registry searches, advocate for transparency, or teach others? Make a commitment and follow through."
        }
      }
    ]
  },

  // MODULE 7: CHRONICLES OF HIDDEN EVIDENCE
  {
    id: 7,
    title: "Chroniken versteckter Beweise",
    subtitle: "Real Cases, Real Decisions",
    estimatedMinutes: 35,
    slides: [
      {
        type: 'learning-objectives',
        content: {
          intro: "By the end of this module, you will be able to:",
          objectives: [
            "Analyze 5 landmark cases of publication bias using real data",
            "Make clinical decisions when facing incomplete evidence",
            "Recognize patterns of data suppression across different therapeutic areas",
            "Apply the two-path framework to evaluate consequences of action vs. inaction",
            "Verinnerlichen der Refrain: Der Trichter sieht, was Worte verbergen"
          ]
        }
      },
      {
        type: 'title',
        content: {
          title: "Chroniken versteckter Beweise",
          subtitle: "Fünf Geschichten aus den Archiven",
          text: "Jede Geschichte beginnt mit einer Frage. Jeder präsentiert eine Auswahl. Jeder enthüllt, was verborgen war. Das sind keine Hypothesen – sie sind passiert. Die Patienten waren echt. Die Daten wurden vergraben. Der Trichter hätte die Wahrheit gesagt."
        }
      },
      {
        type: 'principle',
        content: {
          number: "VI",
          text: "The funnel sees what words conceal."
        }
      },

      // STORY 1: THE PAROXETINE DECEPTION (Study 329)
      {
        type: 'story',
        content: {
          storyNumber: 1,
          title: "Die Paroxetin-Täuschung",
          caseId: "Study 329",
          opening: "Haben Sie darüber nachgedacht, was passiert, wenn die veröffentlichte Aufzeichnung lügt?",
          stats: {
            header: "Die verborgenen Daten",
            items: [
              { value: "275", label: "Adolescents enrolled" },
              { value: "11", label: "Suicide events on paroxetine" },
              { value: "2", label: "Suicide events on placebo" },
              { value: "14", label: "Years until truth emerged" }
            ]
          },
          scenario: {
            title: "Der Entscheidungspunkt",
            text: "The year is 2002. You are a prescribing physician. A depressed teenager sits before you. The journal article on your desk — published in the prestigious Journal of the American Academy of Child & Adolescent Psychiatry — concludes that paroxetine is 'generally well tolerated and effective' for adolescent depression. You have two paths before you."
          },
          pathA: {
            header: "Path A: Trust the Published Paper",
            action: "Sie verschreiben Paroxetin auf der Grundlage der von Experten überprüften Beweise",
            steps: [
              "The published paper shows efficacy on some measures",
              "Safety section mentions some events but appears reassuring",
              "Sie schreiben das Rezept mit Vertrauen",
              "Three weeks later, the patient attempts suicide"
            ],
            consequence: "Sie sind den Beweisen gefolgt. Aber die Beweise waren unvollständig. Die Arbeit, der Sie vertrauen, wurde von einem Ghostwriter verfasst. Der Hauptautor hatte die Rohdaten nicht gesehen. Das Selbstmordsignal – 5,5-mal höher bei Paroxetin – wurde im Kleingedruckten und in den Statistiken versteckt."
          },
          pathB: {
            header: "Weg B: Stellen Sie die fehlenden Daten in Frage",
            action: "Sie bemerken Unstimmigkeiten und graben tiefer",
            steps: [
              "Sie überprüfen das Studienregister – die primären Ergebnisse geändert",
              "Sie bemerken, dass die Autoren Berater des Herstellers sind",
              "Sie fordern den klinischen Studienbericht von der FDA an",
              "You discover 11 suicide-related events vs. 2 on placebo"
            ],
            consequence: "Sie haben Vorsicht gewählt. Sie haben eine Alternative verschrieben. Jahre später, als die Wahrheit ans Licht kam, wurde Ihnen klar, warum Ihre Skepsis Leben rettete. Aber im Jahr 2002 erforderte dieser Weg außerordentliche Wachsamkeit – das System war darauf ausgelegt, sich zu verstecken."
          },
          revelation: {
            header: "The Revelation",
            text: "It took 14 years for the full data to emerge. The paper was ghostwritten by a medical communications company. The named 'author' — a prominent academic — had not analyzed the data. The study actually showed paroxetine was neither safe nor effective. The restoring of Study 329 by RIAT researchers in 2015 exposed one of the greatest publication frauds in psychiatric history.",
            detail: "Source: Le Noury et al. BMJ 2015; Restoring Study 329"
          },
          refrain: "The funnel sees what words conceal."
        }
      },

      // STORY 2: THE REBOXETINE FUNNEL
      {
        type: 'story',
        content: {
          storyNumber: 2,
          title: "Der Reboxetine-Trichter",
          caseId: "NICE Submission / Eyding 2010",
          opening: "What appears when you plot effect against precision?",
          stats: {
            header: "Das Ausmaß der Unterdrückung",
            items: [
              { value: "0.56", label: "Published effect size (SMD)" },
              { value: "0.07", label: "True effect size (with unpublished)" },
              { value: "74%", label: "Patientendaten unterdrückt" },
              { value: "8", label: "Trials never published" }
            ]
          },
          scenario: {
            title: "Der Entscheidungspunkt",
            text: "You are a health technology assessment analyst reviewing reboxetine for national reimbursement. The published meta-analysis shows a standardized mean difference of 0.56 — a moderate-to-large effect. The manufacturer wants approval. Millions in revenue depend on your recommendation. But something bothers you about the funnel plot."
          },
          pathA: {
            header: "Path A: Accept the Published Literature",
            action: "Sie empfehlen eine Genehmigung basierend auf den verfügbaren Daten Beweise",
            steps: [
              "Published trials consistently show benefit",
              "The effect size appears clinically meaningful",
              "Sie schreiben eine positive Beurteilung",
              "Reboxetine is approved and widely prescribed"
            ],
            consequence: "Patienten erhalten ein Medikament, das durch veröffentlichte Beweise unterstützt wird. Diese Patienten erfahren jedoch keinen wirklichen Nutzen – da die veröffentlichten Beweise nur 26 % der Gesamtzahl ausmachten. Die 74 %, die keine Wirkung zeigten, wurden in Unternehmensdateien versteckt."
          },
          pathB: {
            header: "Pfad B: Unveröffentlichte Daten anfordern",
            action: "Sie berufen sich auf Ihre Befugnis, alle Studiendaten anzufordern",
            steps: [
              "Sie bemerken, dass alle veröffentlichten Studien von der Industrie gesponsert werden",
              "Sie Fordern Sie offiziell unveröffentlichte Versuchsdaten von Pfizer an",
              "Sie zeichnen ALLE Daten auf dem Trichter auf – die Asymmetrie erscheint",
              "The true effect is 0.07: clinically meaningless"
            ],
            consequence: "Ihre Forderung nach Transparenz enthüllt die Täuschung. Der Nutzen des Arzneimittels ist nicht belegt. Ihre Empfehlung schützt Patienten vor einer wirkungslosen Behandlung. Genau das hat das IQWiG getan – und Reboxetin wurde daraufhin in mehreren Ländern zurückgezogen oder eingeschränkt."
          },
          revelation: {
            header: "The Revelation",
            text: "When Eyding and colleagues obtained all trial data, the truth was stark: 2,256 patients in 8 trials had been hidden. The published literature — the 'evidence' — was a curated selection designed to show what did not exist. The funnel plot of all data showed what the published plot concealed: a symmetric distribution around zero.",
            detail: "Source: Eyding et al. BMJ 2010"
          },
          refrain: "The funnel sees what words conceal."
        }
      },

      // STORY 3: THE GABAPENTIN GHOST
      {
        type: 'story',
        content: {
          storyNumber: 3,
          title: "Der Geist von Gabapentin",
          caseId: "Pfizer's Hidden Trials",
          opening: "How many trials can hide in plain sight?",
          stats: {
            header: "Die Lücke im Register",
            items: [
              { value: "12", label: "Trials registered" },
              { value: "8", label: "Trials published" },
              { value: "4", label: "Studien ohne Nutzen – versteckt" },
              { value: "$430M", label: "Vergleich für Betrug" }
            ]
          },
          scenario: {
            title: "Der Entscheidungspunkt",
            text: "You are writing a systematic review on gabapentin for neuropathic pain. Your literature search returns 8 published trials, all showing benefit. The Cochrane methodology is clear: you must also search trial registries. When you do, you find 12 trials were registered. Four trials have vanished."
          },
          pathA: {
            header: "Path A: Review Only Published Literature",
            action: "Sie vervollständigen Ihre Bewertung mit den 8 verfügbaren Studien",
            steps: [
              "Your meta-analysis shows gabapentin is effective",
              "The forest plot shows consistent benefit across trials",
              "Sie kommen zu dem Schluss, dass Gabapentin bei neuropathischen Schmerzen wirkt",
              "Guidelines cite your review; prescriptions increase"
            ],
            consequence: "Ihre Bewertung wird Teil der Evidenzbasis. Aber es ist auf Sand gebaut – 33 % der Versuche fehlten. Die vier unveröffentlichten Studien zeigten keinen Nutzen. Ihre ehrliche Arbeit hält eine verzerrte Wahrheit aufrecht, weil Sie die veröffentlichten Aufzeichnungen als vollständig akzeptiert haben."
          },
          pathB: {
            header: "Path B: Hunt the Missing Trials",
            action: "Sie verfolgen die vier fehlenden Studien über alle Kanäle",
            steps: [
              "Sie kontaktieren Pfizer und fordern Studiendaten an – abgelehnt",
              "You file a Freedom of Information request to FDA",
              "Sie finden interne Dokumente aus der Offenlegung von Rechtsstreitigkeiten",
              "Die 4 fehlenden Studien zeigen keinen Nutzen: Die Wirkung verschwindet"
            ],
            consequence: "Your persistence reveals the publication bias. Your review includes a prominent warning about missing data. Your conclusions are appropriately uncertain. When the Pfizer settlement documents later emerge, your caution is vindicated. The 4 trials showed exactly what you suspected: nothing."
          },
          revelation: {
            header: "The Revelation",
            text: "Internal Pfizer documents revealed explicit suppression strategy. One email stated: 'We have to be careful about what we publish.' Draft manuscripts were prepared only for trials where data 'should be positive.' The company paid $430 million in settlements — but had already earned $2.7 billion from off-label promotion. The penalty was the cost of doing business.",
            detail: "Source: Steinman et al. JAMA 2006; DOJ Settlement 2004"
          },
          refrain: "The funnel sees what words conceal."
        }
      },

      // STORY 4: THE TAMIFLU BILLIONS
      {
        type: 'story',
        content: {
          storyNumber: 4,
          title: "Die Tamiflu-Milliarden",
          caseId: "Cochrane Oseltamivir-Rezension",
          opening: "Was kostet versteckte Daten?",
          stats: {
            header: "Die Skala von Investition",
            items: [
              { value: "$9B", label: "Global stockpile spending" },
              { value: "61%", label: "Published reduction in complications" },
              { value: "22,000", label: "Pages of hidden CSRs" },
              { value: "5", label: "Jahre, um Daten zu erhalten" }
            ]
          },
          scenario: {
            title: "Der Entscheidungspunkt",
            text: "Sie beraten ein Gesundheitsministerium zur Pandemievorsorge. Wir schreiben das Jahr 2009. Die Schweinegrippe breitet sich aus. Veröffentlichte Metaanalysen zeigen, dass Tamiflu Grippekomplikationen um 61 % reduziert. Regierungen auf der ganzen Welt horten Vorräte an. Ihr Minister fragt: Sollen wir Milliarden für Tamiflu ausgeben? Die Beweise scheinen klar zu sein."
          },
          pathA: {
            header: "Path A: Trust the Published Meta-Analyses",
            action: "Sie empfehlen eine Bevorratung auf der Grundlage veröffentlichter Beweise",
            steps: [
              "Die Metaanalysen werden in angesehenen Fachzeitschriften veröffentlicht",
              "Die Reduzierung um 61 % klingt erheblich",
              "You recommend $500 million in stockpile purchases",
              "The drugs sit in warehouses; the pandemic wanes"
            ],
            consequence: "Your recommendation followed the evidence that was available. But that evidence was based on published trials — and 60% of patient data came from unpublished manufacturer trials. The real effect on hospitalizations? Not significant. Your country spent hundreds of millions on drugs of uncertain benefit while other health needs went unfunded."
          },
          pathB: {
            header: "Path B: Demand Clinical Study Reports",
            action: "Sie verschieben die Entscheidung, bis Sie alles sehen Daten",
            steps: [
              "Sie bemerken, dass veröffentlichte Studien unveröffentlichte Herstellerdaten zitieren",
              "Sie unterstützen die Kampagne des BMJ für die vollständige Veröffentlichung von Daten",
              "You wait as Cochrane spends 5 years pursuing Roche",
              "Finally: 77 clinical study reports, 22,000 pages"
            ],
            consequence: "Your patience is rewarded with truth. Tamiflu reduces symptom duration by 17 hours — not 'days' as marketed. No evidence it prevents pneumonia or hospitalization. It causes nausea and vomiting. Your recommendation: do not stockpile at pandemic scale. WHO downgrades it from 'essential' to 'complementary' medicine."
          },
          revelation: {
            header: "The Revelation",
            text: "The Cochrane review took 5 years because Roche refused to release Clinical Study Reports. When finally obtained through regulatory channels, 22,000 pages revealed what 10 years of published papers concealed: the benefit was marginal, the harms understated, the hospitalization claim unfounded. Billions in public money had been allocated based on incomplete evidence.",
            detail: "Source: Jefferson et al. Cochrane 2014; BMJ Open Data Campaign"
          },
          refrain: "The funnel sees what words conceal."
        }
      },

      // STORY 5: THE ANTIDEPRESSANT LANDSCAPE
      {
        type: 'story',
        content: {
          storyNumber: 5,
          title: "Die Antidepressivum-Landschaft",
          caseId: "Turner et al. NEJM 2008",
          opening: "Was wäre, wenn Sie sehen könnten, was die FDA? Sah?",
          stats: {
            header: "Die veröffentlichte vs. tatsächliche Aufzeichnung",
            items: [
              { value: "74", label: "Trials in FDA database" },
              { value: "94%", label: "Published as positive" },
              { value: "51%", label: "Actually positive per FDA" },
              { value: "0.15", label: "True effect size (vs. 0.37 published)" }
            ]
          },
          scenario: {
            title: "Der Entscheidungspunkt",
            text: "You are updating national depression treatment guidelines. The published literature overwhelmingly supports antidepressant efficacy — 94% of published trials are positive. Effect sizes appear substantial. But you have access to something rare: the FDA's internal review documents. You can see what the journals did not print."
          },
          pathA: {
            header: "Path A: Follow the Published Literature",
            action: "You write guidelines based on journal publications",
            steps: [
              "Ihre Literaturrecherche findet belastbare Beweise",
              "Effect size meta-analysis shows d = 0.37",
              "You recommend antidepressants as first-line treatment",
              "Patients and clinicians expect substantial benefit"
            ],
            consequence: "Your guidelines set expectations that often are not met. Patients try antidepressants expecting the large effects the literature suggests. When improvement is modest, they feel like failures. Clinicians question their skills. The mismatch between published promise and lived reality creates confusion, non-adherence, and therapeutic nihilism."
          },
          pathB: {
            header: "Pfad B: Integrieren Sie FDA-Überprüfungsdaten",
            action: "Sie analysieren alle Studien – veröffentlichte und unveröffentlicht",
            steps: [
              "Sie erhalten FDA-Prüfungsdokumente für 12 Antidepressiva",
              "Sie entdecken, dass 36 Studien negativ oder fragwürdig waren",
              "Von diesen 36 wurden nur 14 veröffentlicht – und 11 wurden als positiv eingestuft",
              "True effect size: 0.15 (small, not 0.37)"
            ],
            consequence: "Your guidelines are honest about modest efficacy. They recommend antidepressants while acknowledging that benefits are real but smaller than published literature suggests. Patients have accurate expectations. Shared decision-making is possible because the truth is known. When improvement occurs, it is recognized; when it doesn't, alternatives are discussed without shame."
          },
          revelation: {
            header: "The Revelation",
            text: "Erick Turner's landmark study did what no one before had done: compare the FDA's complete record to the published literature. The result was devastating: selective publication inflated apparent efficacy by 32%. The published literature was not the evidence — it was a filtered, biased selection of the evidence. Turner's paper changed how we understand psychiatric drug trials forever.",
            detail: "Source: Turner et al. NEJM 2008"
          },
          refrain: "The funnel sees what words conceal."
        }
      },

      // SYNTHESIS SLIDE
      {
        type: 'content',
        content: {
          title: "The Pattern Across All Five Stories",
          sections: [
            {
              heading: "War war Versteckt",
              items: [
                "Suizidereignisse bei Jugendlichen (Studie 329)",
                "74% of patient data showing no benefit (Reboxetine)",
                "4 negative trials out of 12 registered (Gabapentin)",
                "22,000 pages of clinical study reports (Tamiflu)",
                "36 negative or questionable trials out of 74 (Antidepressants)"
              ]
            },
            {
              heading: "Who Hid It",
              items: [
                "Pharmaceutical companies with financial interests",
                "Medical communication firms ghostwriting papers",
                "Academic 'authors' who lent their names without seeing data",
                "Zeitschriften, die bevorzugt positive Ergebnisse veröffentlichten",
                "Regulierungsbehörden, die über Daten verfügten, aber keine Veröffentlichung erforderten"
              ]
            },
            {
              heading: "What Would Have Revealed It",
              items: [
                "Trial registry searches comparing registered to published",
                "Funnel plots showing asymmetric distributions",
                "Freedom of Information requests to regulatory agencies",
                "Comparison of published outcomes to pre-registered outcomes",
                "Anhaltende Nachfrage nach klinischen Studien Berichte"
              ]
            }
          ]
        }
      },

      // DECISION TREE SYNTHESIS
      {
        type: 'decision-tree',
        content: {
          title: "The Two Paths: A Universal Pattern",
          situation: "In each story, someone faced a choice. The evidence before them seemed clear. The published record pointed one way. But the complete truth pointed another. The detective asks: What would I have done?",
          nodes: [
            {
              id: 'start',
              question: "Sie stoßen auf veröffentlichte Beweise, die eine Behandlung unterstützen. Alle sichtbaren Tests sind positiv. Die Effektstärken sind beeindruckend. Was ist Ihre erste Antwort?",
              branches: [
                { id: 'a', text: "Accept the evidence and act on it — published = peer-reviewed = reliable", nextNode: 'naive' },
                { id: 'b', text: "Ask: What might be missing? Check registries, request unpublished data", nextNode: 'vigilant' }
              ]
            },
            {
              id: 'naive',
              type: 'outcome',
              consequence: 'bad',
              title: "Der Weg des Vertrauens",
              text: "You acted on what was visible. In the five cases you studied: you would have prescribed paroxetine to suicidal adolescents; recommended reboxetine that doesn't work; endorsed gabapentin for conditions it doesn't help; stockpiled billions in marginally effective Tamiflu; and set unrealistic expectations for antidepressants. Every published record seemed solid. Every one was incomplete.",
              realCase: "Dies war jahrzehntelang der Standardpfad der Medizin. Die meisten Leitlinien, die meisten Verschreibungsentscheidungen und die meisten Patientenerwartungen basierten auf veröffentlichter Literatur, in der der Nutzen systematisch überbewertet wurde."
            },
            {
              id: 'vigilant',
              type: 'outcome',
              consequence: 'good',
              title: "Der Weg des Detektivs",
              text: "You questioned what was missing. In each case, the answer was the same: hidden data that reversed or substantially weakened the conclusion. Your skepticism was not cynicism — it was protection. The patients whose lives depended on your decisions were served by your vigilance. The funnel plot, the registry search, the FOIA request — these are not academic exercises. They are shields.",
              realCase: "Jeder größere Fall von Publikationsbias wurde schließlich von Personen aufgedeckt, die sich weigerten, die veröffentlichte Aufzeichnung als vollständig zu akzeptieren. Sie fragten: Wo sind die restlichen Daten?"
            }
          ]
        }
      },

      // THE REFRAIN
      {
        type: 'oath',
        content: {
          header: "Der Refrain des Publication Bias Detective",
          text: "In Paroxetine, the paper said 'safe' — <strong>the funnel sees what words conceal.</strong><br><br>In Reboxetine, the published effect was 0.56 — <strong>the funnel sees what words conceal.</strong><br><br>In Gabapentin, four trials vanished — <strong>the funnel sees what words conceal.</strong><br><br>In Tamiflu, billions were spent on hidden data — <strong>the funnel sees what words conceal.</strong><br><br>In antidepressants, 94% positive became 51% — <strong>the funnel sees what words conceal.</strong><br><br>What words conceal, the detective reveals."
        }
      },

      // KEY TAKEAWAYS
      {
        type: 'key-takeaways',
        content: {
          takeaways: [
            "Publication bias is not an abstract statistical concept — it has body counts",
            "Every case followed the same pattern: financial incentive → selective publication → patient harm",
            "Die Tools zur Erkennung (Registrierungssuche, Funnel Plot, FOIA) hätten in jedem Fall die Wahrheit ans Licht gebracht",
            "Die Wahl an jedem Entscheidungspunkt war: Vertrauen vs. überprüfen",
            "Der Trichter sieht, was Wörter verbergen – aber nur, wenn Sie sich dafür entscheiden,"
          ],
          actionItem: "The next time you read a meta-analysis showing impressive effects, ask yourself: Which of the five stories does this most resemble? Then check the registry. Then look at the funnel. Then decide."
        }
      },

      // FINAL PRINCIPLE
      {
        type: 'cycle-return',
        content: {
          principle: "You have now walked through five chronicles of hidden evidence. In each, the published record lied — not through fabrication, but through omission. In each, patients were harmed by treatments that appeared effective but were not. In each, the funnel plot — that simple scatter of effect against precision — would have shown the asymmetry, the gap, the missing mass of hidden truth. Remember: The funnel sees what words conceal. See what it shows you."
        }
      }
    ]
  }
];

// ============================================================
// INTERACTIVE TOOLS
// ============================================================

// Basic Funnel Plot Tool
function renderFunnelTool(containerId) {
  const container = document.getElementById(containerId);
  if (!container) return;

  container.innerHTML = `
    <div class="tool-controls">
      <div class="tool-control">
        <label>True Effect Size</label>
        <input type="range" id="trueEffect" min="-1" max="1" step="0.1" value="0.3" oninput="updateFunnelPlot()">
        <span id="trueEffectVal">0.3</span>
      </div>
      <div class="tool-control">
        <label>Publication Bias</label>
        <select id="biasLevel" onchange="updateFunnelPlot()">
          <option value="none">None</option>
          <option value="mild">Mild</option>
          <option value="moderate" selected>Moderate</option>
          <option value="severe">Severe</option>
        </select>
      </div>
      <div class="tool-control">
        <label>Number of Studies</label>
        <input type="range" id="numStudies" min="10" max="50" step="5" value="25" oninput="updateFunnelPlot()">
        <span id="numStudiesVal">25</span>
      </div>
    </div>
    <div id="funnelPlotArea" class="plot-area"></div>
    <div id="funnelStats" style="margin-top:1rem;padding:1rem;background:rgba(0,0,0,0.2);border-radius:8px;"></div>
  `;

  updateFunnelPlot();
}

function updateFunnelPlot() {
  const trueEffect = parseFloat(document.getElementById('trueEffect').value);
  const biasLevel = document.getElementById('biasLevel').value;
  const numStudies = parseInt(document.getElementById('numStudies').value);

  document.getElementById('trueEffectVal').textContent = trueEffect.toFixed(1);
  document.getElementById('numStudiesVal').textContent = numStudies;

  // Generate studies
  const studies = [];
  const biasProb = { none: 0, mild: 0.3, moderate: 0.5, severe: 0.7 };
  const suppressProb = biasProb[biasLevel];

  for (let i = 0; i < numStudies * 2; i++) {
    const se = 0.1 + Math.random() * 0.4; // SE between 0.1 and 0.5
    const effect = trueEffect + (Math.random() - 0.5) * se * 4; // scatter around true effect
    const z = effect / se;
    const pval = 2 * (1 - normalCDF(Math.abs(z)));

    // Publication bias: suppress non-significant negative small studies
    const isNegative = effect < trueEffect * 0.5;
    const isSmall = se > 0.25;
    const isNonSig = pval > 0.05;

    const suppress = isNegative && isSmall && isNonSig && Math.random() < suppressProb;

    if (!suppress && studies.length < numStudies) {
      studies.push({ effect, se, pval, suppressed: false });
    }
  }

  // Calculate pooled effect
  const weights = studies.map(s => 1 / (s.se * s.se));
  const sumW = weights.reduce((a, b) => a + b, 0);
  const pooledEffect = studies.reduce((sum, s, i) => sum + weights[i] * s.effect, 0) / sumW;

  // Max SE for contours
  const maxSE = Math.max(...studies.map(s => s.se)) * 1.1;
  const z_05 = 1.96;

  // Create traces
  const studyTrace = {
    x: studies.map(s => s.effect),
    y: studies.map(s => s.se),
    mode: 'markers',
    type: 'scatter',
    marker: {
      size: 10,
      color: studies.map(s => s.pval < 0.05 ? '#3b82f6' : '#94a3b8'),
      line: { color: '#ffffff', width: 1 }
    },
    text: studies.map((s, i) => `Study ${i+1}<br>Effect: ${s.effect.toFixed(2)}<br>SE: ${s.se.toFixed(2)}<br>p: ${s.pval.toFixed(3)}`),
    hoverinfo: 'text',
    name: 'Studies'
  };

  const pooledLine = {
    x: [pooledEffect, pooledEffect],
    y: [0, maxSE],
    mode: 'lines',
    line: { color: '#d4af37', width: 2, dash: 'dash' },
    name: 'Pooled Effect'
  };

  const trueLine = {
    x: [trueEffect, trueEffect],
    y: [0, maxSE],
    mode: 'lines',
    line: { color: '#22c55e', width: 2, dash: 'dot' },
    name: 'True Effect'
  };

  // Contour lines
  const leftContour = {
    x: [pooledEffect, pooledEffect - z_05 * maxSE],
    y: [0, maxSE],
    mode: 'lines',
    line: { color: 'rgba(124,58,237,0.5)', width: 1, dash: 'dot' },
    showlegend: false
  };

  const rightContour = {
    x: [pooledEffect, pooledEffect + z_05 * maxSE],
    y: [0, maxSE],
    mode: 'lines',
    line: { color: 'rgba(124,58,237,0.5)', width: 1, dash: 'dot' },
    showlegend: false
  };

  Plotly.newPlot('funnelPlotArea', [studyTrace, pooledLine, trueLine, leftContour, rightContour], {
    title: 'Funnel Plot',
    xaxis: { title: 'Effect Size', zeroline: true },
    yaxis: { title: 'Standard Error', autorange: 'reversed' },
    showlegend: true,
    legend: { x: 1.02, y: 1 },
    paper_bgcolor: 'rgba(0,0,0,0)',
    plot_bgcolor: 'rgba(0,0,0,0.2)',
    font: { color: '#f5f5f0' }
  }, { responsive: true });

  // Stats
  const inflation = trueEffect !== 0 ? ((pooledEffect - trueEffect) / trueEffect * 100).toFixed(1) : 'N/A';
  const biasDesc = biasLevel === 'none' ? 'no' : biasLevel;
  const asymmetryDesc = biasLevel === 'none' ? 'symmetric (no gaps)' :
    biasLevel === 'mild' ? 'slightly asymmetric with minor gap in lower-left' :
    biasLevel === 'moderate' ? 'moderately asymmetric with visible gap in lower-left' :
    'stark asymmetrisch mit großer Lücke unten links (fehlende kleine negative Studien)';

  document.getElementById('funnelStats').innerHTML = `
    <div class="chart-description" aria-live="polite">
      Funnel plot showing ${numStudies} studies. True effect: ${trueEffect.toFixed(2)}.
      Observed pooled effect: ${pooledEffect.toFixed(2)} (${inflation === 'N/A' ? 'true effect is zero' : inflation > 0 ? inflation + '% inflation' : 'no inflation'}).
      Publication bias level: ${biasDesc}. Plot appears ${asymmetryDesc}.
    </div>
    <button onclick="this.previousElementSibling.classList.toggle('chart-description-visible')"
            style="font-size:0.75rem;padding:0.25rem 0.5rem;margin-bottom:0.75rem;background:rgba(255,255,255,0.1);border:1px solid rgba(255,255,255,0.2);border-radius:4px;color:var(--cream);cursor:pointer;">
      Toggle Chart Description (Screen Reader)
    </button>
    <div style="display:grid;grid-template-columns:repeat(3,1fr);gap:1rem;text-align:center;">
      <div>
        <div style="color:#22c55e;font-size:1.5rem;font-weight:bold;">${trueEffect.toFixed(2)}</div>
        <div style="font-size:0.8rem;color:rgba(255,255,255,0.6);">True Effect</div>
      </div>
      <div>
        <div style="color:#d4af37;font-size:1.5rem;font-weight:bold;">${pooledEffect.toFixed(2)}</div>
        <div style="font-size:0.8rem;color:rgba(255,255,255,0.6);">Observed (Pooled)</div>
      </div>
      <div>
        <div style="color:${inflation === 'N/A' ? '#888' : inflation > 10 ? '#dc2626' : '#16a34a'};font-size:1.5rem;font-weight:bold;">${inflation === 'N/A' ? 'N/A' : (inflation > 0 ? '+' : '') + inflation + '%'}</div>
        <div style="font-size:0.8rem;color:rgba(255,255,255,0.6);">Inflation</div>
      </div>
    </div>
  `;
}

// Contour-Enhanced Funnel Plot
function renderContourTool(containerId) {
  const container = document.getElementById(containerId);
  if (!container) return;

  container.innerHTML = `
    <div class="tool-controls">
      <div class="tool-control">
        <label>Show Contours</label>
        <select id="showContours" onchange="updateContourPlot()">
          <option value="yes" selected>Yes</option>
          <option value="no">No</option>
        </select>
      </div>
      <div class="tool-control">
        <label>Bias Pattern</label>
        <select id="biasPattern" onchange="updateContourPlot()">
          <option value="none">No Bias (Symmetric)</option>
          <option value="pubBias" selected>Publication Bias</option>
          <option value="heterogeneity">Heterogeneity</option>
        </select>
      </div>
    </div>
    <div id="contourPlotArea" class="plot-area"></div>
    <div id="contourInterpret" style="margin-top:1rem;padding:1rem;background:rgba(0,0,0,0.2);border-radius:8px;"></div>
  `;

  updateContourPlot();
}

function updateContourPlot() {
  const showContours = document.getElementById('showContours').value === 'yes';
  const biasPattern = document.getElementById('biasPattern').value;

  // Generate data based on pattern
  const studies = [];
  const trueEffect = 0.3;

  for (let i = 0; i < 30; i++) {
    let se, effect;

    if (biasPattern === 'none') {
      se = 0.1 + Math.random() * 0.35;
      effect = trueEffect + (Math.random() - 0.5) * se * 3;
    } else if (biasPattern === 'pubBias') {
      se = 0.1 + Math.random() * 0.35;
      effect = trueEffect + (Math.random() - 0.5) * se * 3;
      const z = effect / se;
      const pval = 2 * (1 - normalCDF(Math.abs(z)));
      if (effect < 0 && se > 0.2 && pval > 0.05 && Math.random() < 0.7) continue;
    } else { // heterogeneity
      se = 0.1 + Math.random() * 0.35;
      // Small studies have larger effects
      effect = trueEffect + (se > 0.25 ? 0.2 : 0) + (Math.random() - 0.5) * se * 2;
    }

    studies.push({ effect, se });
  }

  const maxSE = Math.max(...studies.map(s => s.se)) * 1.1;
  const pooledEffect = studies.reduce((s, st) => s + st.effect, 0) / studies.length;

  const traces = [];

  // Contour shading
  if (showContours) {
    // p > 0.05 region (non-significant)
    traces.push({
      x: [pooledEffect - 1.96 * maxSE, pooledEffect, pooledEffect + 1.96 * maxSE, pooledEffect - 1.96 * maxSE],
      y: [maxSE, 0, maxSE, maxSE],
      fill: 'toself',
      fillcolor: 'rgba(124,58,237,0.1)',
      line: { color: 'rgba(124,58,237,0.3)' },
      name: 'p < 0.05',
      showlegend: true
    });
  }

  // Studies
  traces.push({
    x: studies.map(s => s.effect),
    y: studies.map(s => s.se),
    mode: 'markers',
    type: 'scatter',
    marker: { size: 10, color: '#3b82f6', line: { color: '#fff', width: 1 } },
    name: 'Studies'
  });

  // Pooled line
  traces.push({
    x: [pooledEffect, pooledEffect],
    y: [0, maxSE],
    mode: 'lines',
    line: { color: '#d4af37', width: 2, dash: 'dash' },
    name: 'Pooled'
  });

  Plotly.newPlot('contourPlotArea', traces, {
    title: 'Contour-Enhanced Funnel Plot',
    xaxis: { title: 'Effect Size' },
    yaxis: { title: 'Standard Error', autorange: 'reversed' },
    showlegend: true,
    paper_bgcolor: 'rgba(0,0,0,0)',
    plot_bgcolor: 'rgba(0,0,0,0.2)',
    font: { color: '#f5f5f0' }
  }, { responsive: true });

  const interpretations = {
    none: "Symmetric funnel. No evidence of publication bias or small-study effects.",
    pubBias: "Asymmetrischer Trichter mit Lücke unten links (nicht signifikanter Bereich) auszusehen. Dieses Muster deutet auf eine Publikationsverzerrung hin – kleine negative Studien wurden nicht veröffentlicht.",
    heterogeneity: "Asymmetrischer Trichter mit kleinen Studien, die größere Effekte zeigen. Könnte ein Publikationsbias ODER echte Unterschiede sein (krankere Patienten in kleinen Studien). Klinische Untersuchung erforderlich."
  };

  document.getElementById('contourInterpret').innerHTML = `<strong>Interpretation:</strong> ${interpretations[biasPattern]}`;
}

// Egger's Test Tool
function renderEggerTool(containerId) {
  const container = document.getElementById(containerId);
  if (!container) return;

  container.innerHTML = `
    <div class="tool-description">Enter effect sizes and standard errors to calculate Egger's regression test.</div>
    <div class="tool-controls" style="flex-direction:column;">
      <textarea id="eggerData" rows="8" style="width:100%;background:rgba(0,0,0,0.3);color:#f5f5f0;border:1px solid rgba(255,255,255,0.2);border-radius:8px;padding:1rem;font-family:monospace;"># Effect, SE (one per line)
0.45, 0.12
0.32, 0.15
0.28, 0.18
0.51, 0.14
0.15, 0.22
0.38, 0.16
0.42, 0.13
0.55, 0.11
0.25, 0.19
0.33, 0.17</textarea>
      <button onclick="runEggerTest()" style="margin-top:1rem;padding:0.75rem 1.5rem;background:var(--teal);border:none;border-radius:8px;color:white;cursor:pointer;font-weight:600;">Run Egger's Test</button>
    </div>
    <div id="eggerResults" style="margin-top:1.5rem;"></div>
  `;
}

function runEggerTest() {
  const dataText = document.getElementById('eggerData').value;
  const lines = dataText.split('\n').filter(l => l.trim() && !l.startsWith('#'));

  const yi = [], sei = [];
  lines.forEach(line => {
    const parts = line.split(',').map(p => parseFloat(p.trim()));
    if (parts.length >= 2 && !isNaN(parts[0]) && !isNaN(parts[1])) {
      yi.push(parts[0]);
      sei.push(parts[1]);
    }
  });

  if (yi.length < 3) {
    document.getElementById('eggerResults').innerHTML = '<p style="color:#dc2626;">Need at least 3 studies for Egger\'s test.</p>';
    return;
  }

  // Weighted least squares regression
  const vi = sei.map(s => s * s);
  const wi = vi.map(v => 1 / v);
  const precision = sei.map(s => 1 / s);
  const zi = yi.map((y, i) => y / sei[i]);

  const k = yi.length;
  const sumW = wi.reduce((a, b) => a + b, 0);
  const sumWx = precision.reduce((sum, x, i) => sum + wi[i] * x, 0);
  const sumWy = zi.reduce((sum, y, i) => sum + wi[i] * y, 0);
  const sumWxy = precision.reduce((sum, x, i) => sum + wi[i] * x * zi[i], 0);
  const sumWx2 = precision.reduce((sum, x, i) => sum + wi[i] * x * x, 0);

  const det = sumW * sumWx2 - sumWx * sumWx;
  const b0 = (sumWx2 * sumWy - sumWx * sumWxy) / det; // intercept
  const b1 = (sumW * sumWxy - sumWx * sumWy) / det;   // slope

  const residuals = zi.map((z, i) => z - (b0 + b1 * precision[i]));
  const sse = residuals.reduce((sum, r, i) => sum + wi[i] * r * r, 0);
  const mse = sse / (k - 2);

  const var_b0 = mse * sumWx2 / det;
  const se_b0 = Math.sqrt(var_b0);
  const t_val = b0 / se_b0;
  const p_val = 2 * (1 - tCDF(Math.abs(t_val), k - 2));

  const significant = p_val < 0.1;

  document.getElementById('eggerResults').innerHTML = `
    <div class="statistic-card" style="background:${significant ? 'rgba(220,38,38,0.2)' : 'rgba(22,163,74,0.2)'};border-color:${significant ? 'rgba(220,38,38,0.4)' : 'rgba(22,163,74,0.4)'};">
      <div style="font-size:1.5rem;font-weight:bold;color:${significant ? '#dc2626' : '#22c55e'};">
        ${significant ? 'Significant Asymmetry Detected' : 'No Significant Asymmetry'}
      </div>
      <div style="margin-top:1rem;display:grid;grid-template-columns:repeat(3,1fr);gap:1rem;">
        <div>
          <div style="font-size:1.2rem;font-weight:bold;">${b0.toFixed(3)}</div>
          <div style="font-size:0.8rem;color:rgba(255,255,255,0.6);">Intercept (b0)</div>
        </div>
        <div>
          <div style="font-size:1.2rem;font-weight:bold;">${t_val.toFixed(2)}</div>
          <div style="font-size:0.8rem;color:rgba(255,255,255,0.6);">t-statistic</div>
        </div>
        <div>
          <div style="font-size:1.2rem;font-weight:bold;">${p_val.toFixed(4)}</div>
          <div style="font-size:0.8rem;color:rgba(255,255,255,0.6);">p-value</div>
        </div>
      </div>
    </div>
    <div style="margin-top:1rem;padding:1rem;background:rgba(0,0,0,0.2);border-radius:8px;">
      <strong>Interpretation:</strong> ${significant
        ? 'p < 0.10 suggests funnel plot asymmetry. This MAY indicate publication bias, but could also reflect heterogeneity or other small-study effects. Investigate further.'
        : 'p >= 0.10 does not suggest asymmetry. However, with ' + k + 'Studien, der Test hat eine begrenzte Aussagekraft. Das Fehlen von Beweisen ist kein Beweis für die Abwesenheit.'}
    </div>
  `;
}

// Trim and Fill Tool
function renderTrimFillTool(containerId) {
  const container = document.getElementById(containerId);
  if (!container) return;

  container.innerHTML = `
    <div class="tool-controls">
      <div class="tool-control">
        <label>Show Original Only</label>
        <input type="checkbox" id="originalOnly" onchange="updateTrimFill()">
      </div>
      <div class="tool-control">
        <label>Asymmetry Level</label>
        <select id="asymLevel" onchange="updateTrimFill()">
          <option value="low">Low</option>
          <option value="moderate" selected>Moderate</option>
          <option value="high">High</option>
        </select>
      </div>
    </div>
    <div id="trimFillPlotArea" class="plot-area"></div>
    <div id="trimFillResults" style="margin-top:1rem;padding:1rem;background:rgba(0,0,0,0.2);border-radius:8px;"></div>
  `;

  updateTrimFill();
}

function updateTrimFill() {
  const originalOnly = document.getElementById('originalOnly').checked;
  const asymLevel = document.getElementById('asymLevel').value;

  const trueEffect = 0.25;
  const suppressProb = { low: 0.2, moderate: 0.5, high: 0.8 }[asymLevel];

  const observed = [];
  for (let i = 0; i < 40; i++) {
    const se = 0.08 + Math.random() * 0.35;
    const effect = trueEffect + (Math.random() - 0.5) * se * 3.5;
    const z = effect / se;
    const pval = 2 * (1 - normalCDF(Math.abs(z)));

    if (effect < 0.1 && se > 0.2 && pval > 0.05 && Math.random() < suppressProb) continue;
    observed.push({ effect, se });
  }

  // Simple trim-and-fill simulation
  const weights = observed.map(s => 1 / (s.se * s.se));
  const sumW = weights.reduce((a, b) => a + b, 0);
  const pooledObs = observed.reduce((sum, s, i) => sum + weights[i] * s.effect, 0) / sumW;

  // Find asymmetric studies and create mirror images
  const imputed = [];
  if (!originalOnly) {
    observed.forEach(s => {
      if (s.effect < pooledObs - 0.1 && s.se > 0.2) return; // keep these
      if (s.effect > pooledObs + 0.15 && s.se > 0.2) {
        // Impute mirror image
        const mirrorEffect = 2 * pooledObs - s.effect;
        imputed.push({ effect: mirrorEffect, se: s.se });
      }
    });
  }

  const allStudies = [...observed, ...imputed];
  const allWeights = allStudies.map(s => 1 / (s.se * s.se));
  const sumAllW = allWeights.reduce((a, b) => a + b, 0);
  const pooledAdj = allStudies.reduce((sum, s, i) => sum + allWeights[i] * s.effect, 0) / sumAllW;

  const maxSE = Math.max(...allStudies.map(s => s.se)) * 1.1;

  const traces = [
    {
      x: observed.map(s => s.effect),
      y: observed.map(s => s.se),
      mode: 'markers',
      marker: { size: 10, color: '#3b82f6', line: { color: '#fff', width: 1 } },
      name: 'Observed'
    }
  ];

  if (!originalOnly && imputed.length > 0) {
    traces.push({
      x: imputed.map(s => s.effect),
      y: imputed.map(s => s.se),
      mode: 'markers',
      marker: { size: 10, color: 'rgba(212,175,55,0)', symbol: 'circle-open', line: { color: '#d4af37', width: 2 } },
      name: 'Imputed (Trim-Fill)'
    });
  }

  traces.push({
    x: [pooledObs, pooledObs],
    y: [0, maxSE],
    mode: 'lines',
    line: { color: '#3b82f6', width: 2, dash: 'dash' },
    name: 'Original Pooled'
  });

  if (!originalOnly) {
    traces.push({
      x: [pooledAdj, pooledAdj],
      y: [0, maxSE],
      mode: 'lines',
      line: { color: '#d4af37', width: 2 },
      name: 'Adjusted Pooled'
    });
  }

  Plotly.newPlot('trimFillPlotArea', traces, {
    title: 'Trim-and-Fill-Analyse',
    xaxis: { title: 'Effect Size' },
    yaxis: { title: 'Standard Error', autorange: 'reversed' },
    showlegend: true,
    paper_bgcolor: 'rgba(0,0,0,0)',
    plot_bgcolor: 'rgba(0,0,0,0.2)',
    font: { color: '#f5f5f0' }
  }, { responsive: true });

  const change = ((pooledAdj - pooledObs) / pooledObs * 100).toFixed(1);
  document.getElementById('trimFillResults').innerHTML = `
    <div style="display:grid;grid-template-columns:repeat(3,1fr);gap:1rem;text-align:center;">
      <div>
        <div style="font-size:1.3rem;font-weight:bold;color:#3b82f6;">${pooledObs.toFixed(3)}</div>
        <div style="font-size:0.8rem;color:rgba(255,255,255,0.6);">Original Effect</div>
      </div>
      <div>
        <div style="font-size:1.3rem;font-weight:bold;color:#d4af37;">${pooledAdj.toFixed(3)}</div>
        <div style="font-size:0.8rem;color:rgba(255,255,255,0.6);">Adjusted Effect</div>
      </div>
      <div>
        <div style="font-size:1.3rem;font-weight:bold;">${imputed.length}</div>
        <div style="font-size:0.8rem;color:rgba(255,255,255,0.6);">Imputed Studies</div>
      </div>
    </div>
    <div style="margin-top:1rem;font-size:0.9rem;color:rgba(255,255,255,0.7);">
      Effect changed by ${change}% after trim-and-fill adjustment.
      <em>Note: Imputed studies are statistical estimates, not real recovered data.</em>
    </div>
  `;
}

// P-Curve Tool
function renderPCurveTool(containerId) {
  const container = document.getElementById(containerId);
  if (!container) return;

  container.innerHTML = `
    <div class="tool-description">Enter p-values from significant studies (p < 0.05) to analyze the p-curve.</div>
    <div class="tool-controls" style="flex-direction:column;">
      <textarea id="pcurveData" rows="6" style="width:100%;background:rgba(0,0,0,0.3);color:#f5f5f0;border:1px solid rgba(255,255,255,0.2);border-radius:8px;padding:1rem;font-family:monospace;"># Enter p-values (p < 0.05), one per line
0.001
0.012
0.003
0.045
0.028
0.015
0.008
0.041
0.022
0.009</textarea>
      <button onclick="runPCurve()" style="margin-top:1rem;padding:0.75rem 1.5rem;background:var(--teal);border:none;border-radius:8px;color:white;cursor:pointer;font-weight:600;">Analyze P-Curve</button>
    </div>
    <div id="pcurvePlotArea" class="plot-area" style="min-height:300px;"></div>
    <div id="pcurveResults" style="margin-top:1rem;"></div>
  `;
}

function runPCurve() {
  const dataText = document.getElementById('pcurveData').value;
  const pvals = dataText.split('\n')
    .map(l => parseFloat(l.trim()))
    .filter(p => !isNaN(p) && p > 0 && p < 0.05);

  if (pvals.length < 5) {
    document.getElementById('pcurveResults').innerHTML = '<p style="color:#dc2626;">Need at least 5 significant p-values.</p>';
    return;
  }

  // Bin p-values
  const bins = [0, 0.01, 0.02, 0.03, 0.04, 0.05];
  const counts = [0, 0, 0, 0, 0];
  pvals.forEach(p => {
    for (let i = 0; i < 5; i++) {
      if (p > bins[i] && p <= bins[i + 1]) counts[i]++;
    }
  });

  // Expected under null (uniform)
  const expected = pvals.length / 5;

  const trace = {
    x: ['0-.01', '.01-.02', '.02-.03', '.03-.04', '.04-.05'],
    y: counts,
    type: 'bar',
    marker: { color: '#3b82f6' },
    name: 'Observed'
  };

  const expectedTrace = {
    x: ['0-.01', '.01-.02', '.02-.03', '.03-.04', '.04-.05'],
    y: [expected, expected, expected, expected, expected],
    type: 'scatter',
    mode: 'lines',
    line: { color: '#dc2626', dash: 'dash', width: 2 },
    name: 'Expected (Null)'
  };

  Plotly.newPlot('pcurvePlotArea', [trace, expectedTrace], {
    title: 'P-Curve Distribution',
    xaxis: { title: 'P-value Range' },
    yaxis: { title: 'Count' },
    paper_bgcolor: 'rgba(0,0,0,0)',
    plot_bgcolor: 'rgba(0,0,0,0.2)',
    font: { color: '#f5f5f0' }
  }, { responsive: true });

  // Simple skewness assessment
  const below025 = pvals.filter(p => p < 0.025).length;
  const above025 = pvals.filter(p => p >= 0.025).length;
  const isRightSkewed = below025 > above025 * 1.5;
  const isFlat = Math.abs(below025 - above025) < pvals.length * 0.2;
  const isLeftSkewed = above025 > below025 * 1.5;

  let interpretation, color;
  if (isRightSkewed) {
    interpretation = "RIGHT-SKEWED: Many p-values well below 0.025. This suggests TRUE evidential value — a real effect exists.";
    color = '#22c55e';
  } else if (isLeftSkewed) {
    interpretation = "LEFT-SKEWED: Excess p-values near 0.05. This suggests P-HACKING or selective reporting.";
    color = '#dc2626';
  } else {
    interpretation = "FLAT: P-Werte ungefähr einheitlich. Dies lässt darauf schließen, dass es entweder KEINE WAHRE WIRKUNG gibt oder dass die Studien stark unterbewertet sind.";
    color = '#f59e0b';
  }

  document.getElementById('pcurveResults').innerHTML = `
    <div class="statistic-card" style="border-color:${color}40;background:${color}20;">
      <div style="font-size:1.2rem;font-weight:bold;color:${color};">${interpretation}</div>
      <div style="margin-top:1rem;font-size:0.9rem;">
        P < 0.025: ${below025} studies (${(below025/pvals.length*100).toFixed(0)}%) |
        P >= 0.025: ${above025} studies (${(above025/pvals.length*100).toFixed(0)}%)
      </div>
    </div>
  `;
}

// Utility functions
function normalCDF(x) {
  const a1 =  0.254829592, a2 = -0.284496736, a3 = 1.421413741;
  const a4 = -1.453152027, a5 = 1.061405429, p = 0.3275911;
  const sign = x < 0 ? -1 : 1;
  x = Math.abs(x) / Math.sqrt(2);
  const t = 1.0 / (1.0 + p * x);
  const y = 1.0 - (((((a5 * t + a4) * t) + a3) * t + a2) * t + a1) * t * Math.exp(-x * x);
  return 0.5 * (1.0 + sign * y);
}

// First set of tCDF/incompleteBeta/betaCF/lgamma removed (duplicate of lines below with different arg order)
// The canonical versions with correct negative-t handling are defined after the Failsafe N tool.

// Failsafe N Calculator Tool
function renderFailsafeTool(containerId) {
  const container = document.getElementById(containerId);
  if (!container) return;

  container.innerHTML = `
    <div class="tool-description">Calculate Rosenthal's Fail-Safe N — the number of null studies needed to make your result non-significant.</div>
    <div class="tool-controls" style="flex-direction:column;">
      <div style="display:grid;grid-template-columns:1fr 1fr;gap:1rem;">
        <div class="tool-control">
          <label>Number of Studies (k)</label>
          <input type="number" id="failsafeK" value="15" min="2" max="200" style="width:100%;">
        </div>
        <div class="tool-control">
          <label>Mean Z-score (or enter individual z below)</label>
          <input type="number" id="failsafeMeanZ" value="2.5" step="0.1" style="width:100%;">
        </div>
      </div>
      <div class="tool-control" style="margin-top:1rem;">
        <label>OR enter individual Z-scores (comma-separated):</label>
        <input type="text" id="failsafeZscores" placeholder="2.1, 3.4, 1.8, 2.9, ..." style="width:100%;">
      </div>
      <button onclick="runFailsafeN()" style="margin-top:1rem;padding:0.75rem 1.5rem;background:var(--teal);border:none;border-radius:8px;color:white;cursor:pointer;font-weight:600;">Calculate Fail-Safe N</button>
    </div>
    <div id="failsafeResults" style="margin-top:1.5rem;"></div>
  `;
}

function runFailsafeN() {
  let k, sumZ, meanZ;

  const zScoresInput = document.getElementById('failsafeZscores').value.trim();

  if (zScoresInput) {
    const zScores = zScoresInput.split(',').map(z => parseFloat(z.trim())).filter(z => !isNaN(z));
    k = zScores.length;
    sumZ = zScores.reduce((a, b) => a + b, 0);
    meanZ = sumZ / k;
  } else {
    k = parseInt(document.getElementById('failsafeK').value);
    meanZ = parseFloat(document.getElementById('failsafeMeanZ').value);
    sumZ = k * meanZ;
  }

  if (k < 2) {
    document.getElementById('failsafeResults').innerHTML = '<p style="color:#dc2626;">Need at least 2 studies.</p>';
    return;
  }

  // Rosenthal's Fail-Safe N formula: N = (sum(Z) / 1.645)^2 - k
  // Or equivalently: N = k * (meanZ / 1.645)^2 - k
  const criticalZ = 1.645; // one-tailed p = 0.05
  const failsafeN = Math.max(0, Math.pow(sumZ / criticalZ, 2) - k);
  const roundedN = Math.ceil(failsafeN);

  // Interpretation thresholds
  const threshold5k1 = 5 * k + 10; // Rosenthal's rule: N > 5k + 10 is robust
  const isRobust = roundedN > threshold5k1;

  const robustColor = isRobust ? '#22c55e' : '#dc2626';
  const robustText = isRobust
    ? `ROBUST: Fail-Safe N (${roundedN}) exceeds 5k + 10 (${threshold5k1}). Would need ${roundedN} null studies to nullify the effect.`
    : `FRAGILE: Fail-Safe N (${roundedN}) is less than 5k + 10 (${threshold5k1}). Result may be vulnerable to publication bias.`;

  document.getElementById('failsafeResults').innerHTML = `
    <div class="statistic-card" style="border-color:${robustColor}40;background:${robustColor}20;">
      <div style="font-size:3rem;font-weight:bold;color:${robustColor};">${roundedN}</div>
      <div style="font-size:1rem;margin-top:0.5rem;">Fail-Safe N (Rosenthal)</div>
    </div>
    <div style="margin-top:1rem;padding:1rem;background:rgba(0,0,0,0.2);border-radius:8px;">
      <strong style="color:${robustColor};">${robustText}</strong>
      <div style="margin-top:1rem;font-size:0.9rem;color:rgba(255,255,255,0.7);">
        <strong>Interpretation:</strong> ${roundedN} unpublished null studies would need to exist in file drawers to reduce your meta-analytic effect to non-significance.
      </div>
      <div style="margin-top:0.75rem;font-size:0.85rem;color:rgba(255,255,255,0.5);">
        <strong>Caveat:</strong> Fail-Safe N is criticized for assuming missing studies have exactly zero effect. Modern methods (selection models, trim-and-fill) are preferred. Use Fail-Safe N as a quick heuristic, not definitive evidence.
      </div>
    </div>
    <div style="margin-top:1rem;padding:1rem;background:rgba(124,58,237,0.1);border-radius:8px;font-size:0.85rem;">
      <strong>Formula:</strong> N = (ΣZ / 1.645)² - k = (${sumZ.toFixed(2)} / 1.645)² - ${k} = ${failsafeN.toFixed(1)}
    </div>
  `;
}

// PET-PEESE Calculator Tool
function renderPetPeeseTool(containerId) {
  const container = document.getElementById(containerId);
  if (!container) return;

  container.innerHTML = `
    <div class="tool-description">Calculate PET-PEESE bias-corrected effect estimates from your meta-analysis data.</div>
    <div style="margin:1rem 0;">
      <label style="display:block;margin-bottom:0.5rem;color:var(--gold);">Enter study data (one per line: effect, SE)</label>
      <textarea id="petpeeseData" rows="8" placeholder="0.45, 0.12
0.32, 0.15
0.58, 0.18
0.21, 0.22
0.67, 0.11" style="width:100%;padding:0.75rem;background:rgba(0,0,0,0.3);border:1px solid var(--gold);border-radius:8px;color:white;font-family:monospace;"></textarea>
      <p style="font-size:0.8rem;color:rgba(255,255,255,0.5);margin-top:0.5rem;">Format: effect size, standard error (comma separated, one study per line)</p>
    </div>
    <button onclick="runPetPeese()" style="padding:0.75rem 1.5rem;background:var(--purple);border:none;border-radius:8px;color:white;cursor:pointer;font-weight:600;">Calculate PET-PEESE</button>
    <div id="petpeeseResults" style="margin-top:1.5rem;"></div>
  `;
}

function runPetPeese() {
  const dataText = document.getElementById('petpeeseData').value.trim();
  const lines = dataText.split('\n').filter(l => l.trim());

  if (lines.length < 5) {
    document.getElementById('petpeeseResults').innerHTML = '<p style="color:#dc2626;">Need at least 5 studies for reliable PET-PEESE estimates.</p>';
    return;
  }

  // Parse data
  const studies = [];
  for (const line of lines) {
    const [effect, se] = line.split(',').map(v => parseFloat(v.trim()));
    if (!isNaN(effect) && !isNaN(se) && se > 0) {
      studies.push({ effect, se, var: se * se });
    }
  }

  if (studies.length < 5) {
    document.getElementById('petpeeseResults').innerHTML = '<p style="color:#dc2626;">Could not parse enough valid data. Check format.</p>';
    return;
  }

  const k = studies.length;

  // Calculate weighted means for reference
  const weights = studies.map(s => 1 / s.var);
  const sumW = weights.reduce((a, b) => a + b, 0);
  const naiveEffect = studies.reduce((sum, s, i) => sum + weights[i] * s.effect, 0) / sumW;

  // PET: effect = b0 + b1 * SE (weighted by 1/variance)
  // Simple weighted least squares
  const meanSE = studies.reduce((sum, s, i) => sum + weights[i] * s.se, 0) / sumW;
  const ssxx_pet = studies.reduce((sum, s, i) => sum + weights[i] * Math.pow(s.se - meanSE, 2), 0);
  const ssxy_pet = studies.reduce((sum, s, i) => sum + weights[i] * (s.se - meanSE) * (s.effect - naiveEffect), 0);
  const b1_pet = ssxy_pet / ssxx_pet;
  const b0_pet = naiveEffect - b1_pet * meanSE;

  // Calculate SE of intercept for PET (proper WLS: Var(b0) = MSE * sum(w*x^2) / det)
  const residuals_pet = studies.map(s => s.effect - (b0_pet + b1_pet * s.se));
  const mse_pet = residuals_pet.reduce((sum, r, i) => sum + weights[i] * r * r, 0) / (k - 2);
  const sumWx2_pet = studies.reduce((sum, s, i) => sum + weights[i] * s.se * s.se, 0);
  const sumWx_pet = studies.reduce((sum, s, i) => sum + weights[i] * s.se, 0);
  const det_pet = sumW * sumWx2_pet - sumWx_pet * sumWx_pet;
  const se_b0_pet = Math.sqrt(mse_pet * sumWx2_pet / det_pet);
  const t_pet = b0_pet / se_b0_pet;
  const p_pet = 2 * (1 - tCDF(Math.abs(t_pet), k - 2));

  // PEESE: effect = b0 + b1 * variance
  const meanVar = studies.reduce((sum, s, i) => sum + weights[i] * s.var, 0) / sumW;
  const ssxx_peese = studies.reduce((sum, s, i) => sum + weights[i] * Math.pow(s.var - meanVar, 2), 0);
  const ssxy_peese = studies.reduce((sum, s, i) => sum + weights[i] * (s.var - meanVar) * (s.effect - naiveEffect), 0);
  const b1_peese = ssxy_peese / ssxx_peese;
  const b0_peese = naiveEffect - b1_peese * meanVar;

  // Calculate SE of intercept for PEESE (proper WLS)
  const residuals_peese = studies.map(s => s.effect - (b0_peese + b1_peese * s.var));
  const mse_peese = residuals_peese.reduce((sum, r, i) => sum + weights[i] * r * r, 0) / (k - 2);
  const sumWx2_peese = studies.reduce((sum, s, i) => sum + weights[i] * s.var * s.var, 0);
  const sumWx_peese = studies.reduce((sum, s, i) => sum + weights[i] * s.var, 0);
  const det_peese = sumW * sumWx2_peese - sumWx_peese * sumWx_peese;
  const se_b0_peese = Math.sqrt(mse_peese * sumWx2_peese / det_peese);

  // Conditional estimator: Use PET to test, PEESE to estimate
  const petSignificant = p_pet < 0.10;
  const conditionalEffect = petSignificant ? b0_peese : b0_pet;
  const conditionalLabel = petSignificant ? 'PEESE (true effect likely exists)' : 'PET (no evidence for true effect)';

  // Calculate percent reduction
  const reduction = ((naiveEffect - conditionalEffect) / naiveEffect * 100).toFixed(1);

  document.getElementById('petpeeseResults').innerHTML = `
    <div style="display:grid;grid-template-columns:repeat(3,1fr);gap:1rem;margin-bottom:1.5rem;">
      <div style="padding:1rem;background:rgba(59,130,246,0.2);border-radius:8px;text-align:center;">
        <div style="font-size:1.8rem;font-weight:bold;color:#3b82f6;">${naiveEffect.toFixed(3)}</div>
        <div style="font-size:0.85rem;">Naive (Uncorrected)</div>
      </div>
      <div style="padding:1rem;background:rgba(168,85,247,0.2);border-radius:8px;text-align:center;">
        <div style="font-size:1.8rem;font-weight:bold;color:#a855f7;">${b0_pet.toFixed(3)}</div>
        <div style="font-size:0.85rem;">PET Intercept</div>
        <div style="font-size:0.75rem;color:rgba(255,255,255,0.5);">p = ${p_pet.toFixed(3)}</div>
      </div>
      <div style="padding:1rem;background:rgba(236,72,153,0.2);border-radius:8px;text-align:center;">
        <div style="font-size:1.8rem;font-weight:bold;color:#ec4899;">${b0_peese.toFixed(3)}</div>
        <div style="font-size:0.85rem;">PEESE Intercept</div>
      </div>
    </div>

    <div style="padding:1.5rem;background:rgba(34,197,94,0.2);border:2px solid rgba(34,197,94,0.4);border-radius:12px;margin-bottom:1.5rem;">
      <div style="font-size:0.9rem;color:#4ade80;margin-bottom:0.5rem;">CONDITIONAL ESTIMATE (Recommended)</div>
      <div style="font-size:2.5rem;font-weight:bold;color:#22c55e;">${conditionalEffect.toFixed(3)}</div>
      <div style="font-size:0.9rem;margin-top:0.5rem;">${conditionalLabel}</div>
      <div style="font-size:0.85rem;color:rgba(255,255,255,0.6);margin-top:0.5rem;">
        Bias correction: ${reduction > 0 ? reduction + '% reduction' : Math.abs(reduction) + '% increase'} from naive estimate
      </div>
    </div>

    <div style="padding:1rem;background:rgba(0,0,0,0.2);border-radius:8px;font-size:0.9rem;">
      <strong>Interpretation:</strong><br>
      ${petSignificant
        ? `PET intercept is significant (p=${p_pet.toFixed(3)} < 0.10), suggesting a true effect exists after accounting for bias. Use PEESE estimate (${b0_peese.toFixed(3)}) as the bias-corrected effect.`
        : `PET intercept is not significant (p=${p_pet.toFixed(3)} >= 0.10), suggesting no reliable evidence for a true effect after accounting for publication bias. The apparent effect may be largely due to bias.`
      }
    </div>

    <div style="margin-top:1rem;padding:1rem;background:rgba(124,58,237,0.1);border-radius:8px;font-size:0.8rem;color:rgba(255,255,255,0.6);">
      <strong>Technical notes:</strong> PET-PEESE uses weighted least squares with inverse-variance weights. The two-step conditional estimator tests for true effect with PET (threshold p<0.10), then uses PEESE if effect exists. With ${k} studies, these estimates have ${k < 10 ? 'limited' : 'moderate'} reliability.
    </div>
  `;
}

// Simple t-distribution CDF approximation
function tCDF(t, df) {
  const x = df / (df + t * t);
  const a = df / 2;
  const b = 0.5;
  // Incomplete beta function approximation
  if (t < 0) return 0.5 * incompleteBeta(x, a, b);
  return 1 - 0.5 * incompleteBeta(x, a, b);
}

function incompleteBeta(x, a, b) {
  // Simple approximation using continued fraction
  const bt = Math.exp(
    lgamma(a + b) - lgamma(a) - lgamma(b) + a * Math.log(x) + b * Math.log(1 - x)
  );
  if (x < (a + 1) / (a + b + 2)) {
    return bt * betacf(x, a, b) / a;
  }
  return 1 - bt * betacf(1 - x, b, a) / b;
}

function betacf(x, a, b) {
  const maxIt = 100;
  const eps = 1e-8;
  let qab = a + b;
  let qap = a + 1;
  let qam = a - 1;
  let c = 1;
  let d = 1 - qab * x / qap;
  if (Math.abs(d) < 1e-30) d = 1e-30;
  d = 1 / d;
  let h = d;
  for (let m = 1; m <= maxIt; m++) {
    let m2 = 2 * m;
    let aa = m * (b - m) * x / ((qam + m2) * (a + m2));
    d = 1 + aa * d;
    if (Math.abs(d) < 1e-30) d = 1e-30;
    c = 1 + aa / c;
    if (Math.abs(c) < 1e-30) c = 1e-30;
    d = 1 / d;
    h *= d * c;
    aa = -(a + m) * (qab + m) * x / ((a + m2) * (qap + m2));
    d = 1 + aa * d;
    if (Math.abs(d) < 1e-30) d = 1e-30;
    c = 1 + aa / c;
    if (Math.abs(c) < 1e-30) c = 1e-30;
    d = 1 / d;
    let del = d * c;
    h *= del;
    if (Math.abs(del - 1) < eps) break;
  }
  return h;
}

function lgamma(x) {
  const c = [76.18009172947146, -86.50532032941677, 24.01409824083091,
    -1.231739572450155, 0.001208650973866179, -0.000005395239384953];
  let y = x;
  let tmp = x + 5.5;
  tmp -= (x + 0.5) * Math.log(tmp);
  let ser = 1.000000000190015;
  for (let j = 0; j < 6; j++) ser += c[j] / ++y;
  return -tmp + Math.log(2.5066282746310005 * ser / x);
}

// Registry Gap Tool (placeholder visualization)
function renderRegistryTool(containerId) {
  const container = document.getElementById(containerId);
  if (!container) return;

  container.innerHTML = `
    <div style="text-align:center;padding:2rem;">
      <div style="font-size:4rem;margin-bottom:1rem;">🔍</div>
      <h3 style="color:var(--gold);margin-bottom:1rem;">Registry Gap Analysis</h3>
      <p style="color:rgba(255,255,255,0.7);margin-bottom:2rem;">Compare registered vs. published trials to identify evidence gaps.</p>
      <div style="display:grid;grid-template-columns:1fr 1fr;gap:2rem;text-align:center;">
        <div style="padding:1.5rem;background:rgba(59,130,246,0.2);border-radius:12px;border:1px solid rgba(59,130,246,0.4);">
          <div style="font-size:2.5rem;font-weight:bold;color:#3b82f6;">23</div>
          <div>Registered Trials</div>
        </div>
        <div style="padding:1.5rem;background:rgba(22,163,74,0.2);border-radius:12px;border:1px solid rgba(22,163,74,0.4);">
          <div style="font-size:2.5rem;font-weight:bold;color:#22c55e;">15</div>
          <div>Published Results</div>
        </div>
      </div>
      <div style="margin-top:2rem;padding:1.5rem;background:rgba(220,38,38,0.2);border-radius:12px;border:1px solid rgba(220,38,38,0.4);">
        <div style="font-size:2rem;font-weight:bold;color:#dc2626;">8 Missing</div>
        <div>Trials completed but never published (35%)</div>
      </div>
      <p style="margin-top:1.5rem;font-size:0.9rem;color:rgba(255,255,255,0.5);">
        Search ClinicalTrials.gov for your intervention to identify potential missing studies.
      </p>
    </div>
  `;
}

// ============================================================
// CORE COURSE FUNCTIONALITY
// ============================================================
const STORAGE_KEY = 'publicationBiasDetective_v1';

let state = {
  currentModule: 0,
  currentSlide: 0,
  completedModules: [],
  certificateShown: false
};

function loadState() {
  try {
    const saved = localStorage.getItem(STORAGE_KEY);
    if (saved) state = { ...state, ...JSON.parse(saved) };
  } catch (e) {
    console.warn('Corrupt state, using defaults');
  }
}

function saveState() {
  localStorage.setItem(STORAGE_KEY, JSON.stringify(state));
}

function initCourse() {
  loadState();
  renderModuleList();
  renderSlide();
  updateProgress();

  // Keyboard navigation handled by setupKeyboardNavigation() — no duplicate listener here
}

function renderModuleList() {
  const list = document.getElementById('moduleList');
  list.innerHTML = modules.map((m, i) => `
    <div class="module-item ${i === state.currentModule ? 'active' : ''} ${state.completedModules.includes(i) ? 'completed' : ''}"
         onclick="goToModule(${i})">
      <div class="module-number">${i}</div>
      <div class="module-info">
        <div class="module-title">${m.title}</div>
        <div class="module-subtitle">${m.subtitle}</div>
        ${m.estimatedMinutes ? `<div class="module-time">${m.estimatedMinutes} min</div>` : ''}
      </div>
    </div>
  `).join('');
}

function renderSlide() {
  const module = modules[state.currentModule];
  const slide = module.slides[state.currentSlide];
  const container = document.getElementById('main-content');

  document.getElementById('moduleIndicator').textContent = `Case File ${module.id}: ${module.title}`;
  document.getElementById('slideCounter').textContent = `${state.currentSlide + 1} / ${module.slides.length}`;

  container.innerHTML = `<div class="slide active animate-in">${renderSlideContent(slide)}</div>`;

  document.getElementById('prevBtn').disabled = state.currentSlide === 0;
  document.getElementById('nextBtn').disabled = state.currentSlide === module.slides.length - 1;

  // Initialize tools
  setTimeout(() => {
    if (slide.type === 'tool-funnel') renderFunnelTool(slide.content.id);
    if (slide.type === 'tool-contour') renderContourTool(slide.content.id);
    if (slide.type === 'tool-egger') renderEggerTool(slide.content.id);
    if (slide.type === 'tool-trimfill') renderTrimFillTool(slide.content.id);
    if (slide.type === 'tool-petpeese') renderPetPeeseTool(slide.content.id);
    if (slide.type === 'tool-pcurve') renderPCurveTool(slide.content.id);
    if (slide.type === 'tool-registry') renderRegistryTool(slide.content.id);
    if (slide.type === 'tool-failsafe') renderFailsafeTool(slide.content.id);
  }, 100);
}

function renderSlideContent(slide) {
  switch(slide.type) {
    case 'title':
      const isMainTitle = slide.content.title === "Publication Bias Detective";
      const readingLevelHtml = isMainTitle ? `
        <div style="margin-top:1.5rem;">
          <span class="reading-level">Reading Level: Graduate/Professional</span>
        </div>
        <p style="font-size:0.85rem;color:rgba(255,255,255,0.5);margin-top:0.75rem;">
          Total Course Time: ~3 hours | Best for: Researchers, Clinicians, Systematic Reviewers
        </p>
      ` : '';
      return `<div style="text-align:center;padding:3rem;">
        <h1 class="slide-title" style="font-size:2.5rem;border:none;">${slide.content.title}</h1>
        <p style="font-size:1.3rem;color:var(--gold);margin-bottom:1.5rem;">${slide.content.subtitle}</p>
        <p style="font-size:1.1rem;opacity:0.8;max-width:600px;margin:0 auto;">${slide.content.text}</p>
        ${readingLevelHtml}
      </div>`;

    case 'principle':
      return `<div class="principle-display">
        <div class="principle-number">${slide.content.number}</div>
        <p class="principle-text">"${slide.content.text}"</p>
      </div>`;

    case 'rhetoric':
      return `<div class="rhetoric-question">${slide.content.question}</div>`;

    case 'case-file':
      return `<div class="case-file">
        <div class="case-file-header">
          <span class="case-number">${slide.content.caseNumber}</span>
          <div>
            <div class="case-title">${slide.content.title}</div>
            <div class="case-source">${slide.content.source}</div>
          </div>
        </div>
        <div class="evidence-timeline">
          ${slide.content.timeline.map(e => `
            <div class="timeline-event ${e.type || ''}">
              <div class="timeline-year">${e.year}</div>
              <div class="timeline-text">${e.text}</div>
            </div>
          `).join('')}
        </div>
        ${slide.content.realData ? `
          <div style="margin-top:1.5rem;padding:1rem;background:rgba(0,0,0,0.2);border-radius:8px;">
            <strong style="color:var(--gold);">Evidence Summary:</strong>
            <div style="display:grid;grid-template-columns:repeat(2,1fr);gap:0.5rem;margin-top:0.75rem;">
              ${Object.entries(slide.content.realData).map(([k,v]) => `
                <div><span style="color:rgba(255,255,255,0.6);">${k}:</span> ${v}</div>
              `).join('')}
            </div>
          </div>
        ` : ''}
      </div>`;

    case 'statistic-card':
      return `<div class="statistic-card">
        <div class="statistic-value">${slide.content.value}</div>
        <div class="statistic-label">${slide.content.label}</div>
        <div class="statistic-context">${slide.content.context}</div>
      </div>`;

    case 'death-toll':
      return `<div class="death-toll">
        <div class="death-toll-number">${slide.content.number}</div>
        <div class="death-toll-label">${slide.content.label}</div>
        <div class="death-toll-source">${slide.content.source}</div>
      </div>`;

    case 'oath':
      return `<div class="oath-box">
        <div class="oath-header">${slide.content.header}</div>
        <div class="oath-text">${slide.content.text}</div>
      </div>`;

    case 'contrast':
      return `<div>
        <h2 class="slide-title">${slide.content.title}</h2>
        <div class="contrast-box">
          <div class="contrast-side dark">
            <div class="contrast-header">${slide.content.darkSide.header}</div>
            <ul class="contrast-items">
              ${slide.content.darkSide.items.map(i => `<li>${i}</li>`).join('')}
            </ul>
            <div class="contrast-consequence">${slide.content.darkSide.consequence}</div>
          </div>
          <div class="contrast-side light">
            <div class="contrast-header">${slide.content.lightSide.header}</div>
            <ul class="contrast-items">
              ${slide.content.lightSide.items.map(i => `<li>${i}</li>`).join('')}
            </ul>
            <div class="contrast-consequence">${slide.content.lightSide.consequence}</div>
          </div>
        </div>
      </div>`;

    case 'content':
      return `<div>
        <h2 class="slide-title">${slide.content.title}</h2>
        ${slide.content.sections.map(s => `
          <div class="method-box">
            <h3>${s.heading}</h3>
            ${s.items ? `<ul>${s.items.map(i => `<li>${i}</li>`).join('')}</ul>` : ''}
          </div>
        `).join('')}
      </div>`;

    case 'decision-tree':
      return renderDecisionTree(slide.content);

    case 'clinical-guide':
      return `<div class="clinical-guide">
        <h3>${slide.content.title}</h3>
        <ul>${slide.content.items.map(i => `<li>${i}</li>`).join('')}</ul>
      </div>`;

    case 'cycle-return':
      return `<div class="cycle-return">
        <p style="font-size:0.8rem;color:var(--gold);text-transform:uppercase;margin-bottom:0.5rem;">Return to the Principle</p>
        <p class="principle-recall">"${slide.content.principle}"</p>
      </div>`;

    case 'quiz':
      return renderQuiz(slide.content);

    case 'tool-funnel':
    case 'tool-contour':
    case 'tool-egger':
    case 'tool-trimfill':
    case 'tool-pcurve':
    case 'tool-registry':
    case 'tool-failsafe':
    case 'tool-petpeese':
      return `<div class="tool-panel">
        <div class="tool-header">
          <span class="tool-icon">🔧</span>
          <span class="tool-title">${slide.content.title}</span>
        </div>
        <p class="tool-description">${slide.content.description}</p>
        <div id="${slide.content.id}"></div>
      </div>`;

    case 'learning-objectives':
      return `<div class="learning-objectives">
        <div class="learning-objectives-header">
          <span class="objectives-icon">🎯</span>
          <span>Learning Objectives</span>
        </div>
        <p style="margin-bottom:1rem;opacity:0.9;">${slide.content.intro || 'By the end of this module, you will be able to:'}</p>
        <ul>
          ${slide.content.objectives.map(obj => `<li>${obj}</li>`).join('')}
        </ul>
      </div>`;

    case 'key-takeaways':
      return `<div class="key-takeaways">
        <div class="key-takeaways-header">
          <span class="takeaways-icon">✅</span>
          <span>Key Takeaways</span>
        </div>
        <ul>
          ${slide.content.takeaways.map(t => `<li>${t}</li>`).join('')}
        </ul>
        ${slide.content.actionItem ? `
          <div class="action-item">
            <strong>Action Item:</strong> ${slide.content.actionItem}
          </div>
        ` : ''}
      </div>`;

    case 'common-mistakes':
      return `<div class="common-mistakes">
        <div class="mistakes-header">
          <span class="mistakes-icon">⚠️</span>
          <span>Common Mistakes to Avoid</span>
        </div>
        <ul>
          ${slide.content.mistakes.map(m => `<li><strong>${m.mistake}:</strong> ${m.correction}</li>`).join('')}
        </ul>
      </div>`;

    case 'patient-communication':
      return `<div class="patient-communication">
        <div class="communication-header">
          <span class="communication-icon">💬</span>
          <span>Patient Communication Script</span>
        </div>
        <div class="scenario">${slide.content.scenario}</div>
        <div class="script-box">
          <div class="script-label">What to say:</div>
          <div class="script-text">"${slide.content.script}"</div>
        </div>
        ${slide.content.keyPoints ? `
          <div class="key-points">
            <strong>Key communication points:</strong>
            <ul>${slide.content.keyPoints.map(p => `<li>${p}</li>`).join('')}</ul>
          </div>
        ` : ''}
      </div>`;

    case 'protagonist-story':
      return `<div class="protagonist-story">
        <div class="protagonist-header">
          <div class="protagonist-name">${slide.content.name}</div>
          <div class="protagonist-role">${slide.content.role}</div>
        </div>
        <div class="protagonist-narrative">${slide.content.narrative}</div>
        ${slide.content.quote ? `
          <blockquote class="protagonist-quote">"${slide.content.quote}"</blockquote>
        ` : ''}
        ${slide.content.impact ? `
          <div class="protagonist-impact">
            <strong>Impact:</strong> ${slide.content.impact}
          </div>
        ` : ''}
      </div>`;

    case 'legal-disclaimer':
      return `<div class="legal-disclaimer">
        <div class="disclaimer-header">
          <span class="disclaimer-icon">⚖️</span>
          <span>Important Legal Notice</span>
        </div>
        <div class="disclaimer-text">${slide.content.text}</div>
        ${slide.content.resources ? `
          <div class="disclaimer-resources">
            <strong>Resources:</strong>
            <ul>${slide.content.resources.map(r => `<li><a href="${r.url}" target="_blank">${r.name}</a></li>`).join('')}</ul>
          </div>
        ` : ''}
      </div>`;

    case 'printable-checklist':
      return `<div class="printable-checklist">
        <div class="checklist-header">
          <span class="checklist-icon">📋</span>
          <span>${slide.content.title}</span>
        </div>
        <p class="print-instruction">Print this checklist to use when reading meta-analyses</p>
        ${slide.content.sections.map(section => `
          <div class="checklist-section">
            <h4>${section.heading}</h4>
            <ul>
              ${section.items.map(item => `<li><input type="checkbox" class="checklist-box"> ${item}</li>`).join('')}
            </ul>
          </div>
        `).join('')}
        <button class="print-btn" onclick="window.print()">🖨️ Print Checklist</button>
      </div>`;

    case 'practice-case':
      return `<div class="practice-case">
        <div class="practice-header">
          <span class="practice-icon">🔬</span>
          <span>Practice Case: ${slide.content.title}</span>
        </div>
        <div class="case-scenario">${slide.content.scenario}</div>
        ${slide.content.data ? `
          <div class="sample-data">
            <h4>Sample Data:</h4>
            <table class="data-table">
              <thead><tr>${slide.content.data.headers.map(h => `<th>${h}</th>`).join('')}</tr></thead>
              <tbody>${slide.content.data.rows.map(row => `<tr>${row.map(cell => `<td>${cell}</td>`).join('')}</tr>`).join('')}</tbody>
            </table>
          </div>
        ` : ''}
        <div class="practice-questions">
          <h4>Questions to consider:</h4>
          <ol>${slide.content.questions.map(q => `<li>${q}</li>`).join('')}</ol>
        </div>
        ${slide.content.answers ? `
          <details class="answers-reveal">
            <summary>Reveal Answers</summary>
            <ol>${slide.content.answers.map(a => `<li>${a}</li>`).join('')}</ol>
          </details>
        ` : ''}
      </div>`;

    case 'pre-assessment':
      return `<div class="pre-assessment">
        <div class="assessment-header">
          <span class="assessment-icon">📝</span>
          <span>Pre-Assessment: Test Your Current Knowledge</span>
        </div>
        <p>${slide.content.intro}</p>
        <div id="preAssessmentQuiz"></div>
      </div>`;

    case 'redemption-story':
      return `<div class="redemption-story">
        <div class="redemption-header">
          <span class="redemption-icon">🌟</span>
          <span>A Different Path: ${slide.content.title}</span>
        </div>
        <div class="redemption-narrative">${slide.content.narrative}</div>
        <div class="redemption-lesson">
          <strong>The Lesson:</strong> ${slide.content.lesson}
        </div>
      </div>`;

    case 'story':
      return `<div class="story-container">
        <div class="story-opening">${slide.content.opening}</div>

        <div style="display:flex;align-items:center;gap:1rem;margin-bottom:1.5rem;">
          <span style="background:var(--evidence-red);color:white;padding:0.5rem 1rem;border-radius:4px;font-weight:700;font-size:0.8rem;text-transform:uppercase;">Story ${slide.content.storyNumber}</span>
          <div>
            <h2 style="font-family:'Cormorant Garamond',serif;font-size:1.8rem;color:var(--gold);margin:0;">${slide.content.title}</h2>
            <p style="font-size:0.85rem;color:rgba(255,255,255,0.6);margin:0;">${slide.content.caseId}</p>
          </div>
        </div>

        <div class="stats-box">
          <div class="stats-box-header">
            <span style="font-size:1.2rem;">📊</span>
            ${slide.content.stats.header}
          </div>
          ${slide.content.stats.items.map(item => `
            <div class="stat-item">
              <div class="stat-value">${item.value}</div>
              <div class="stat-label">${item.label}</div>
            </div>
          `).join('')}
        </div>

        <div class="interactive-decision-tree">
          <div class="decision-scenario">
            <div class="decision-scenario-title">${slide.content.scenario.title}</div>
            <p style="margin:0;line-height:1.7;">${slide.content.scenario.text}</p>
          </div>

          <div class="decision-path path-a" tabindex="0" role="button" onclick="this.classList.toggle('expanded')" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.classList.toggle('expanded');}">
            <div class="path-header">
              <span style="font-size:1.2rem;">❌</span>
              ${slide.content.pathA.header}
              <span class="path-arrow">→</span>
            </div>
            <p style="margin:0.5rem 0;font-style:italic;color:rgba(255,255,255,0.8);">${slide.content.pathA.action}</p>
            <div class="story-timeline" style="margin:1rem 0;">
              ${slide.content.pathA.steps.map((step, i) => `
                <div class="timeline-step ${i === slide.content.pathA.steps.length - 1 ? 'danger' : ''}">
                  <div class="step-label">Step ${i + 1}</div>
                  <div class="step-content">${step}</div>
                </div>
              `).join('')}
            </div>
            <div class="path-consequence">
              <strong style="color:#fca5a5;">Consequence:</strong> ${slide.content.pathA.consequence}
            </div>
          </div>

          <div class="decision-path path-b" tabindex="0" role="button" onclick="this.classList.toggle('expanded')" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.classList.toggle('expanded');}">
            <div class="path-header">
              <span style="font-size:1.2rem;">✓</span>
              ${slide.content.pathB.header}
              <span class="path-arrow">→</span>
            </div>
            <p style="margin:0.5rem 0;font-style:italic;color:rgba(255,255,255,0.8);">${slide.content.pathB.action}</p>
            <div class="story-timeline" style="margin:1rem 0;">
              ${slide.content.pathB.steps.map((step, i) => `
                <div class="timeline-step ${i === slide.content.pathB.steps.length - 1 ? 'success' : ''}">
                  <div class="step-label">Step ${i + 1}</div>
                  <div class="step-content">${step}</div>
                </div>
              `).join('')}
            </div>
            <div class="path-consequence">
              <strong style="color:#86efac;">Consequence:</strong> ${slide.content.pathB.consequence}
            </div>
          </div>
        </div>

        <div class="revelation-box">
          <div class="revelation-header">✦ ${slide.content.revelation.header} ✦</div>
          <p class="revelation-text">${slide.content.revelation.text}</p>
          <p class="revelation-detail">${slide.content.revelation.detail}</p>
        </div>

        <div class="story-refrain">
          <p>"${slide.content.refrain}"</p>
        </div>
      </div>`;

    default:
      return `<p>Unknown slide type: ${slide.type}</p>`;
  }
}

// Store current decision tree nodes to avoid XSS risk from inline JSON
let currentDecisionNodes = [];

function renderDecisionTree(content) {
  // Store nodes in module-level variable for safe access
  currentDecisionNodes = content.nodes;
  return `<div class="decision-tree">
    <div class="decision-title">${content.title}</div>
    <div class="decision-situation">${content.situation}</div>
    <div id="decisionContent" aria-live="polite" aria-atomic="true">${renderDecisionNode(content.nodes[0])}</div>
  </div>`;
}

function renderDecisionNode(node) {
  if (node.type === 'outcome') {
    return `<div class="decision-outcome ${node.consequence}">
      <div class="outcome-title">${node.title}</div>
      <div class="outcome-text">${node.text}</div>
      <div class="outcome-case">${node.realCase}</div>
    </div>`;
  }

  return `<div class="decision-node">
    <div class="decision-question">${node.question}</div>
    <div class="decision-branches">
      ${node.branches.map(b => `
        <button class="decision-branch" data-next-node="${b.nextNode}" onclick="selectDecisionBranch(this.dataset.nextNode)" tabindex="0">
          ${b.text}
        </button>
      `).join('')}
    </div>
  </div>`;
}

function selectDecisionBranch(nodeId) {
  const node = currentDecisionNodes.find(n => n.id === nodeId);
  if (node) {
    document.getElementById('decisionContent').innerHTML = renderDecisionNode(node);
  }
}

function renderQuiz(content) {
  const quizKey = `${state.currentModule}-${state.currentSlide}`;
  return `<div class="quiz-container">
    <div class="quiz-question">${content.question}</div>
    <div class="quiz-options">
      ${content.options.map(opt => `
        <div class="quiz-option" data-id="${opt.id}" onclick="selectQuizOption('${opt.id}', ${opt.correct}, this)">
          ${opt.text}
        </div>
      `).join('')}
    </div>
    <div class="quiz-explanation">${content.explanation}</div>
  </div>`;
}

function selectQuizOption(id, correct, element) {
  document.querySelectorAll('.quiz-option').forEach(o => {
    o.style.pointerEvents = 'none';
    const module = modules[state.currentModule];
    const slide = module.slides[state.currentSlide];
    const opt = slide.content.options.find(op => op.id === o.dataset.id);
    if (opt?.correct) o.classList.add('correct');
  });
  if (!correct) element.classList.add('incorrect');
  document.querySelector('.quiz-explanation').classList.add('visible');
}

function prevSlide() {
  if (state.currentSlide > 0) {
    state.currentSlide--;
    renderSlide();
    saveState();
  }
}

function nextSlide() {
  const module = modules[state.currentModule];
  if (state.currentSlide < module.slides.length - 1) {
    state.currentSlide++;
    renderSlide();
    saveState();
    checkCourseCompletion();
  }
}

function goToModule(index) {
  if (index !== state.currentModule) {
    if (state.currentSlide === modules[state.currentModule].slides.length - 1 &&
        !state.completedModules.includes(state.currentModule)) {
      state.completedModules.push(state.currentModule);
    }
    state.currentModule = index;
    state.currentSlide = 0;
    renderModuleList();
    renderSlide();
    updateProgress();
    saveState();
  }
}

function updateProgress() {
  const percent = Math.round((state.completedModules.length / modules.length) * 100);
  document.getElementById('progressPercent').textContent = `${percent}%`;
  document.getElementById('progressFill').style.width = `${percent}%`;
}

function openGlossary() {
  document.getElementById('glossaryOverlay').classList.add('open');
  renderGlossary();
}

function closeGlossary() {
  document.getElementById('glossaryOverlay').classList.remove('open');
}

function renderGlossary(filter = '') {
  const filtered = glossaryTerms.filter(t =>
    t.term.toLowerCase().includes(filter.toLowerCase()) ||
    t.def.toLowerCase().includes(filter.toLowerCase())
  );
  document.getElementById('glossaryContent').innerHTML = filtered.map(t => `
    <div class="glossary-term">
      <strong style="color:var(--gold);">${t.term}</strong><br>
      <span style="color:rgba(255,255,255,0.7);">${t.def}</span>
    </div>
  `).join('');
}

function filterGlossary() {
  renderGlossary(document.getElementById('glossarySearch').value);
}

// ============================================================
// THEME TOGGLE (Dark/Light Mode)
// ============================================================
function toggleTheme() {
  const body = document.body;
  const toggle = document.getElementById('themeToggle');
  const isLight = body.classList.toggle('light-mode');
  toggle.textContent = isLight ? '☀️' : '🌙';
  toggle.setAttribute('aria-label', isLight ? 'Switch to dark mode' : 'Switch to light mode');
  localStorage.setItem('pubBiasTheme', isLight ? 'light' : 'dark');
}

function loadTheme() {
  const saved = localStorage.getItem('pubBiasTheme');
  if (saved === 'light') {
    document.body.classList.add('light-mode');
    document.getElementById('themeToggle').textContent = '☀️';
  }
}

// ============================================================
// CERTIFICATE OF COMPLETION
// ============================================================
function checkCourseCompletion() {
  // Check if all modules are completed
  if (state.completedModules.length >= modules.length - 1) {
    // Check if on last slide of last module
    const lastModule = modules[modules.length - 1];
    if (state.currentModule === modules.length - 1 &&
        state.currentSlide === lastModule.slides.length - 1 &&
        !state.certificateShown) {
      state.certificateShown = true;
      saveState();
      setTimeout(() => {
        document.getElementById('nameInputModal').classList.add('open');
        document.getElementById('investigatorName').focus();
      }, 1000);
    }
  }
}

function generateCertificate() {
  const name = document.getElementById('investigatorName').value.trim();
  if (!name) {
    alert('Please enter your name to generate the certificate.');
    return;
  }

  // Close name input modal
  document.getElementById('nameInputModal').classList.remove('open');

  // Generate certificate ID
  const certId = 'PBD-' + Date.now().toString(36).toUpperCase() + Math.random().toString(36).substr(2, 4).toUpperCase();

  // Format date
  const date = new Date().toLocaleDateString('en-US', {
    year: 'numeric',
    month: 'long',
    day: 'numeric'
  });

  // Update certificate
  document.getElementById('certName').textContent = name;
  document.getElementById('certDate').textContent = `Completed on: ${date}`;
  document.getElementById('certId').textContent = `Certificate ID: ${certId}`;

  // Show certificate
  document.getElementById('certificateOverlay').classList.add('open');
}

function closeCertificate() {
  document.getElementById('certificateOverlay').classList.remove('open');
}

function printCertificate() {
  const cert = document.getElementById('certificateContainer');
  const printWindow = window.open('', '_blank');
  printWindow.document.write(`
    <!DOCTYPE html>
    <html>
    <head>
      <title>Publication Bias Detective - Certificate</title>
      <link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:wght@400;600;700&family=Source+Sans+Pro:wght@400;600&display=swap" rel="stylesheet">
      <style>
        body {
          margin: 0; padding: 2rem;
          font-family: 'Source Sans Pro', sans-serif;
          display: flex; justify-content: center; align-items: center;
          min-height: 100vh; background: #f5f5f5;
        }
        .cert {
          background: linear-gradient(135deg, #fdf6e3 0%, #fff8dc 50%, #fdf6e3 100%);
          border: 8px double #d4af37;
          border-radius: 12px;
          padding: 3rem;
          max-width: 700px;
          text-align: center;
          position: relative;
        }
        .seal {
          position: absolute; top: -30px; left: 50%;
          transform: translateX(-50%);
          width: 60px; height: 60px;
          background: linear-gradient(135deg, #d4af37, #c5a028);
          border-radius: 50%;
          display: flex; align-items: center; justify-content: center;
          font-size: 1.8rem;
        }
        h1 {
          font-family: 'Cormorant Garamond', serif;
          font-size: 2.5rem; color: #1e3a5f;
          text-transform: uppercase; letter-spacing: 0.15em;
          margin-top: 1rem;
        }
        .subtitle { color: #666; margin-bottom: 1.5rem; }
        .body { font-size: 1.1rem; color: #333; line-height: 1.8; margin: 1.5rem 0; }
        .name {
          font-family: 'Cormorant Garamond', serif;
          font-size: 2rem; font-weight: 700; color: #991b1b;
          border-bottom: 2px solid #d4af37;
          display: inline-block; padding: 0 2rem 0.5rem; margin: 1rem 0;
        }
        .date { font-size: 0.9rem; color: #666; margin-top: 1.5rem; }
        .id { font-size: 0.75rem; color: #999; margin-top: 0.5rem; font-family: monospace; }
        @media print {
          body { background: white; }
          .cert { box-shadow: none; }
        }
      </style>
    </head>
    <body>
      <div class="cert">
        <div class="seal">🏆</div>
        <h1>Certificate of Completion</h1>
        <p class="subtitle">Publication Bias Detective Training Program</p>
        <div class="body">
          <p>This is to certify that</p>
          <div class="name">${document.getElementById('certName').textContent}</div>
          <p>has successfully completed the</p>
          <p><strong style="color: #1e3a5f; font-size: 1.2rem;">Publication Bias Detective Course</strong></p>
          <p>demonstrating proficiency in identifying, assessing, and mitigating publication bias in systematic reviews and meta-analyses.</p>
        </div>
        <div class="date">${document.getElementById('certDate').textContent}</div>
        <div class="id">${document.getElementById('certId').textContent}</div>
      </div>
    </body>
    </html>
  `);
  printWindow.document.close();
  setTimeout(() => printWindow.print(), 500);
}

// ============================================================
// PDF EXPORT FOR CHECKLIST
// ============================================================
function exportChecklistPDF() {
  const checklistContent = `
PUBLICATION BIAS DETECTION CHECKLIST
=====================================

BEFORE STARTING
[ ] Registered protocol (PROSPERO) with bias assessment plan
[ ] Pre-specified primary outcome
[ ] Comprehensive search strategy including grey literature

SEARCH EXECUTION
[ ] Multiple databases (PubMed, Embase, Cochrane, etc.)
[ ] ClinicalTrials.gov + WHO ICTRP for registered trials
[ ] Conference abstracts and dissertations
[ ] Contact authors for unpublished data
[ ] No language restrictions (or justify if restricted)

VISUAL ASSESSMENT
[ ] Funnel plot (if ≥10 studies)
[ ] Contour-enhanced funnel plot
[ ] Doi plot with LFK index

STATISTICAL TESTS
[ ] Egger's test (continuous outcomes)
[ ] Harbord's or Peters' test (binary outcomes)
[ ] Begg's rank correlation
[ ] Document: k = ___, Egger p = ___

SENSITIVITY ANALYSES
[ ] Trim-and-fill (report adjusted estimate)
[ ] PET-PEESE (report conditional estimate)
[ ] Selection models (3PSM if available)
[ ] Compare with registered trial results

REPORTING
[ ] PRISMA flow diagram with reasons for exclusion
[ ] Table comparing published vs. unpublished studies
[ ] GRADE assessment for publication bias
[ ] Plain-language summary of bias impact

INTERPRETATION TEMPLATE
"Publication bias assessment: [Visual inspection / Statistical tests]
[suggested / did not suggest] the presence of small-study effects.
Sensitivity analyses [adjusted the pooled estimate from X to Y /
did not substantially change the results]. The certainty of evidence
was [downgraded / not downgraded] for publication bias."
`;

  // Create and download text file
  const blob = new Blob([checklistContent], { type: 'text/plain' });
  const link = document.createElement('a');
  link.href = URL.createObjectURL(blob);
  link.download = 'publication-bias-checklist.txt';
  link.click();
  URL.revokeObjectURL(link.href);
}

// ============================================================
// SERVICE WORKER FOR OFFLINE ACCESS
// ============================================================
function registerServiceWorker() {
  if ('serviceWorker' in navigator) {
    window.addEventListener('load', () => {
      // Create inline service worker
      const swCode = `
const CACHE_NAME = 'pub-bias-detective-v1';
const urlsToCache = [
  './',
  './publication-bias-detective.html'
];

self.addEventListener('install', event => {
  event.waitUntil(
    caches.open(CACHE_NAME)
      .then(cache => cache.addAll(urlsToCache))
  );
});

self.addEventListener('fetch', event => {
  event.respondWith(
    caches.match(event.request)
      .then(response => {
        if (response) return response;
        return fetch(event.request).then(response => {
          if (!response || response.status !== 200) return response;
          const responseToCache = response.clone();
          caches.open(CACHE_NAME).then(cache => {
            cache.put(event.request, responseToCache);
          });
          return response;
        });
      })
  );
});
`;

      const blob = new Blob([swCode], { type: 'application/javascript' });
      const swUrl = URL.createObjectURL(blob);

      navigator.serviceWorker.register(swUrl)
        .then(reg => console.log('Service Worker registered for offline access'))
        .catch(err => console.log('Service Worker registration skipped:', err.message));
    });
  }
}

// ============================================================
// KEYBOARD NAVIGATION ENHANCEMENT
// ============================================================
function setupKeyboardNavigation() {
  document.addEventListener('keydown', (e) => {
    // Arrow key navigation for slides
    if (e.key === 'ArrowRight' || e.key === 'ArrowDown') {
      if (!e.target.matches('input, textarea, select')) {
        nextSlide();
      }
    } else if (e.key === 'ArrowLeft' || e.key === 'ArrowUp') {
      if (!e.target.matches('input, textarea, select')) {
        prevSlide();
      }
    } else if (e.key === 'Escape') {
      closeGlossary();
      closeCertificate();
      document.getElementById('nameInputModal').classList.remove('open');
    }
  });

  // Make module items keyboard focusable
  document.querySelectorAll('.module-item').forEach((item, index) => {
    item.setAttribute('tabindex', '0');
    item.setAttribute('role', 'button');
    item.addEventListener('keydown', (e) => {
      if (e.key === 'Enter' || e.key === ' ') {
        e.preventDefault();
        goToModule(index);
      }
    });
  });
}

// ============================================================
// SCORM/LMS COMPATIBILITY WRAPPER
// ============================================================
const SCORM = {
  initialized: false,

  init: function() {
    // Check for SCORM API
    if (typeof window.API !== 'undefined' || typeof window.API_1484_11 !== 'undefined') {
      const api = window.API_1484_11 || window.API;
      if (api) {
        api.Initialize('');
        this.initialized = true;
        // SCORM API initialized
      }
    }
    return this.initialized;
  },

  setProgress: function(percent) {
    if (!this.initialized) return;
    const api = window.API_1484_11 || window.API;
    if (api) {
      api.SetValue('cmi.progress_measure', (percent / 100).toFixed(2));
      api.Commit('');
    }
  },

  setComplete: function() {
    if (!this.initialized) return;
    const api = window.API_1484_11 || window.API;
    if (api) {
      api.SetValue('cmi.completion_status', 'completed');
      api.SetValue('cmi.success_status', 'passed');
      api.Commit('');
    }
  },

  terminate: function() {
    if (!this.initialized) return;
    const api = window.API_1484_11 || window.API;
    if (api) {
      api.Terminate('');
    }
  }
};

// Hook SCORM into progress updates
const originalUpdateProgress = updateProgress;
updateProgress = function() {
  originalUpdateProgress();
  const percent = Math.round((state.completedModules.length / modules.length) * 100);
  SCORM.setProgress(percent);
  if (percent >= 100) {
    SCORM.setComplete();
  }
};

// Initialize on page load
document.addEventListener('DOMContentLoaded', () => {
  loadTheme();
  SCORM.init();
  registerServiceWorker();
  setTimeout(setupKeyboardNavigation, 100);
});

// Terminate SCORM on page unload
window.addEventListener('beforeunload', () => {
  SCORM.terminate();
});

document.addEventListener('DOMContentLoaded', initCourse);
</script>
<!-- Floating Glossary Button (visible on mobile) -->
<button aria-label="Open Glossary" class="floating-glossary" onclick="openGlossary()">
  📖
</button>
</body>
</html>
